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Abbreviations 
Ac      acetyl 
Boc     tert–butoxycarbonyl 
brsm     base on recovered starting material 
Cu                  copper 
DIPEA          diisopropylethylamine 
DMAP     4-(dimethylamino)pyridine  
DMF     N,N-dimethylformamide 
DMSO     dimethyl sulfoxide 
DCE     1,2-dichloroethane 
DCM     dichloromethane 
IBX     2-iodoxybenzoic acid 
KIE     Kinetic Isotope Effect 
LAH     lithium aluminum hydride 
LDA     lithium diisopropylamide 
Min     minute(s) 
Mo                  molybdenum 
MPO     4-methoxypyridine N-oxide 
NMP     N-methylpyrrolidone, 
Pd                  palladium 
RT      room temperature 
Rh      rhodium 
TBS          tert-butyldimethylsilyl 
TEA     triethylamine 
THF     tetrahydrofuranyl 
TLC     thin-layer chromatography 
Ts      4-toluenesulfonyl 
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Abstract 
 
1. Palladium–Catalyzed Oxirane–Opening Reaction with Arenes via C–H Bond Activation1) 
In the past several decades, palladium–
catalyzed C–H bond transformations have 
been developed dramatically. For example, 
coupling reactions of aromatic compounds 
with organohalides and organometallic 
reagents, insertion reactions of unsaturated 
molecules, such as acrylates, into a C–H 
bond of aromatic substrates, and introduction of heteroatom functionalities into aromatic 
compounds were reported. There is no report, however, about palladium–catalyzed coupling 
reaction between aromatic substrates and strained compounds via C–H bond activation.  
I focused on oxiranes as a coupling partner because, to the best of my knowledge, there is no 
report on transition metal–catalyzed intermolecular direct C–H bond transformations using 
oxiranes as substrates. As a result of investigations, I succeeded to develop palladium–catalyzed 
C−H activation/C−C coupling reaction between arenes and oxiranes. The reaction proceeded at 
room temperature with high functional group tolerance, and the products were obtained in good 
to excellent yields, even in gram scale. By using N–methoxybenzamide as a substrate, I obtained 
3–substituted isochroman–1–ones. The coupling reaction proceeded with stereoretention. KIE 
experiments suggested that C–H bond activation is the rate–determining step. 
 
2. Copper–Catalyzed Intramolecular C(sp3)–H and C(sp2)–H Amidation by Oxidative 
Cyclization
2)
 
   I developed the first 
example of copper–catalyzed 
intramolecular C(sp
3
)–H and 
C(sp
2
)–H amidation. The 
reaction is also the first example 
of first row transition metal–
catalyzed carbon–heteroatom bond formation. The reaction has broad substrate scope, and 
Abstract 
5 
 
synthetically useful β–lactams were obtained from quinolyl amides in excellent yields, even in 
gram–scale. The reaction proceeded at a terminal methyl group as well as the internal benzylic 
position of an alkyl chain. By slightly modifying the reaction conditions, the reaction pathway 
switched to C(sp
2
)–H amidation for a specific substrate, and 2–indolinone was selectively 
produced in high yield. Since the quinolyl directing group could be removed by oxidation, this 
reaction must become a useful method to synthesize β–lactams and 2–indolinones. 
 
3. Copper–Mediated C(sp3)–H and C(sp2)–H Acetoxylation3) 
I developed the first example of a 
copper–mediated intermolecular 
acetoxylation via C(sp
3
)–H activation. This 
reaction is also the first-row transition 
metal–mediated intermolecular carbon–
heteroatom bond formation. The reaction 
absolutely proceeded at the β-methyl group. The seric effect played an important role in the 
distribution of the products. This reaction has high functional group tolerance, and the reaction 
proceeded in excellent yield, even in gram–scale, for a complicated compound. The directing 
group can be removed by oxidation using a 5–methoxyquinolyl group as a directing group. This 
acetoxylation can be applied to a complex molecule, which will lead to late–stage 
functionalization. Deuterium labeling experiments suggested that the C(sp
3
)–H bond activation 
step is not the rate–determining step, which is different from copper–catalyzed intramolecular 
C(sp
3
)–H amidation. Aromatic C(sp2)–H acetoxylation also proceeded under the similar reaction 
conditions.  
 
4. Copper–Catalyzed Intramolecular N–S Bond Formation4) 
 
Abstract 
6 
 
Copper–catalyzed 
synthesis of 
benzo[d]isothiazol–
3(2H)–ones and N–
acylbenzothiazetidine 
by intramolecular 
dehydrogenative 
cyclization is developed. 
The reaction proceeded 
under oxygen 
atmosphere with 0.3% 
CuI, and without any 
additives. In this reaction, a new nitrogen–sulfur (N–S) bond is formed by N–H/S–H coupling. 
The present reaction has high functional group tolerance and gives products in gram scale. This 
method promotes double cyclization, allowing for synthesis of a drug intermediate, which can be 
used to synthesize anti–inflammatory drugs. 
 
5. Molybdenum–Mediated Desulfurization of Thiols and Disulfides5) 
Mo(CO)6–mediated desulfurization of thiols and 
disulfides was realized. In this reaction, the mercapto groups 
of aryl, benzyl, and primary and secondary alkyl thiols; and 
S–S single bonds of disulfides could be removed. This reaction has high functional group 
tolerance. In addition, the desulfurization reaction was not affected by steric hindrance. The 
results of the reactions in acetone–d6 suggested that the hydrogen sources in thiol and disulfide 
desulfurization were the hydrogen atom(s) of an SH group and acetone (solvent), respectively, 
and the desulfurization reaction proceeded via the formation of an organomolybdenum species. 
 
References:  
1) Wang, Z.; Kuninobu, Y.; Kanai, M. J. Am. Chem. Soc. 2015, 137, 6140.  
2) Wang, Z.; Ni, J.; Kuninobu, Y.; Kanai, M. Angew. Chem. Int. Ed. 2014, 53, 3496.  
3) Wang, Z.; Kuninobu, Y.; Kanai, M. Org. Lett. 2014, 16, 4790. 
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4) Wang, Z.; Kuninobu, Y.; Kanai, M. J. Org. Chem. 2013, 78, 7337. 
5) Wang, Z.; Kuninobu, Y.; Kanai, M. Synlett 2014, 25, 1869. 
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Introduction for Projects 1-3 
 
Total synthesis of natural products is one of the most important research areas of organic 
chemistry, and is the fusion of science and art on the molecular level. Total synthesis of natural 
products has not only an important theoretical and practical significance for the development of 
chemistry itself, but also a positive strategic significance to improve the capability of an 
independent innovation in a drug development, to protect the ecological resource and 
environment, and to train professional organic chemists.  
 
Total synthesis of natural products has a long history. As showed in Figure 1, in 1821, 
Wöhler firstly synthesized urea from an inorganic substance (ammonium cyanate) in his labratory, 
therefore, it can be said that he created a new era of organic synthesis. In 1845, Kolbe 
synthesized acetic acid from inorganic compounds for the first time. In 1903, Gustav Kangpa 
synthesized camphor, which is the first example of industrialization. In 1902, the German chemist 
Willstätter synthesized tropine ketones, symbolizing the beginning of multi–step organic 
syntheses. In 1916, Robinson implemented and biomimetically synthesized tropine ketones, 
which was not only a big step in alkaloid chemistry but also showed that tandem reactions in a 
one–pot synthesis are capable of forming bicyclic molecules. In 1992, the Japanese chemist 
Introduction for Project 1~3 
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Yoshito Kishi synthesized palytoxins, which inspired synthetic chemists that all natural products 
could be synthesize in the labrotary, from then on. 
There are also some famous naturally derived drugs, which were synthesized by some groups 
(Figure 2). In 1950, Woodward synthesized quinine, and at that time, he proposed the conception 
of total synthesis. Morphine was synthesized by Gates in 1956. As the development of synthetic 
strategy and methods, chemists spent a shorter time to finish the total synthesis of complex 
natural products. Total synthesis of quinine and morphine took for more than 100 years from the 
isolation, but only 30 years were needed for the total synthesis of palitaxol and penicillin. 
However, the way to obtain commercially available molecules is extraction of the compounds 
from natural sources rather than total synthesis of the molecules.  
 
 
 
At present, challenging the complexity of single molecule is not the mainstream of modern 
organic synthesis, but synthetic chemists move their attention to collective total synthesis and 
build a molecule library. On the other hand, discovering new reactions and strategies to improve 
the efficiency of total synthesis is another urgent task. After I joined Kanai’s lab, I focus on 
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developing new methods and designing new strategies to efficiently synthesize duocarmycin 
family natural products.  
   Duocarmycin family natural products, alkaloids, were isolated from Streptomyces bacteria in 
1988 (Figure 3).
1
 These molecules can bind to the minor groove of DNA and alkylate the 
nucleobase adenine at the N3 position. The irreversible alkylation of DNA disrupts the nucleic 
acid architecture, which eventually leads to tumor cell death. A mechanism of the action of 
duocarmycins is different from that of tubulin binders, such as taxol and vinblastine. Boger and 
other groups created a better understanding of the pharmacophore and mechanism of action of 
duocarmycins.
2 
 
 
 
At present, there are several reports on the total synthesis of duodarmycins. However, the 
routes for the synthesis of duocarmycin are long and inefficiently. Fukuyama used the longest 
linear 25 steps to complete the total synthesis of duocarmycin A from commercially available 
compounds.
3 
As showed in Scheme 1, Fukuyama started his total synthesis from compound I1 
with 2 bromo atoms and 1 iodo atom, which can be prepared from commercially available 
compounds in 4 steps. Using 1,4–addition reaction, the first stereocenter was introduced and 
compound I2 was obtained. Then the unnecessary chain was removed using 2 steps to give 
aldehyde I4. A formyl group of coumound I4 was reduced to produce alcohol I5. A nitro group of 
I5 was selectively reduced and protected in 4 steps, and N-benzylamine I9 was obtained. The first 
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indolene structure of Duocarmycin was constructed by intramolecular Ullman coupling reaction, 
and successive protection of the hydroxy group of alcohol I10 to give dihydroindole I11. Then I11 
was coupled with oxazolone I12, and the second sterocenter of Duocarmycin was introduced. 
Selective introduction of a bromo atom to the formed I13, and the second indolene structure of 
Duocarmycin was constructed by successive Ullman coupling reaction to give tricyclo compound 
I15. The N-benzyl protecting group of I15 was selectively removed in 2 steps, and compound I17 
was prepared. Duocarmycin A was synthesized in 5 steps from compound I17. In this route, the 
author took many steps to adjust the oxidation states, to selectively introduce functional groups, 
and to manipulate many protecting groups. These factors made this route inefficient.  
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In order to develop an efficiently route for the synthesis of duocarmycin family natural 
products, I designed a new strategy based on developing new methods. The key reactions are 
catalytic triple intramolecular C–H amidation followed by dehydrogenation and transition–metal–
Introduction for Project 1~3 
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catalyzed oxirane–opening reaction with arenes via C–H activation (Scheme 2). The detailed 
background of each method will be summarized in the Introduction section of each project. 
 
 
 
References: 
1 (a) Yasuzawa, T.; Iida, T.; Muroi, K.; Ichimura, M.; Takahashi, K.; Sano, H. Chem. Pharm. Bull. 
1988, 36, 3728. (b) Takahashi, I.; Takahashi, K.; Ichimura, M.; Morimoto, M.; Asano, K.; 
Kawamoto, I.; Tomita, F.; Nakano, H. J. Antibiot. 1988, 41. 1915. 
2 (a) Tercel, M.; McManaway, S. P.; Leung, E.; Liyanage, H. D. S.; Lu, G.–L.; Pruijn, F. B. 
Angew. Chem. Int. Ed. 2013, 52, 5442. (b) Boger, D. L.; Johnson, D. S. Proc. Nat. Acad. Sci. U. S. 
A. 1995, 92, 3642. (c) Tietze, L. F.; Krewer, B. Chem. Bio. Drug. Des. 2009, 74, 205. 
3 Yamada, K.; Kurokawa, T.; Tokuyama, H.; Fukuyama, T. J. Am. Chem. Soc. 2003, 125, 6630. 
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1. Palladium–Catalyzed Oxirane–Opening Reaction with Arenes via 
C–H Bond Activation 
1.1. Introduction 
 
Compared with classical coupling  
reactions, C-H transformations are 
environmentally benign reactions, which 
do not need to prefunctionalize the starting 
materials. In the last few decades, C–H 
bond transformations have attracted 
widespread attention as efficient and ideal 
reactions, and have been dramatically 
advanced.
1
 Among the transition metal–
catalyzed C–H transformations, there are 
several reports on transiton–metal–
catalyzed C–H alkylation reactions of 
arenes
2
, using alkyltin
3
 and alkylboron
4
 
reagents, alkyl halides,
5
 alkenes,
6
 and 
alkanes as coupling partners (Figure 1-1).
7
 Another possible alkylation reagent is oxiranes, and 
synthetically–useful substituted–phenethyl alcohols could be synthesized with high atom–
economy if a C–C bond formation reaction via ring–opening of oxiranes with arenes is achieved. 
There are a lot of reports on transition metal catalyzed C–H activation and coupling with strained 
ring, such as aziridines, 
methylenecyclopropanes, 
cyclopropenes, cyclopropenones, and 
diazabicyclic olefins (Figure 1-2).
12
 
Rhodium catalysts show superiority in this field, which mainly attributed to the mild reaction 
conditions. To our knowledge, however, there is only one report of transition metal–catalyzed, 
intermolecular SN2’–type reactions via C–H activation using vinyl oxiranes as coupling partners 
(Figure 1-3a).
8–12
 The SN2–type ring–opening reactions of oxiranes by carbon nucleophiles is 
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difficult due to low reactivity of oxiranes. For example, it is necessary to activate oxiranes by 
BF3•OEt2 even when highly reactive organolithium reagents are used.
13
 On the other hand, the 
coordination ability of oxygen atom in oxiranes is weak compared with the most used nitrogen 
atom. Here, I realized a palladium–catalyzed C–H activation/SN2–type oxirane–opening reaction 
with broad substrate 
scope (Figure 1-3b). 
This is the first example 
of palladium–catalyzed 
C–H transformation via 
ring–opening of strained 
substrates.
11,12
 The main 
reason for no example of 
palladium–catalyzed C–
H 
transformation/coupling with strained compounds is that palladium–catalyzed C–H 
transformations generally proceed under harsh conditions, such as high temperature, long 
reaction time, and a lot of additives (oxidative reagents, base, or other transition metals), which 
causes decomposition of the strained rings. With these problems in mind, I began our research on 
a palladium–catalyzed C–H transformation using oxiranes as coupling partners. 
 
1.2. Optimization Studies 
 
I initially investigated a reaction between 2–phenylpyridine (1a) and 2–ethyloxirane. 
Formation of the desired coupling product, however, was not achieved using various transition 
metal salts and complexes under different reaction conditions. A main reason is that the nitrogen 
atom coordination ability is stronger than oxygen atom of oxirane, which causes that the 
transition metal was surrounded by the pyridine substrate rather than oxirane. In addition, the 
basicity of the nitrogen atom caused decomposition of the oxirane. I thought that using oxiranes 
bearing additional heteroatoms, which act as an additional catalyst coordination sites, might solve 
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the weak coordination ability of oxiranes. Therefore, I investigated the reaction using 2–
(phenoxymethyl)oxirane (2a), because the two oxygen atoms of 2a should coordinate to a metal 
center by chelation. Acetic acid (AcOH) was selected as a solvent because acids should accelerate 
oxirane ring–opening reactions. Several metal salts were screened at 100 oC (Table 1-1, entries 1–
5), but the desired coupling reaction only occurred when using Pd(OAc)2. Alkylated product 3a 
was formed in 11% yield (Table 1-1, entry 5). The low yield resulted mainly from the 
decomposition of oxirane 2a due to the acidity of AcOH. Therefore, I used 1,1,1,3,3,3–
hexafluoro–2–propanol (HFIP) as a mixed solvent because (1) HFIP is a highly polarized solvent, 
which dilutes the concentration AcOH rather than decrease the acidity of AcOH; and (2) the 
electron poor oxygen atom of HFIP weakly coordinates to a palladium catalyst and will not 
strongly affect the property of the palladium catalyst due to the electronic withdrawing effect and 
steric effect of fluoride atoms. Screening of various AcOH/HFIP ratios (Table 1-1, entries 6–9) 
revealed that an AcOH/HFIP ratio of 2:8 increased the yield of 3a to 30% (Table 1-1, entry 7). 
Unfortunately, a large amount of 2a decomposed under the reaction conditions. To improve the 
yield, I performed a reaction at lower temperature to suppress the decomposition of 2a (Table 1-1, 
entries 10–13). The desired product 3a was obtained quantitatively at room temperature (Table 
1-1, entry 13). The yield of 3a decreased to 76% when 1.5 equiv of oxirane 2a was used (Table 
1-1, entry 14). Therefore, 2.0 equiv of oxiranes was used in the subsequent experiments. This 
result is especially noteworthy because of the few examples of palladium–catalyzed C–H 
transformations that proceed at room temperature.
14 
The reaction proceeds wihout any additives 
and byproducts. 
 
entry Catalyst solvent temp [°C] yield [%]
b
 (3a) 
1 Rh(OAc)2 AcOH 100 0 
2 ReCl(CO)5 AcOH 100 0 
1. Palladium-Catalyzed Oxirane-Openning Reaction with Arenes via C-H Activation 
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3 Co(OAc)2 AcOH 100 0 
4 Mn(OAc)3·2H2O AcOH 100 0 
5 Pd(OAc)2 AcOH 100 11 
6 Pd(OAc)2 AcOH/HFIP (1:9) 100 22 
7 Pd(OAc)2 AcOH/HFIP (2:8) 100 30 
8 Pd(OAc)2 AcOH/HFIP (3:7) 100 18 
9 Pd(OAc)2 HFIP 100 0 
10 Pd(OAc)2 AcOH/HFIP (2:8) 90 31 
11 Pd(OAc)2 AcOH/HFIP (2:8) 80 37 
12 Pd(OAc)2 AcOH/HFIP (2:8) 60 74 
13 Pd(OAc)2 AcOH/HFIP (2:8) 25 >99 
14 Pd(OAc)2
c
 AcOH/HFIP (2:8) 25 76 
a
Reactions conditions: 1a (0.200 mmol), 2a (0.400 mmol), solvent (1.0 mL). 
b
Yield was 
determined by 
1
H NMR using 1,1,2,2–tetrachloroethane as an internal standard. c2a (0.300 mmol, 
1.5 equiv). 
 
1.3. Substrate Scope and Mechanism Research 
 
With the best conditions in hand, I next explored the scope and limitations of this system 
under the optimized reaction conditions (Table 1-2). At first, I investigated the arenes with 
different substituents. 2–Phenylpyridines bearing an electron–donating (MeO and Me) or –
withdrawing (CO2Et, Br, and F) group at the 4–position of the benzene ring coupled smoothly 
with oxirane 2a, without loss of the functional groups. Although two possible regioisomers might 
be formed when a substituent exists at the 3–position of an aromatic ring of 2–phenylpyridines 1g 
and 1h, only single isomers 3g and 3h formed because the reaction occurred only at the less 
hindered site. The coupling reaction was not inhibited by steric hindrance from a substituent at 
the 2–position of 1i and 1j. The corresponding products 3k, 3l, and 3m, derived from 
pyridylnaphthalenes 1k and 1l, and benzo[h]quinoline 1m, were produced in high yields. An 
electron–donating or –withdrawing substituent on the pyridine ring of 1n and 1o was also 
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tolerated in this reaction. The yield of alkylated product 3p was not obviously decreased by steric 
hindrance from a substituent at the 6–position of the pyridine ring. An isoquinolinyl or quinolinyl 
group also worked as a directing group, and the corresponding alkylated products 3q
15
 and 3r 
were obtained in 87% and 97% yields, respectively.  
 
 
 
Next, I investigated coupling reactions between different type of oxiranes and arenes with 
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different directing groups (Table 1-3). I found that the β–oxygen atom of oxirane is necessary for 
coupling with 2–phenylpyridine. A substituent on the oxygen atom of 2–(phenoxymethyl)oxirane 
(2a) could be changed to several different types of substituents. 2–(Aryloxymethyl)oxiranes 
produced the corresponding coupling products 3s–3u in 43%–81% yields. In the case of oxirane 
with a 4–(9H–carbazolyl) group, the desired reaction proceeded without NH group protection, the 
low yield mainly attributed to the low solubility of this oxirane. The corresponding coupling 
products 3v–3z, 3A–3B, 3I were obtained in 58%–94% yields when oxiranes bearing an aliphatic 
substituent on the oxygen atom were used as substrates. The desired products were not produced, 
however, when the substituent on the oxygen atom was larger: namely, a trityl group. These 
results are likely due to inhibition of the coordination of an oxygen atom to a palladium center by 
steric hindrance, on the other hand, the solubity of oxirane with big substituents is low. By 
changing 2–phenylpyridines to other aromatic compounds with qunolinyl and isoquinolinyl, such 
as benzo[h]quinoline and 1–phenylisoquinoline, the coupling reaction proceeded in good to 
excellent yields using a variety of oxiranes other than 2–(alkoxymethyl)oxiranes. The coupling 
reaction proceeded using an oxirane without an oxygen atom at the –position, and provided the 
coupling product 3C in 83% yield. The coupling reaction had high functional group tolerance, 
and gave the desired product with the following functional groups, including C=C double bond 
(3D), isoindoline–1,3–dione (3E) and carbamate (3F) moieties, and ester (3G, 3H, 3I, 3K, and 
3M) and tosyl (3L) groups. In the case of an oxirane with a double bond, the yield of 3D was 
moderate, likely due to decomposition of the palladium catalyst with the formation of a 
palladium black. A coupling product 3I was also produced using a 1,1–disubstituted oxirane. For 
the products 3J, 3k, and 3L, attribute to the strong intromolecular hydrogen bond in CDCl3, a 
rotamers can be observed. By using an aromatic compound with an aminoquinolinyl directing 
group which is a very common directing group in transition–metal–catalyzed C–H transforations, 
the desired product 3M was obtained in 67% yield. A coupling product 3N was obtained in 71% 
yield using acetophenone O–methyl oxime as a substrate without destroying the directing group. 
The desired reaction did not proceed, however, using 2–vinyloxirane and 1,2–disubstituted 
oxiranes (methyl 3–methyloxirane–2–carboxylate and dimethyl (2S,3R)–oxirane–2,3–
dicarboxylate) under the same reaction conditions. 
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3–Substituted isochroman–1–ones are important frameworks in natural products and 
pharmaceutical compounds.
15
 When N–methoxybenzamide and oxiranes were used as substrates, 
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coupling reaction and successive cyclization proceeded and 3–substituted isochroman–1–ones 
5a–5d were obtained in 58%–75% yields (Table 1-4). The desired product 5b was obtained using 
an oxirane without an additional coordinating oxygen atom, but 2–hexyloxirane did not produce a 
coupling product at all. This result indicated that π–electrons of the phenyl group of the oxirane 
might coordinate to the palladium catalyst. 
 
 
 
The reaction could be performed on gram scale (eq 1-1). Treatment of 1.00 g of 1a with 2.0 
equiv of oxirane 2a gave 1.42 g of 3a in 73% yield.  
 
 
 
To determine the rate–determining step of the present reaction, a deuterium–labeling 
experiment was performed. Treatment of 2–phenylpyridine (1a) or deuterated 2–phenylpyridine 
(1a–d5) with oxirane 2a revealed a kinetic isotope effect value of 2.6. Although the value is a 
little smaller than the previously reported on palladium–catalyzed C–H transformation, this result 
suggested that C–H bond activation is the rate–determining step (eqs 1-2 and 1-3).  
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When an enantiomerically pure oxirane (S)–2e or (R)–2f was used, the coupling reactions 
proceeded with stereoretention and the corresponding products 3v and 3w were obtained in more 
than 99% ee (eqs 1-4 and 1-5). These findings suggested that oxiranes 2 were not racemized by 
ring–opening and reconstruction of the oxirane rings under the reaction conditions, in other 
words, the other C–O bond did not intend in this reaction. 
 
 
 
In previous reports, dinuclear palladium complex X (eqs 1-6 and 1-7) was demonstrated to 
be an active intermediate for Pd–catalyzed C–H bond transformations of 2–phenylpyridines.18 
Therefore, the complex was synthesized and the following two reactions were investigated: (1) a 
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reaction between 2– phenylpyridine (1a) and oxirane 2a in the presence of a catalytic amount of 
X (eq 1-6); and (2) a reaction between a stoichiometric amount of palladium complex X and 
oxirane 2a (eq 1-7). The desired coupling reaction, however, did not proceed at all even at an 
elevated temperature (80 
o
C). Based on these results, I concluded that dinuclear palladium(II) 
complex X was not a catalytic species in our reaction. The result implies that palladium(IV) 
species generated via oxidation by substrate oxiranes might be an active catalyst for this 
reaction.
17,18
  
 
 
 
One possible pathway is similar to the proposed mechanism of rhodium(III)–catalyzed C–C 
coupling between 2–phenylpyridines and aziridines (Scheme 1-1).19 Wherein the reaction mainly 
proceeded at internal carbon of oxirane 2 rather than terminal carbon of 2. In this reaction, the C–
C coupling reaction occurs at a more–substituted carbon atom of aziridines. On the other hand, 
the present reaction occurred at a less–substituted carbon atom of oxiranes. Therefore, the 
mechanisms of the two reactions may be different. 
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Thus, I considered two possible mechanisms (Schemes 1-2 and 1-3) based on the previous 
reports and our experiments.
20
  
Scheme 1-2: (1) coordination of oxirane 2 to Pd(OAc)2; (2) coordination of 2–
phenylpyridine derivative 1 to the formed Pd(II) intermediate and C–H bond activation via 
elimination of acetic acid to give intermediate C via a CMD mechanism;
21
 (3) insertion of 
oxirane 2 into the formed Pd(II)–carbon bond of C via ring–opening of oxirane 2 to give 
intermediate D;
22
 and (4) protonation of intermediate D to give a coupling product 3 and 
regenerate Pd(OAc)2. The key feature of this mechanism is that the C–H activation proceeded by 
palladium (II) via CMD mechanism and the palladium does not change the value in this reaction. 
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Scheme 1-3: (1) oxidative addition of oxirane 2 to a Pd(II) catalyst to give a Pd(IV) 
intermediate; (2) coordination of 2–phenylpyridine derivative 1 to the Pd(IV) intermediate and 
C–H bond activation via the elimination of acetic acid to give intermediate E;23 (3) reductive 
elimination to give intermediate F via the formation of a C(sp
2
)–C(sp3) bond;24 and (4) 
protonation of intermediate F to give a coupling product 3 and regenerate Pd(OAc)2. The main 
point for this mechanism is that palladium (IV) promoted the C–H activation via a CMD 
mechaniam rather than palladium (II) in Scheme 2, and the reaction involves 
palladium(II)/palladium(IV) cycles. At present, the mechanism is not clear, but further detailed 
studies are ongoing in our lab. On the other hand, I began to apply it to the total synthesis of 
duocarmycin. 
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1.4. Summary 
 
In summary, a palladium–catalyzed coupling reaction between an ortho–C(sp2) atom of 
arenes and a C(sp
3
) atom of oxiranes was realized (Figure 1-4). This is first example of 
palladium–catalyzed C–H transformation using a strained compound as a coupling partner. This 
is also the first example of a transition metal–catalyzed intermolecular direct coupling reaction 
between a C–H bond of arenes and a carbon atom of oxirane rings via C–H bond activation. The 
reaction exhibited a wide substrate scope (arenes with 7 types of directing groups and 6 types of 
oxiranes) and proceed at room temperature in good to excellent yields without any additives, 
even in gram scale. This is an atom economical and environmental benign reaction. By using an 
N–methoxybenzamide as a substrate, 3–substituted isochroman–1–ones, which are a very 
important scaffold in natural produts and drug molecules, were obtained in one–pot procedure. 
Kinetic isotope effect experiments suggested that C–H bond activation was involved in a rate–
determining step of the coupling reaction. These findings provide useful insights into synthetic 
organic chemistry, especially, C–H bond transformations. At present, we are trying to elucidate 
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the detailed mechanism and use it to the total synthesis of duocarmycin.  
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7330. 
 
1.6. Experimental 
 
General. All reactions were carried out in a dry solvent under argon atmosphere unless otherwise 
noted. [Pd(OAc)2] (purity: 99.98%) was purchased from Aldrich Co. Methanol, hexafluoro–2–
isopropanol (HFIP), and acetic acid were purchased from Wako Pure Chemical Industries, and 
were dried and degassed before use. NMR spectra were recorded on JEOL ECX500 (500 MHz for 
1
H NMR and 125 MHz for 
13
C NMR) and JEOL ECS400 (400 MHz for 
1
H NMR and 100 MHz for 
13
C NMR) spectrometer. Proton chemical shifts are reported relative to a residual solvent peak 
(CDCl3 at 7.26 ppm, CD3OD at 3.31 ppm, and (CD3)2CO at 2.05 ppm). Carbon chemical shifts are 
reported relative to a residual solvent peak (CDCl3 at 77.3 ppm, CD3OD at 49.0 ppm, and 
(CD3)2CO at 29.8 ppm). The following abbreviations were used to designate multiplicities: s = 
singlet, d = doublet, t = triplet, q = quartet, quint = quintet, m = multiplet, br = broad. IR spectra 
were recorded on a JASCO FT/IR–410. High–resolution mass spectra (HRMS) were measured on 
a JEOL JMS–T100LC AccuTOF spectrometer (for HRMS). 
 
Typical Procedure for the Palladium–Catalyzed C(sp2)–C(sp3) Coupling Reaction between 
2–Phenylpyridine (1a) and 2–(Phenoxymethyl)oxirane (2a). A mixture of 2–phenylpyridine (1a, 
31.0 mg, 0.200 mmol), 2–(phenoxymethyl)oxirane (2a, 60.1 mg, 0.400 mmol), Pd(OAc)2 (4.49 mg, 
0.0200 mmol), HFIP (0.80 mL), and acetic acid (0.20 mL) was stirred at 25 °C for 24 h under Ar 
atmosphere. Then, the reaction mixture was quenched with saturated aq. Na2CO3 (5.0 mL), and the 
mixture was extracted with ethyl acetate (3 x 25 mL). The organic phase was dried over Na2SO4, 
filtered, and concentrated in vacuo. The crude product was purified by column chromatography on 
silica gel (hexane / EtOAc = 3:1) to give 3a as a yellow oil (61.1 mg, >99%). [Note: When a 
mixture of Pd(OAc)2 and 2–phenylpyridine (1a) was stayed for a long time (more than 20 min) 
before addition of 2–(phenoxymethyl)oxirane (2a), the yield of 3a became lower (~10%).] 
 
1–Phenoxy–3–(2–(2–pyridinyl)phenyl)–2–propanol (3a). 61.1 mg, >99%, yellow oil; 1H NMR 
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(400 MHz, CDCl3) δ 8.62 (d, J = 4.9 Hz, 1H), 8.05 (brs, 1H), 7.85 (ddd, J = 
7.7, 7.7, 1.8 Hz, 1H), 7.57 (d, J = 8.0 Hz, 1H), 7.38–7.33 (m, 3H), 7.33–7.26 
(m, 4H), 6.99–6.94 (m, 3H), 4.35–4.28 (m, 1H), 4.15 (dd, J = 9.1, 4.6 Hz, 
1H), 3.98 (dd, J = 9.1, 6.9 Hz, 1H), 3.12–2.95 (m, 2H); 13C NMR (125 MHz, 
CD3OD) δ 160.3, 148.7, 141.3, 139.2, 138.0, 132.2, 131.03, 131.02, 130.4, 130.0, 127.7, 126.1, 
123.7, 121.8, 115.6, 72.6, 72.3, 37.5; IR (KBr, ν / cm–1) 3432, 2921, 2864, 1639, 1597, 1562, 1495, 
1473, 1443, 1428, 1299, 1246, 1172, 1153, 1040, 1000, 918, 797, 753, 692, 631; HRMS (ESI+) 
Calcd for C20H19NO2 (M+Na
+
) 328.1308, Found 328.1308. 
 
1–(5–Methoxy–2–(2–pyridinyl)phenyl)–3–phenoxy–2–propanol 
(3b).62.4 mg, 93%, yellow solid; 
1
H NMR (400 MHz, CDCl3) δ 8.58 (d, J = 
5.2 Hz, 1H), 8.20 (brs, 1H), 7.82 (ddd, J = 7.8, 7.8, 1.8 Hz, 1H), 7.53 (d, J = 
8.0 Hz, 1H), 7.36 (d, J = 8.5 Hz, 1H), 7.33–7.27 (m, 3H), 7.00–6.91 (m, 4H), 
6.88 (dd, J = 8.5, 2.7 Hz, 1H), 4.39–4.24 (m, 1H), 4.15 (dd, J = 9.1, 4.5 Hz, 
1H), 3.95 (dd, J = 9.1, 7.2 Hz, 1H), 3.77 (s, 3H), 3.10–2.94 (m, 2H); 13C NMR (100 MHz, CDCl3) 
δ 160.4, 159.2, 158.6, 147.3, 139.1, 138.0, 132.7, 131.7, 129.7, 124.8, 121.9, 120.9, 116.2, 114.8, 
113.0, 72.0, 71.3, 55.5, 37.1; IR (KBr, ν / cm–1) 3423, 2959, 2931, 2858, 2719, 1643, 1561, 1496, 
1469, 1430, 1321, 1287, 1247, 1172, 1154, 1115, 1042, 1018, 998, 819, 789, 691; HRMS (ESI
+
) 
Calcd for C21H21NO3 (M+Na
+
) 358.1414, Found 358.1415. 
 
1–(5–Methyl–2–(2–pyridinyl)phenyl)–3–phenoxy–2–propanol (3c). 
53.7 mg, 84%, yellow solid; 
1
H NMR (400 MHz, CDCl3) δ 8.60 (d, J = 4.9 
Hz, 1H), 8.07 (brs, 1H), 7.84 (ddd, J = 7.8, 7.8, 1.8 Hz, 1H), 7.55 (d, J = 8.0 
Hz, 1H), 7.37–7.27 (m, 5H), 7.15 (d, J = 7.9 Hz, 1H), 7.01–6.91 (m, 3H), 
4.20–4.38 (m, 1H), 4.15 (dd, J = 9.1, 4.5 Hz, 1H), 3.96 (dd, J = 9.1, 7.0 Hz, 
1H), 3.07–2.91 (m, 2H), 2.39 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 159.3, 159.0, 147.3, 139.3, 
138.0, 137.3, 137.2, 132.2, 130.3, 129.6, 127.6, 124.9, 122.2, 120.9, 114.9, 72.3, 71.5, 36.9, 21.4; 
IR (KBr, ν / cm–1) 3433, 2923, 2863, 2777, 1642, 1599, 1496, 1471, 1430, 1380, 1336, 1300, 1247, 
1173, 1153, 1130, 1113, 1095, 1078, 1040, 1000, 938, 915, 883, 826, 788, 754, 736, 692, 666, 633; 
HRMS (ESI+) Calcd for C21H21NO2 (M+Na
+
) 342.1465, Found 342.1477. 
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Ethyl 3–(2–hydroxy–3–phenoxypropyl)–4–(2–pyridinyl)benzoate (3d). 57.4 mg, 76%, yellow 
solid; 
1
H NMR (400 MHz, CDCl3) δ 8.64 (d, J = 4.9 Hz, 1H), 8.13 (d, J = 1.6 
Hz, 1H), 8.00 (dd, J = 8.0, 1.7 Hz, 1H), 7.89 (ddd, J = 7.8, 7.8, 1.7 Hz, 1H), 
7.72 (brs, 1H), 7.59 (d, J = 7.8 Hz, 1H), 7.49 (d, J = 8.0 Hz, 1H), 7.32–7.43 
(m, 1.1 Hz, 1H), 7.34–7.25 (m, 2H), 7.01–6.87 (m, 3H), 4.39 (q, J = 7.1 Hz, 
2H), 4.26–4.38 (m, 1H), 4.14 (dd, J = 9.1, 4.5 Hz, 1H), 3.97 (dd, J = 9.1, 6.6 
Hz, 1H), 3.13–2.98 (m, 2H), 1.38 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 166.5, 159.2, 
158.1, 147.7, 143.9, 138.2, 137.9, 132.6, 131.2, 130.4, 129.7, 127.9, 125.2, 123.0, 121.0, 114.8, 
72.2, 71.4, 61.4, 36.8, 14.6; IR (KBr, ν / cm–1) 3420, 2921, 2864, 1714, 1640, 1599, 1496, 1470, 
1432, 1366, 1288, 1248, 1189, 1110, 1039, 1020, 894, 796, 754, 691, 667, 631; HRMS (ESI+) 
Calcd for C23H23NO4 (M+Na
+
) 400.1519, Found 400.1526.
 
 
1–(5–Bromo–2–(2–pyridinyl)phenyl)–3–phenoxy–2–propanol (3e). 63.8 
mg, 83%, yellow solid; 
1
H NMR (400 MHz, CDCl3) δ 8.56 (d, J = 4.9 Hz, 
1H), 7.81 (ddd, J = 7.7, 7.7, 1.7 Hz, 1H), 7.76 (brs, 1H), 7.56 (d, J = 1.7 Hz, 
1H), 7.48 (dd, J = 8.2, 0.7 Hz, 1H), 7.42 (dd, J = 8.2, 1.9 Hz, 1H), 7.34–7.19 
(m, 4H), 6.95–6.86 (m, 3H), 4.29–4.16 (m, 1H), 4.08 (dd, J = 9.1, 4.4 Hz, 1H), 
3.90 (dd, J = 9.1, 6.9 Hz, 1H), 3.00–2.87 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 159.1, 157.9, 
147.7, 139.9, 138.8, 138.3, 134.3, 131.8, 130.0, 129.7, 124.9, 123.6, 122.7, 121.0, 114.8, 72.2, 71.4, 
36.8; IR (KBr, / cm
–1
) 3418, 2928, 2867, 1640, 1589, 1562, 1496, 1469, 1429, 1446, 1025, 918, 
786，753，691; HRMS (ESI+) Calcd for C20H18BrNO2 (M+Na
+
) 406.0413, Found 406.0418. 
 
1–(5–Fluoro–2–(2–pyridinyl)phenyl)–3–phenoxy–2–propanol (3f). 50.4 
mg, 78%, yellow solid; 
1
H NMR (400 MHz, CDCl3) δ 8.61 (d, J = 4.8 Hz, 
1H), 7.96–7.81 (m, 2H), 7.54 (d, J = 8.2 Hz, 1H), 7.44–7.23 (m, 4H), 7.16 (dd, 
J = 9.7, 2.4 Hz, 1H), 7.08–7.01 (m, 1H), 6.98–6.93 (m, 3H), 4.36–4.23 (m, 
1H), 4.14 (dd, J = 9.1, 4.4 Hz, 1H), 3.95 (dd, J = 9.1, 7.0 Hz, 1H), 3.07–2.95 
(m, 2H); 
13
C NMR (125 MHz, CDCl3) δ 163.3 (d, J =250 Hz), 159.2, 158.1, 147.6, 140.8 (d, J = 8.5 
Hz), 138.2, 136.2 (d, J = 2.2 Hz), 132.1 (d, J = 8.9 Hz), 129.7, 125.0, 122.5, 121.0, 118.0 (d, J = 
20.4 Hz), 114.9, 114.0 (d, J = 21.0 Hz), 72.1, 71.3, 37.0; IR (KBr, ν / cm–1) 3443, 2921, 2864, 1640, 
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1597, 1562, 1496, 1470, 1432, 1377, 1288, 1247, 1173, 1153, 1119, 1073, 1038, 947, 788, 754, 690, 
668; HRMS (ESI+) Calcd for C20H18FNO2 (M+Na
+
) 346.1214, Found 346.1204.
 
 
1–(4–Methoxy–2–(2–pyridinyl)phenyl)–3–phenoxy–2–propanol 
(3g). 58.4 mg, 87%, yellow solid; 
1
H NMR (400 MHz, CDCl3) δ 8.61 
(d, J = 4.6 Hz, 1H), 7.86 (ddd, J = 7.7, 7.7, 1.8 Hz, 1H), 7.81 (brs, 1H), 
7.56 (d, J = 7.7 Hz, 1H), 7.37–7.23 (m, 4H), 7.01–6.90 (m, 5H), 4.30–
4.20 (m, 1H), 4.11 (dd, J = 9.1, 4.6 Hz, 1H), 3.93 (dd, J = 9.1, 6.9 Hz, 
1H), 3.84 (s, 3H), 2.99 (dd, J = 13.9, 3.9 Hz, 1H), 2.91 (dd, J = 13.9, 8.7 Hz, 1H); 
13
C NMR (100 
MHz, CDCl3) δ 159.2, 158.9, 158.2, 147.5, 140.9, 138.1, 132.6, 129.7, 129.4, 125.0, 122.5, 120.9, 
115.8, 115.0, 114.8, 72.0, 71.4, 55.7, 35.9; IR (KBr, ν / cm–1) 3475, 2921, 2864, 1643, 1597, 1562, 
1496, 1476, 1429, 1428, 1297, 1246, 1226, 1173, 1095, 1034, 1000, 918, 814, 794, 756, 691, 676, 
666; HRMS (ESI
+
) Calcd for C21H21NO3 (M+Na
+
) 358.1414, Found 358.1420. 
 
1–Phenoxy–3–(3–(2–pyridinyl)–[1,1'–biphenyl]–4–yl)–2–propanol 
(3h). 71.7 mg, 94%, yellow solid; 
1
H NMR (400 MHz, CDCl3) δ 8.65 
(d, J = 4.1 Hz, 1H), 7.99 (brs, 1H), 7.88 (ddd, J = 7.7, 7.7, 1.8 Hz, 1H), 
7.72–7.59 (m, 5H), 7.52 (d, J = 8.4 Hz, 1H), 7.46 (dd, J = 10.4, 4.8 Hz, 
2H), 7.42–7.28 (m, 4H), 7.04–6.93 (m, 3H), 4.34 (brs, 1H), 4.17 (dd, J = 9.1, 4.5 Hz, 1H), 3.99 (dd, 
J = 9.1, 7.0 Hz, 1H), 3.18–3.01 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 159.2, 158.9, 147.5, 140.8, 
140.3, 139.9, 138.2, 136.5, 132.0, 129.7, 129.14, 129.06, 128.1, 127.6, 127.4, 125.1, 122.5, 120.9, 
114.8, 72.1, 71.4, 36.5; IR (KBr, ν / cm–1) 3443, 2931, 2864, 1644, 1496, 1473, 1429, 1391, 1289, 
1251, 1172, 1153, 1139, 1115, 1096, 1077, 1038, 1020, 1003, 920, 892, 854, 833, 794, 727, 692, 
648, 636, 613; HRMS (ESI
+
) Calcd for C26H23NO2 (M+Na
+
) 404.1621, Found 404.1628. 
 
1–(3–Methoxy–2–(2–pyridinyl)phenyl)–3–phenoxy–2–propanol (3i). 62.3 mg, 93%, yellow 
solid; 
1
H NMR (400 MHz, CDCl3) δ 8.59 (dd, J = 4.9, 0.8 Hz, 1H), 
7.72 (ddd, J = 7.8, 7.8, 1.4 Hz, 1H), 7.49 (d, J = 8.0 Hz, 1H), 7.31 (t, J 
= 8.0 Hz, 1H), 7.29–7.18 (m, 4H), 7.00 (d, J = 7.7 Hz, 1H), 6.87–6.92 
(m, 4H), 4.14–4.20 (m, 1H), 4.01 (dd, J = 9.1, 4.6 Hz, 1H), 3.83 (dd, J 
= 9.1, 6.7 Hz, 1H), 3.69 (s, 3H), 2.84 (dd, J = 13.5, 3.8 Hz, 1H), 2.60 (dd, J = 13.5, 9.4 Hz, 1H); 
13
C 
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NMR (100 MHz, CDCl3) δ 159.2, 157.1, 155.1, 147.9, 139.3, 136.4, 129.9, 129.6, 129.4, 128.0, 
123.2, 122.3, 120.9, 114.8, 109.3, 72.1, 71.0, 55.9, 36.8; IR (KBr, ν / cm–1) 3434, 2963, 2933, 2868, 
1733, 1645, 1600, 1496, 1469, 1457, 1437, 1375, 1285, 1250, 1172, 1152, 1079, 1040, 998, 935, 
882, 802, 784, 752, 692, 668; HRMS (ESI
+
) Calcd for C21H21NO3 (M+Na
+
) 358.1414, Found 
358.1407. 
 
1–Phenoxy–3–(2–(2–pyridinyl)–[1,1'–biphenyl]–3–yl)–2–propanol (3j). 60.3 mg, 79%, yellow 
solid; 
1
H NMR (500 MHz, CDCl3) δ 8.61 (dd, J = 4.1, 1.1 Hz, 1H), 
7.56–7.30 (m, 5H), 7.29–7.20 (m, 2H), 7.17–7.06 (m, 4H), 7.01 (dd, J = 
6.3, 2.8 Hz, 2H), 6.93–6.90 (m, 3H), 6.77 (d, J = 8.2 Hz, 1H), 4.16–
4.28 (m, 1H), 4.10 (dd, J = 9.0, 4.2 Hz, 1H), 3.85 (dd, J = 9.0, 6.7 Hz, 
1H), 2.80–3.05 (m, 1H), 2.45–2.73 (m, 1H); 13C NMR (125 MHz, CDCl3) δ
 
159.2, 158.2, 
154.03,147.6, 142.0, 136.5, 130.7, 130.1, 129.7, 128.8, 128.1, 127.9, 127.8, 126.7, 122.0, 121.3, 
121.0, 116.8, 114.8, 70.0, 63.5, 33.8; IR (KBr, ν / cm–1) 3434, 2921, 2864, 1643, 1597, 1562, 1496, 
1473, 1443, 1423, 1290, 1246, 1172, 1153, 1079, 1024, 918, 805, 789, 754, 702, 667; HRMS (ESI
+
) 
Calcd for C26H23NO2 (M+Na
+
) 404.1621, Found 404.1614. 
 
1–Phenoxy–3–(1–(2–pyridinyl)–2–naphthalenyl)–2–propanol (3k). 61.1 mg, 86%, yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 8.77 (d, J = 3.9 Hz, 1H), 7.96–7.81 (m, 
3H), 7.59–7.52 (m, 2H), 7.50–7.35 (m, 4H), 7.32–7.25 (m, 3H), 7.02–
6.89 (m, 3H), 4.16–4.32 (m, 1H), 4.11 (dd, J = 9.2, 4.4 Hz, 1H), 3.89 
(dd, J = 9.2, 6.4 Hz, 1H),
 
3.09 (dd, J = 13.7, 3.4 Hz, 1H), 2.65 (dd, J = 
13.7, 10.9 Hz, 1H);
 13
C NMR (125 MHz, CDCl3) δ 159.2, 157.3, 149.0, 136.9, 135.6, 132.7, 132.1, 
129.73, 129.65, 129.5, 128.5, 128.2, 127.5, 126.8, 125.7, 125.6, 122.8, 121.0, 114.8, 72.8, 71.1, 
38.1; IR (KBr, ν / cm–1) 3433, 2921, 2864, 1644, 1597, 1562, 1495, 1473, 1443, 1385, 1299, 1246, 
1172, 1153, 1040, 1000, 918, 797, 752, 692, 623; HRMS (ESI
+
) Calcd for C24H21NO2 (M+Na
+
) 
378.1465, Found 378.1476. 
 
1–Phenoxy–3–(3–(2–pyridinyl)–2–naphthalenyl)–2–propanol (3l). 59.7 mg, 84%, yellow solid; 
1
H NMR (400 MHz, CDCl3) δ 8.66 (d, J = 4.8 Hz, 1H), 7.99–7.74 (m, 6H), 7.70 (d, J = 8.0 Hz, 1H), 
7.56–7.41 (m, 2H), 7.42–7.24 (m, 3H), 7.05–6.86 (m, 3H), 4.32–4.42 (m, 1H), 4.17 (dd, J = 9.1, 4.5 
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Hz, 1H), 4.01 (dd, J = 9.1, 6.9 Hz, 1H), 3.24 (dd, J = 13.7, 4.0 Hz, 1H), 
3.14 (dd, J = 13.7, 9.1 Hz, 1H); 
13
C NMR (125 MHz, CDCl3) δ 159.3, 
159.2, 147.6, 138.4, 138.2, 135.1, 133.9, 132.2, 130.3, 130.0, 129.7, 128.1, 
127.5, 127.0, 126.2, 125.4, 122.4, 121.0, 114.9, 72.1, 72.0, 36.8; IR (KBr, 
ν / cm–1) 3434, 2953，2923, 2865, 1636, 1598, 1567, 1496, 1481, 1427, 
1382, 1335, 1290, 1246, 1173, 1153, 1112, 1095, 1079, 1040, 1012, 954, 892, 859, 814, 790, 752, 
691, 668, 634; HRMS (ESI
+
) Calcd for C24H21NO2 (M+Na
+
) 378.1465, Found 378.1468. 
 
1–(Benzo[h]quinolin–10–yl)–3–phenoxy–2–propanol (3m). 58.0 mg, 88%, yellow solid; 1H 
NMR (500 MHz, CDCl3) δ 8.92 (d, J = 4.1 Hz, 1H), 8.23 (d, J = 7.9 Hz, 
1H), 7.87–7.77 (m, 2H), 7.68–7.53 (m, 4H), 7.33 (t, J = 7.8 Hz, 2H), 7.04 
(d, J = 8.0 Hz, 2H), 6.98 (t, J = 7.2 Hz, 1H), 6.24 (d, J = 4.1 Hz, 1H), 4.68–
4.57 (m, 1H), 4.29–4.18 (m, 3H), 3.96 (dd, J = 13.2, 3.7 Hz, 1H); 13C 
NMR (125 MHz, CDCl3) δ 159.3, 147.4, 146.8, 138.5, 136.9, 135.8, 133.0, 132.8, 130.2, 129.9, 
129.7, 128.0, 127.9, 125.4, 121.7, 121.0, 115.0, 73.0, 72.2, 40.2; IR (KBr, ν / cm–1) 3433, 2965, 
2921, 2864, 1716, 1645, 1597, 1562, 1496, 1470, 1443, 1394, 1377, 1288, 1248, 1172, 1124, 1074, 
1038, 981, 923, 835, 754, 732, 691, 667; HRMS (ESI+) Calcd for C22H19NO2 (M+Na
+
) 352.1308, 
Found 352.1311.
 
 
1–(2–(3–Methyl–2–pyridinyl)phenyl)–3–phenoxy–2–propanol (3n). 
53.7 mg, 84%, yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 8.41 (d, J = 4.8 
Hz, 1H), 7.62 (d, J = 7.8 Hz, 1H), 7.41 (brs, 1H), 7.35 (t, J = 6.6 Hz, 1H), 
7.28–7.12 (m, 6H), 6.94–6.81 (m, 3H), 4.21–4.09 (m, 1H), 3.88–3.69 (m, 
1H), 3.81 (dd, J = 9.1, 6.6 Hz, 1H), 2.88 (brs, 1H), 2.58 (brs, 1H), 2.19 (s, 3H); 
13
C NMR (125 MHz, 
CD3OD) δ 160.2, 146.7, 140.9, 140.5, 137.8, 134.0, 133.5, 132.0, 130.4, 130.3, 129.6, 127.5, 124.2, 
121.8, 115.5, 72.2, 71.5, 38.0, 19.4; IR (KBr, ν / cm–1) 3433, 2921, 2864, 1645, 1600, 1586, 1494, 
1446, 1291, 1246, 1172, 1116, 1077, 1039, 1021, 972, 754, 691; HRMS (ESI+) Calcd for 
C21H21NO2 (M+Na
+
) 342.1465, Found 342.1479. 
 
1–Phenoxy–3–(2–(4–(trifluoromethyl)–2–pyridinyl)phenyl)–2–propanol (3o). 68.7 mg, 92%, 
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yellow solid; 
1
H NMR (400 MHz, CDCl3) δ 8.68 (d, J = 4.3 Hz, 1H), 
7.80 (ddd, J = 7.7, 7.7, 1.6 Hz, 1H), 7.43–7.21 (m, 6H), 7.18 (d, J = 7.2 
Hz, 1H), 6.93 (t, J = 7.2 Hz, 1H), 6.88 (d, J = 8.0 Hz, 2H), 6.55 (brs, 
1H), 4.15 (brs, 1H), 4.01 (brs, 1H), 3.84 (brs, 1H), 2.90 (brs, 1H), 2.45 
(brs, 1H); 
13
C NMR (125 MHz, CDCl3) δ 160.1, 158.8, 149.3, 141.2, 
136.8 (q, J = 32.5 Hz), 135.2, 131.4, 130.3, 129.6 (q, J = 4.6 Hz), 128.9, 128.6, 127.2, 124.4, 122.2 
(q, J = 38.4 Hz), 121.0 (q, J = 24.9 Hz), 114.8, 73.1, 68.1, 34.2; IR (KBr, ν / cm–1) 3429, 2963, 2931, 
2864, 1673, 1645, 1562, 1496, 1470, 1443, 1394, 1377, 1288, 1235, 1172, 1124, 1074, 977, 923, 
835, 797, 754, 691, 667, 647, 611; HRMS (ESI+) Calcd for C21H18F3NO2 (M+Na
+
) 396.1182, 
Found 396.1179. 
 
1–(2–(6–Methyl–2–pyridinyl)phenyl)–3–phenoxy–2–propanol (3p). 
46.6 mg, 73%, yellow solid; 
1
H NMR (400 MHz, CDCl3) δ 8.20 (brs, 1H), 
7.74 (t, J = 7.7 Hz, 1H), 7.48–7.25 (m, 7H), 7.19 (d, J = 7.6 Hz, 1H), 7.02–
6.91 (m, 3H), 4.43–4.25 (m, 1H), 4.17 (dd, J = 9.1, 4.2 Hz, 1H), 3.99 (dd, J 
= 9.1, 6.9 Hz, 1H), 3.11–3.00 (m, 2H), 2.66 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 159.2, 158.3, 
156.8, 140.2, 138.2, 137.4, 131.4, 130.2, 129.6, 129.2, 126.7, 121.98, 121.96, 120.9, 114.8, 72.2, 
71.5, 36.8, 23.8; IR (KBr, ν / cm–1) 3428, 2921, 2871, 2658, 1643, 1495, 1456, 1376, 1337, 1290, 
1246, 1172, 1115, 1097, 1077, 1039, 1008, 948, 909, 881, 854, 805, 755; HRMS (ESI+) Calcd for 
C21H21NO2 (M+Na
+
) 342.1465, Found 342.1477. 
 
1–(2–(1–Isoquinolinyl)phenyl)–3–phenoxy–2–propanol (3q). 61.8 
mg, 87%, yellow solid;
 1
H NMR (500 MHz, CDCl3) δ 8.56 (d, J = 5.8 
Hz, 1H), 7.93 (dd, J = 13.5, 8.4 Hz, 2H), 7.77–7.70 (m, 2H), 7.59 (d, J 
= 7.7 Hz, 1H), 7.57–7.48 (m, 2H), 7.46–7.34 (m, 3H), 7.33–7.23 (m, 
3H), 6.96–6.86 (m, 2H), 4.32–4.21 (m, 1H), 4.08 (dd, J = 9.2, 4.5 Hz, 1H), 3.88 (dd, J = 16.0, 9.2 
Hz, 1H), 3.02 (dd, J = 13.6, 3.4 Hz, 1H), 2.69 (dd, J = 13.6, 10.9 Hz, 1H); 
13
C NMR (125 MHz, 
C6D12) δ 160.1, 159.2, 140.5, 138.8, 138.0, 137.5, 131.3, 131.1, 130.9, 129.7, 129.6, 129.5, 128.3, 
127.7, 127.3, 125.8, 120.9, 120.8, 114.8, 72.8, 72.0, 37.4; IR (KBr, ν / cm–1) 3444, 2921, 2867, 
1836, 1771, 1637, 1558, 1495, 1455, 1418, 1386, 1359, 1320, 1290, 1246, 1172, 1103, 1078, 1042, 
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1020, 979, 909, 827, 806, 731, 692; HRMS (ESI
+
) Calcd for C24H21NO2 (M+Na
+
) 378.1465, Found 
378.1476. 
 
2–Phenoxy–1–(2–(2–quinolinyl)phenyl)ethanol (3r). 66.2 mg, 97%, 
yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 8.40 (dd, J = 5.1, 1.6 Hz, 1H), 
8.32 (d, J = 8.4 Hz, 1H), 8.25 (d, J = 8.4 Hz, 1H), 7.90 (d, J = 8.1 Hz, 1H), 
7.77 (dd, J = 7.7, 7.7 Hz, 1H), 7.71 (dd, J = 8.4, 1.6 Hz, 1H), 7.64–7.56 (m, 
2H), 7.52 (d, J = 7.6 Hz, 1H), 7.47 (dd, J = 7.5, 7.5 Hz, 1H), 7.40 (t, J = 7.4 
Hz, 1H), 7.31–7.24 (m, 2H), 6.97–6.89 (m, 3H), 4.45–4.35 (m, 1H), 4.21 (dd, J = 9.3, 5.2 Hz, 1H), 
4.03 (dd, J = 9.3, 4.3 Hz, 1H), 3.18 (dd, J = 14.0, 9.9 Hz, 1H), 3.09 (dd, J = 14.0, 2.5 Hz, 1H); 
13
C 
NMR (125 MHz, CDCl3) δ 159.3, 158.7, 146.3, 140.1, 138.0, 131.7, 130.6, 129.61, 129.59, 129.5, 
128.7, 127.7, 127.2, 126.91, 126.89, 126.86, 122.8, 120.9, 114.9, 72.2, 71.8, 37.0; IR (KBr, ν / cm–
1
) 3431, 2921, 2864, 1637, 1620, 1601, 1558, 1496, 1467, 1425, 1378, 1340, 1317, 1290, 1246, 
1173, 1117, 1079, 1045, 950, 920, 882, 836, 754, 739, 692, 631; HRMS (ESI+) Calcd for 
C23H19NO2 (M+Na
+
) 378.4183, Found 378.1476.
 
 
1–(2–Methoxyphenoxy)–3–(2–(2–pyridinyl)phenyl)–2–propanol 
(3s). 49.6 mg, 74%, yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 8.60 
(dd, J = 4.2, 0.9 Hz, 1H), 7.84 (ddd, J = 7.7, 7.7, 1.7 Hz, 1H), 7.76 (brs, 
1H), 7.56 (d, J = 8.0 Hz, 1H), 7.45 (d, J = 7.1 Hz, 1H), 7.41 (dd, J = 7.0, 
7.0 Hz, 2H), 7.35–7.29 (m, 2H), 7.02–6.98 (m, 1H), 6.96–6.89 (m, 3H), 4.39–4.29 (m, 1H), 4.20 
(dd, J = 9.5, 4.7 Hz, 1H), 3.98 (dd, J = 9.5, 7.2 Hz, 1H), 3.85 (s, 3H), 3.10 (dd, J = 13.7, 3.8 Hz, 1H), 
3.02 (dd, J = 13.7, 9.1 Hz, 1H);
 13
C NMR (125 MHz, CDCl3) δ 159.0, 149.9, 148.9, 147.5, 140.0, 
138.0, 137.6, 131.6, 130.3, 129.3, 126.7, 125.0, 122.3, 121.5, 121.2, 114.2, 112.4, 73.5, 71.3, 56.2, 
36.9; IR (KBr, ν / cm–1) 3429, 2951, 2874, 1644, 1506, 1473, 1456, 1428, 1374, 1329, 1254, 1226, 
1178, 1124, 1026, 1010, 926, 787, 745, 678, 604; HRMS (ESI
+
) Calcd for C21H21NO3 (M+Na
+
) 
358.1414, Found 358.1415. 
 
1–((4–Methoxybenzyl)oxy)–3–(2–(2–pyridinyl)phenyl)–2–propanol (3t).60.3 mg, 81%, yellow 
solid;
 1
H NMR (500 MHz, CDCl3) δ 8.61 (d, J = 5.3 Hz, 1H), 7.90 (brs, 1H), 7.85 (dd, J = 7.8, 7.8 
Hz, 1H), 7.56 (d, J = 7.8 Hz, 1H), 7.37–7.46 (m, 3H), 7.33 (dd, J = 9.7, 3.9 Hz, 2H), 6.94–6.87 (m, 
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2H), 6.87–6.82 (m, 2H), 4.17–4.36 (m, 1H), 4.09 (dd, J = 9.1, 4.6 
Hz, 1H), 3.92 (dd, J = 9.1, 6.4 Hz, 1H), 3.78 (s, 3H), 3.04 (dd, J = 
13.6, 3.8 Hz, 1H), 2.98 (dd, J = 13.6, 9.0 Hz, 1H); 
13
C NMR (125 
MHz, CDCl3) δ 159.0, 154.0, 153.5, 147.4, 139.9, 138.0, 137.5, 
131.5, 130.3, 129.3, 126.8, 125.0, 122.4, 115.7, 114.9, 72.9, 71.5, 56.0, 36.8; IR (KBr, ν / cm–1) 
3411, 2911, 2874, 1637, 1560, 1541, 1508, 1473, 1456, 1440, 1289, 1232, 1180, 1106, 1039, 823, 
747, 709, 680, 668; HRMS (ESI
+
) Calcd for C21H21NO3 (M+Na
+
) 358.1414, Found 358.1415. 
 
1–((9H–Carbazol–4–yl)oxy)–3–(2–(2–pyridinyl)phenyl)–2–
propanol (3u).
 
33.9 mg, 43%, yellow solid; 
1
H NMR (500 MHz, 
CDCl3) δ 8.65 (d, J = 3.7 Hz, 1H), 8.25 (d, J = 7.6 Hz, 1H), 8.07 (brs, 
1H), 7.88 (dd, J = 7.7, 7.7 Hz, 1H), 7.60 (d, J = 7.9 Hz, 1H), 7.53 (d, 
J = 7.9 Hz, 1H), 7.48–7.28 (m, 7H), 7.11 (dd, J = 7.4, 7.4 Hz, 1H), 
7.06 (d, J = 8.1 Hz, 1H), 6.75 (d, J = 7.9 Hz, 1H), 4.59–4.48 (m, 1H), 4.42 (dd, J = 7.5, 3.1 Hz, 1H), 
4.26 (dd, J = 15.1, 7.5 Hz, 1H), 3.30–3.19 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 158.9, 155.8, 
147.5, 139.0, 138.2, 137.6, 131.7, 130.5, 129.5, 127.1, 127.0, 126.9, 125.12, 125.06, 122.4, 123.3, 
123.0, 122.5, 119.8, 113.0, 110.2, 103.7, 101.6, 72.3, 72.0, 37.2; IR (KBr, ν / cm–1) 3443, 2921, 
2864, 2358, 2330, 1639, 1597, 1562, 1495, 1473, 1443, 1428, 1299, 1264, 1171, 1143, 1140, 938, 
707, 631; HRMS (ESI+) Calcd for C20H15D4NO2 (M+Na
+
) 332.1559, Found 417.1576.
 
 
1–Methoxy–3–(2–(2–pyridinyl)phenyl)–2–propanol (3v). 39.4 mg, 81%, 
yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 8.61 (d, J = 5.1 Hz, 1H), 7.84 
(ddd, J = 7.7, 7.7, 1.8 Hz, 1H), 7.55 (d, J = 7.9 Hz, 1H), 7.50 (brs, 1H), 7.43–
7.37 (m, 3H), 7.35–7.29 (m, 2H), 4.17–3.99 (m, 1H), 3.52 (dd, J = 9.4, 5.3 
Hz, 1H), 3.44 (s, 3H), 3.41 (dd, J = 9.4, 6.3 Hz, 1H), 2.90 (dd, J = 13.6, 3.8 Hz, 1H), 2.84 (dd, J = 
13.6, 9.1 Hz, 1H); 
13
C NMR (125 MHz, CDCl3) δ 159.1, 147.6, 140.0, 137.9, 137.8, 131.54, 131.49, 
130.3, 129.3, 126.7, 122.3, 77.8, 71.9, 59.4, 37.0; IR (KBr, ν / cm–1) 3522, 2941, 2864, 1643, 1597, 
1562, 1495, 1473, 1443, 1428, 1299, 1246, 1172, 1153, 1127, 1080, 1003, 818, 797, 753, 678, 669; 
HRMS (ESI+) Calcd for C15H17NO2 (M+Na
+
) 266.1151, Found 266.1149. 
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1–(Benzyloxy)–3–(2–(2–pyridinyl)phenyl)–2–propanol (3w). 58.1 mg, 
91%, yellow solid;
 1
H NMR (500 MHz, CDCl3) δ 8.44 (dd, J = 5.4, 1.4 
Hz, 1H), 7.69 (ddd, J = 7.9, 7.9, 2.0 Hz, 1H), 7.40 (d, J = 8.0 Hz, 1H), 
7.38 (brs, 1H), 7.28–7.11 (m, 10H), 4.52–4.45 (m, 2H), 4.02–3.93 (m, 
1H), 3.50 (dd, J = 9.4, 4.8 Hz, 1H), 3.37 (dd, J = 9.4, 6.5 Hz, 1H), 2.81 (dd, J = 13.6, 3.9 Hz, 1H), 
2.75 (dd, J = 13.6, 8.9 Hz, 1H); 
13
C NMR (125 MHz, CDCl3) δ 159.1, 147.6, 134.0, 138.9, 137.90, 
137.85, 131.5, 130.3, 129.2, 128.6, 127.9, 127.7, 126.7, 124.9, 122.3, 75.2, 73.6, 72.0, 37.0; IR 
(KBr, ν / cm–1) 3367, 2921, 2859, 1644, 1496, 1474, 1453, 1442, 1427, 1362, 1302, 1267, 1206, 
1180, 1119, 1020, 1026, 1000, 910, 835, 798, 732, 698, 664, 632; HRMS (ESI+) Calcd for 
C21H21NO2 (M+Na
+
) 342.1465, Found 342.1469. 
 
1–(Allyloxy)–3–(2–(2–pyridinyl)phenyl)–2–propanol (3x). 44.7 mg, 
83%, yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 8.61 (dd, J = 5.3, 1.3 
Hz, 1H), 7.83 (ddd, J = 7.7, 7.7, 1.6 Hz, 1H), 7.54 (d, J = 8.2 Hz, 1H), 
7.49 (brs, 1H), 7.45–7.28 (m, 5H), 6.00–5.89 (m, 1H), 5.33–5.27 (m, 
1H), 5.21–5.14 (m, 1H), 4.13–4.03 (m, 3H), 3.59 (dd, J = 9.4, 5.1 Hz, 1H), 3.45 (dd, J = 9.4, 6.6 Hz, 
1H), 2.94 (dd, J = 13.6, 3.8 Hz, 1H), 2.86 (dd, J = 13.6, 9.4 Hz, 1H); 
13
C NMR (125 MHz, CDCl3) 
δ 159.1, 147.5, 139.9, 137.91, 137.86, 135.2, 131.5, 130.3, 129.2, 126.6, 124.9, 122.3, 117.0, 75.3, 
72.5, 72.0, 37.0; IR (KBr, ν / cm–1) 3434, 2921, 2864, 1645, 1597, 1562, 1495, 1473, 1443, 1427, 
1299, 1238, 1172, 1153, 1094, 1024, 1000, 929, 797, 753, 667, 631; HRMS (ESI
+
) Calcd for 
C17H19NO2 (M+Na
+
) 292.1308, Found 292.1300. 
 
1–(2–(2–Pyridinyl)phenyl)–3–(2,2,3,3–tetrafluoropropoxy)–2–
propanol (3y). 54.2 mg, 79%, yellow solid;
 1
H NMR (500 MHz, 
CDCl3) δ 8.59 (d, J = 4.1 Hz, 1H), 7.86 (ddd, J = 7.8, 7.8, 1.9 Hz, 
1H), 7.82 (brs, 1H), 7.56 (d, J = 8.0 Hz, 1H), 7.46–7.37 (m, 3H), 
7.36–7.31 (m, 2H), 5.94 (tt, J = 53.3, 5.2 Hz, 1H), 4.08 (dd, J = 8.5, 4.4 Hz, 1H), 3.97 (tt, J = 12.6, 
1.6 Hz, 2H), 3.70 (dd, J = 9.7, 4.7 Hz, 1H), 3.64 (dd, J = 9.7, 5.7 Hz, 1H), 2.95–2.78 (m, 2H); 13C 
NMR (125 MHz, CDCl3) δ 158.9, 147.4, 139.9, 138.1, 137.5, 131.4, 130.3, 129.4, 126.9, 125.0, 
122.4, 115.3 (tt, J = 251, 26.3 Hz), 109.4 (tt, J = 250, 23.5 Hz), 77.5, 72.0, 68.9 (t, J = 28.4 Hz), 
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36.6; IR (KBr, ν / cm–1) 3242, 2931, 2863, 1636, 1597, 1552, 1495, 1473, 1444, 1375, 1275, 1121, 
1074, 915, 767; HRMS (ESI
+
) Calcd for C17H17F4NO2 (M+Na
+
) 366.1088, Found 366.1098. 
 
1–(Benzo[h]quinolin–10–yl)–3–methoxy–2–propanol (3z). 50.3 mg, 
94%, yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 8.92 (dd, J = 4.5, 1.8 Hz, 
1H), 8.20 (dd, J = 8.0, 1.8 Hz, 1H), 7.88–7.77 (m, 2H), 7.68–7.59 (m, 3H), 
7.53 (dd, J = 8.0, 4.5 Hz, 1H), 5.68 (brs, 1H), 4.46–4.34 (m, 1H), 4.09 (dd, 
J = 13.1, 8.1 Hz, 1H), 3.83 (dd, J = 13.1, 3.9 Hz, 1H), 3.73–3.59 (m, 2H), 3.50 (s, 3H); 13C NMR 
(125 MHz, CDCl3) δ 147.5, 146.8, 138.9, 136.8, 135.8, 132.6, 130.1, 129.6, 127.93, 127.91, 127.8, 
125.4, 121.5, 77.6, 73.1, 59.4, 40.5; IR (KBr, ν / cm–1) 3566, 3048, 2960, 2904, 2884, 1508, 1421, 
1394, 1338, 1196, 1125, 964, 885, 763, 731; HRMS (ESI
+
) Calcd for C17H17NO2 (M+Na
+
) 
290.1151, Found 290.1162. 
 
1–(Benzo[h]quinolin–10–yl)–3–butoxy–2–propanol (3A). 43.9 mg, 
71%, yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 8.93 (d, J = 2.9 Hz, 
1H), 8.22 (d, J = 7.8 Hz, 1H), 7.82 (dd, J = 8.8, 2.9 Hz, 2H), 7.64 (t, J = 
6.7 Hz, 3H), 7.54 (dd, J = 7.8, 4.3 Hz, 1H), 5.61 (brs, 1H), 4.47–4.36 (m, 
1H), 4.10 (dd, J = 13.0, 8.0 Hz, 1H), 3.86 (dd, J = 13.0, 4.0 Hz, 1H), 3.66 (d, J = 5.5 Hz, 2H), 3.57 
(t, J = 6.6 Hz, 2H), 1.76–1.61 (m, 2H), 1.48–1.40 (m, 2H), 0.95 (t, J = 7.4 Hz, 3H); 13C NMR (125 
MHz, CDCl3) δ 147.6, 146.8, 139.0, 136.8, 135.8, 132.7, 130.1, 129.7, 127.94, 127.89, 127.7, 
125.4, 121.5, 75.6, 73.2, 71.5, 40.6, 32.2, 19.7, 14.2; IR (KBr, ν / cm–1) 3420, 3056, 2956, 2931, 
2866, 1734, 1592, 1570, 1425, 1393, 1237, 1122, 835, 806, 731; HRMS (ESI
+
) Calcd for 
C20H23NO2 (M+Na
+
) 332.1621, Found 332.1623.
 
 
1–(Benzo[h]quinolin–10–yl)–3–((2–ethylhexyl)oxy)–2–
propanol (3B). 42.4 mg, 58%, yellow solid; 
1
H NMR (500 
MHz, CDCl3) δ 8.93 (d, J = 3.6 Hz, 1H), 8.22 (d, J = 7.1 Hz, 
1H), 7.82 (d, J = 8.2 Hz, 2H), 7.69–7.59 (m, 3H), 7.54 (dd, J 
= 7.9, 4.3 Hz, 1H), 5.64 (brs, 1H), 4.41–4.37 (m, 1H), 4.11 (dd, J = 13.1, 7.9 Hz, 1H), 3.87 (dd, J = 
13.1, 3.9 Hz, 1H), 3.66–3.61 (m, 2H), 3.51–3.39 (m, 2H), 1.59 (dd, J = 15.2, 9.2 Hz, 2H), 1.52–
1.19 (m, 7H), 0.93–0.86 (m, 6H); 13C NMR (125 MHz, CDCl3) δ 147.6, 146.8, 139.1, 136.7, 135.8, 
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132.7, 130.2, 129.7, 127.9, 127.9, 127.7, 125.4, 121.5, 75.7, 74.6, 73.3, 40.6, 40.0, 30.9, 29.4, 24.2, 
23.4, 14.4, 11.4; IR (KBr, ν / cm–1) 3445, 3159, 3057, 2959, 2903, 2858, 1733, 1457, 1394, 1263, 
1103, 835, 731; HRMS (ESI+) Calcd for C24H31NO2 (M+Na
+
) 388.2247, Found 388.2253. 
 
1–(Benzo[h]quinolin–10–yl)–3–phenyl–2–propanol (3C). 52.0 mg, 83%, 
yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 8.60 (dd, J = 4.3, 1.6 Hz, 1H), 
8.09 (dd, J = 8.1, 1.6 Hz, 1H), 7.70 (dd, J = 8.1, 3.6 Hz, 2H), 7.55–7.49 (m, 
2H), 7.45–7.37 (m, 2H), 7.32–7.25 (m, 4H), 7.21–7.15 (m, 1H), 5.58 (brs, 
1H), 4.51–4.35 (m, 1H), 4.02 (dd, J = 13.0, 9.1 Hz, 1H), 3.64 (dd, J = 13.0, 3.3 Hz, 1H), 3.13–2.99 
(m, 2H); 
13
C NMR (125 MHz, CD3OD) δ 148.6, 147.9, 140.9, 140.4, 137.4, 136.9, 133.7, 130.9, 
130.6, 130.2, 129.2, 129.0, 128.6, 128.5, 127.0, 126.4, 122.3, 75.8, 45.9, 45.4; IR (KBr, ν / cm–1) 
3393, 3031, 3025, 2917, 2848, 1591, 1570, 1515, 1496, 1426, 1394, 1325, 1168, 1125, 1081, 1049, 
976, 908, 834, 797, 749, 729, 701; HRMS (ESI+) Calcd for C22H19NO (M+Na
+
) 336.1359, Found 
336.1364.
 
 
1–(Benzo[h]quinolin–10–yl)hex–5–en–2–ol (3D). 27.2 mg, 49%, 
yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 8.92 (dd, J = 4.5, 1.8 Hz, 
1H), 8.23 (dd, J = 8.0, 1.8 Hz, 1H), 7.82 (d, J = 8.7 Hz, 2H), 7.67–7.61 
(m, 2H), 7.60–7.57 (m, 1H), 7.55 (dd, J = 8.0, 4.5 Hz, 1H), 5.96 (ddt, J 
= 17.0, 10.2, 6.6 Hz, 1H), 5.65 (brs, 1H), 5.11 (dd, J = 17.0, 1.8 Hz, 1H), 5.00 (d, J = 10.2 Hz, 1H), 
4.26–4.22 (m, 1H), 4.07 (dd, J = 13.0, 8.4 Hz, 1H), 3.79 (dd, J = 13.0, 3.6 Hz, 1H), 2.48–2.27 (m, 
2H), 1.95–1.83 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 147.6, 146.8, 139.5, 136.9, 135.8, 132.6, 
130.2, 129.7, 128.0, 127.9, 127.7, 126.9, 125.4, 121.6, 114.6, 74.3, 43.7, 38.1, 30.4; IR (KBr, ν / 
cm
–1
) 3419, 2921, 2849, 1639, 1592, 1571, 1514, 1426, 1393, 1317, 1168, 1124, 1065, 908, 834, 
808, 760, 731, 667; HRMS (ESI+) Calcd for C19H19NO (M+Na
+
) 300.1359, Found 300.1368. 
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2–(3–(Benzo[h]quinolin–10–yl)–2–hydroxypropyl)isoindoline–
1,3–dione (3E). 50.6 mg, 66%, yellow solid; 1H NMR (500 MHz, 
CDCl3) δ 8.97 (d, J = 4.4 Hz, 1H), 8.22 (d, J = 8.0 Hz, 1H), 7.91–
7.84 (m, 2H), 7.84–7.80 (m, 2H), 7.76–7.68 (m, 2H), 7.68–7.60 (m, 
3H), 7.55 (dd, J = 8.0, 4.7 Hz, 1H), 5.67 (brs, 1H), 7.59–4.56 (m, 
1H), 4.23–4.06 (m, 3H), 3.82 (dd, J = 13.1, 3.4 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 169.1, 
147.4, 147.1, 138.3, 136.9, 135.8, 134.1, 132.52, 132.49, 131.9, 130.2, 129.6, 128.0, 127.9, 125.5, 
123.5, 121.7, 72.3, 45.4, 41.7; IR (KBr, ν / cm–1) 3508, 3049, 2933, 1770, 1709, 1467, 1427, 1393, 
1011, 896, 837, 794, 763, 724, 714, 628; HRMS (ESI+) Calcd for C24H18N2O3 (M+Na
+
) 405.1210, 
Found 405.1218. 
 
tert–Butyl (3–(benzo[h]quinolin–10–yl)–2–hydroxypropyl)carbamate (3F). 38.1 mg, 54%, 
yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 8.93 (d, J = 2.7 Hz, 
1H), 8.25 (d, J = 7.9 Hz, 1H), 7.83 (d, J = 8.6 Hz, 2H), 7.72–7.51 
(m, 4H), 6.09 (brs, 1H), 5.22 (brs, 1H), 4.28 (brs, 1H), 4.18 (dd, J 
= 12.8, 9.1 Hz, 1H), 3.64 (dd, J = 12.8, 3.2 Hz, 2H), 3.41–3.29 (m, 
1H), 1.47 (s, 9H); 
13
C NMR (125 MHz, CDCl3) δ 156.7, 147.4, 146.7, 138.7, 137.1, 135.8, 132.6, 
130.0, 129.8, 128.12, 128.07, 127.9, 125.5, 121.7, 74.1, 47.7, 41.3, 30.0, 28.7; IR (KBr, ν / 
cm–1) 3360, 3049, 2963, 2924, 2853, 1706, 1508, 1457, 1428, 1392, 1365, 1250, 1170, 1089, 
894, 835, 763, 731; HRMS (ESI+) Calcd for C21H24N2O3 (M+Na
+
) 375.1679, Found 375.1682. 
 
Ethyl 4–(benzo[h]quinolin–10–yl)–3–hydroxybutanoate (3G). 54.5 
mg, 88%, yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 8.93 (dd, J = 4.4, 
1.8 Hz, 1H), 8.22 (dd, J = 8.0, 1.8 Hz, 1H), 7.83 (dd, J = 11.4, 5.2 Hz, 
2H), 7.63 (ddd, J = 8.8, 8.3, 2.0 Hz, 3H), 7.55 (dd, J = 8.0, 4.4 Hz, 1H), 
5.84 (brs, 1H), 4.72–4.68 (m, 1H), 4.20 (q, J = 7.0 Hz, 2H), 4.11 (dd, J = 13.1, 8.1 Hz, 1H), 3.91 (dd, 
J = 13.1, 4.0 Hz, 1H), 2.86–2.70 (m, 2H), 1.29 (t, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 
172.7, 147.5, 146.9, 138.5, 137.5, 136.8, 135.8, 132.8, 130.1, 129.6, 128.0, 127.9, 125.5, 121.6, 
77.5, 71.3, 60.7, 43.2, 14.5; IR (KBr, ν / cm–1) 3524, 3157, 2971, 2873, 1731, 1592, 1570, 1515, 
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1425, 1394, 1372, 1271, 1151, 1032, 836, 732; HRMS (ESI+) Calcd for C19H19NO3 (M+Na
+
) 
332.1257, Found 332.1249.
 
 
Methyl 3–(benzo[h]quinolin–10–yl)–2–hydroxypropanoate (3H). 
51.2 mg, 91%, yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 8.96 (dd, J = 
4.5, 1.8 Hz, 1H), 8.25 (dd, J = 8.0, 1.8 Hz, 1H), 7.88–7.81 (m, 2H), 7.70–
7.61 (m, 3H), 7.58 (dd, J = 8.0, 4.5 Hz, 1H), 7.08 (brs, 1H), 4.96–4.87 (m, 
1H), 4.36 (dd, J = 13.2, 9.2 Hz, 1H), 4.03 (dd, J = 13.2, 4.1 Hz, 1H), 3.82 (s, 3H); 
13
C NMR (125 
MHz, CDCl3) δ 175.8, 147.3, 146.9, 137.3, 137.2, 135.8, 132.5, 130.2, 129.7, 128.2, 128.1, 128.0, 
125.5, 121.9, 74.8, 52.3, 40.5; IR (KBr, ν / cm–1) 3481, 3157, 2951, 2865, 1735, 1592, 1508, 1435, 
1395, 1206, 1113, 1026, 837, 730; HRMS (ESI+) Calcd for C17H15NO3 (M+Na
+
) 304.0944, Found 
304.0939. 
 
Methyl 3–(benzo[h]quinolin–10–yl)–2–hydroxy–2–methylpropanoate 
(3I).
 
50.8 mg, 86%, yellow solid; 
1
H NMR (500 MHz, CDCl3 δ 8.94 (dd, J 
= 4.5, 1.7 Hz, 1H), 8.26 (dd, J = 8.0, 1.7 Hz, 1H), 8.16 (brs, 1H), 7.91–7.78 
(m, 2H), 7.71–7.52 (m, 4H), 4.46 (d, J = 13.5 Hz, 1H), 3.91 (d, J = 13.5 Hz, 
1H), 3.78 (s, 3H), 1.71 (s, 3H); 
13
C NMR (125 MHz, CDCl3) δ 177.8, 146.9, 146.7, 137.5, 136.0, 
135.8, 133.9, 130.7, 129.9, 128.4, 128.1, 127.8, 125.3, 121.9, 52.4, 44.7, 26.7, 21.5; IR (KBr, ν / 
cm
–1
) 3436,  2983, 2864, 1733, 1643, 1573, 1517, 1426, 1395, 1369, 1329, 1256, 1112, 982, 840, 
743, 731, 668; HRMS (ESI+) Calcd for C18H17NO3 (M+Na
+
) 318.1101, Found 318.1111. 
 
1–(Benzyloxy)–3–(2–(isoquinolin–1–yl)phenyl)–2–propanol (3J). 
67.2 mg, 91% (dr = 3:1 in CDCl3), yellow solid; 
1
H NMR (500 MHz, 
CDCl3) δ 8.52–8.48 (m, 1.33H), 7.89–7.83 (m, 2.66H), 7.73 (d, J = 8.5 
Hz, 0.33 H), 7.70–7.59 (m, 3H), 7.59–7.20 (m, 11H), 6.80 (brs, 1H), 
5.42 (brs, 0.33H), 4.56–4.47 (m, 2.67H), 4.08–3.99 (m, 1.33H), 3.56 (dd, J = 9.5, 4.7 Hz, 1H), 
3.44–3.30 (m, 1.67H), 2.90 (dd, J = 13.7, 3.5 Hz, 1.33H), 2.63 (dd, J = 14.0, 5.7 Hz, 0.33H), 2.54 
(dd, J = 13.6, 10.6 Hz, 1H); 
13
C NMR (125 MHz, CDCl3) δ 160.2, 140.6, 139.0, 138.8, 138.1, 137.4, 
131.8, 131.2, 131.1, 130.8, 129.4, 128.6, 128.5, 128.2, 128.0, 128.0, 127.8, 127.7, 127.2, 126.1, 
125.7, 120.6, 75.7, 73.5, 73.4, 72.6, 72.5, 69.4, 37.5, 37.0; IR (KBr, ν / cm–1) 3421, 3058, 3031, 
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2924, 2856, 1734, 1622, 1586, 1558, 1496, 1455, 1386, 1359, 1320, 1244, 1101, 1028, 978, 909, 
876, 828, 747, 697, 681, 630; HRMS (ESI+) Calcd for C25H23NO2 (M+Na
+
) 392.1621, Found 
392.1628.
 
 
Methyl 2–hydroxy–3–(2–(isoquinolin–1–yl)phenyl)propanoate 
(3K). 37.9 mg, 78% (dr = 3:1 in CDCl3; dr = 1:1 in CD3OD), yellow 
solid; 
1
H NMR (500 MHz, CDCl3) δ 8.62 (d, J = 5.8 Hz, 1H), 8.55 (d, J 
= 5.8 Hz, 0.33H), 8.25 (brs, 1H), 7.93 (dd, J = 13.8, 8.4 Hz, 2.33H), 
7.86 (d, J = 8.5 Hz, 0.33H), 7.77–7.69 (m, 2.33H), 7.59 (d, J = 7.7 Hz, 1H), 7.57–7.49 (m, 2H), 
7.46–7.32 (m, 3H), 4.67–4.56 (m, 0.33H), 4.47 (dd, J = 11.6, 3.7 Hz, 1H), 3.73 (s, 3.33H), 3.22 (dd, 
J = 14.2, 3.7 Hz, 0.33H), 3.10 (dd, J = 13.7, 3.7 Hz, 1H), 3.00 (dd, J = 14.2, 5.5 Hz, 0.33H), 2.80 
(dd, J = 13.5, 11.8 Hz, 1H); 
1
H NMR (500 MHz, CD3OD) δ 8.53 (d, J = 5.8 Hz, 1H), 8.49 (d, J = 
5.8 Hz, 1H), 8.02 (dd, J = 8.2, 2.1 Hz, 2H), 7.88 (dd, J = 5.7, 2.9 Hz, 2H), 7.83–7.74 (m, 3H), 7.68 
(d, J = 8.4 Hz, 1H), 7.62–7.46 (m, 6H), 7.45–7.39 (m, 2H), 7.38–7.34 (m, 1H), 7.32 (d, J = 7.5 Hz, 
1H), 4.10 (ddd, J = 14.4, 8.8, 5.0 Hz, 2H), 3.54 (s, 3H), 3.47 (s, 3H), 3.07 (dd, J = 14.0, 4.7 Hz, 1H), 
2.86 (dd, J = 14.1, 7.8 Hz, 1H), 2.77 (dd, J = 14.0, 5.0 Hz, 1H), 2.65 (dd, J = 14.0, 9.8 Hz, 1H); 
13
C 
NMR (125 MHz, CDCl3) δ 175.4, 159.4, 140.4, 138.0, 137.6, 137.3, 135.8, 131.6, 131.2, 131.0, 
130.9, 129.7, 129.2, 128.2, 127.9, 127.8, 127.8, 127.3, 127.2, 126.4, 126.2, 121.0, 73.3, 52.2, 37.4, 
37.0; IR (KBr, ν / cm–1) 3159, 3057, 2951, 2863, 1748, 1622, 1587, 1558, 1490, 1443, 1385, 1359, 
1322, 1270, 1208, 1173, 1114, 1018, 978, 876, 829, 806, 763, 734, 695, 680, 631; HRMS (ESI+) 
Calcd for C19H17NO3 (M+Na
+
) 330.1101, Found 330.1099. 
 
2–Hydroxy–3–(2–(isoquinolin–1–yl)phenyl)propyl 4–methylbenzenesulfonate (3L). 59.0 mg, 
68%, yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 9.36–9.32 (m, 1H), 
8.33–8.29 (m, 1H), 8.24–8.18 (m, 2H), 8.10 (dd, J = 7.2, 7.2 Hz, 1H), 
7.92–7.83 (m, 1H), 7.80 (d, J = 7.8 Hz, 2H), 7.67 (d, J = 5.7 Hz, 1H), 
7.64–7.58 (m, 2H), 7.54 (d, J = 7.4 Hz, 1H), 7.13 (d, J = 7.8 Hz, 2H), 
6.37 (brs, 1H), 5.56 (d, J = 13.2 Hz, 1H), 4.96–4.92 (m, 1H), 4.26 (d, J = 13.2 Hz, 1H), 3.22 (dd, J 
= 13.8, 7.2 Hz, 1H), 2.29 (s, 3H), 2.29–2.24 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 157.6, 146.1, 
143.3, 139.9, 139.6, 139.1, 138.4, 136.1, 133.3, 132.2, 131.4, 130.6, 129.9, 128.9, 128.5, 127.8, 
126.9, 126.3, 125.4, 75.0, 64.4, 37.8, 21.6; IR (KBr, ν / cm–1) 3306, 3058, 2964, 2925, 2857, 1734, 
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1628,  1603, 1561, 1511, 1454, 1431, 1401, 1379, 1334, 1264, 1222, 1179, 1121, 1089, 1033, 
1011, 937, 917, 880, 816, 766, 734, 700, 681, 639, 623; HRMS (ESI+) Calcd for C25H23NO4S 
(M+Na
+
) 456.1240, Found 456.1230. 
 
Methyl 2–hydroxy–3–(3–methyl–2–(quinolin–8–ylcarbamoyl)phenyl)propanoate (3M). 48.8 
mg, 67%, yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 9.99 (s, 1H), 9.94–
8.80 (m, 2H), 8.22 (dd, J = 8.3, 1.6 Hz, 1H), 7.67–7.59 (m, 2H), 7.49 (dd, 
J = 8.3, 4.2 Hz, 1H), 7.34 (t, J = 7.6 Hz, 1H), 7.21 (dd, J = 12.8, 7.6 Hz, 
2H), 5.51 (brs, 1H), 4.51 (dd, J = 10.0, 3.5 Hz, 1H), 3.72 (s, 3H), 3.24 (dd, 
J = 14.1, 3.5 Hz, 1H), 3.03 (dd, J = 14.1, 10.0 Hz, 1H), 2.49 (s, 3H); 
13
C 
NMR (125 MHz, CDCl3) δ 174.7, 169.0, 149.1, 139.3, 138.5, 137.0, 135.5, 134.6, 134.1, 129.8, 
129.4, 128.6, 127.6, 127.4, 123.1, 122.0, 119.1, 72.8, 52.6, 38.6, 20.2; IR (KBr, ν / cm–1) 3346, 
3058, 2952, 1741, 1670, 1523, 1485, 1325, 1268, 1102, 827, 791, 668; HRMS (ESI+) Calcd for 
C21H20N2O4 (M+Na
+
) 387.1315, Found 387.1305. 
 
(E)–Methyl 2–hydroxy–3–(2–(1–(methoxyimino)ethyl)phenyl)propanoate (3N). 35.7 mg, 
71%, yellow solid;
 1
H NMR (500 MHz, CDCl3) δ 7.36–7.27 (m, 4H), 5.43 (d, 
J = 7.1 Hz, 1H), 4.47–4.43 (m, 1H), 4.06 (s, 3H), 3.79 (s, 3H), 3.21–3.17 (m, 
2H), 2.24 (s, 3H); 
13
C NMR (125 MHz, CDCl3) δ 175.2, 156.1, 137.4, 135.1, 
131.0, 129.3, 128.7, 127.3, 72.9, 62.3, 52.4, 37.6, 16.6; IR (KBr, ν / cm–1) 
3481, 3056, 2952, 2865, 2754, 1744, 1541, 1438, 1364, 1277, 1208, 1099, 1044, 887, 762, 638; 
HRMS (ESI+) Calcd for C13H17NO4 (M+Na
+
) 274.1050, Found 274.1059. 
 
Methyl 6–methyl–1–oxoisochroman–3–carboxylate1 (5a). 30.0 mg, 
68%, yellow solid;
 1
H NMR (500 MHz, CDCl3) δ 7.99 (d, J = 7.9 Hz, 1H), 
7.21 (d, J = 7.9 Hz, 1H), 7.05 (s, 1H), 5.15 (dd, J = 5.8, 5.3 Hz, 1H), 3.74 
(s, 3H), 3.38 (dd, J = 16.5, 5.3 Hz, 1H), 3.25 (dd, J = 16.5, 5.8 Hz, 1H), 2.40 (s, 3H); 
13
C NMR (125 
MHz, CDCl3) δ 169.8, 163.7, 145.4, 136.5, 130.7, 129.4, 128.3, 122.4, 75.2, 53.2, 30.4, 22.0; IR 
(KBr, ν / cm–1) 3429, 2960, 1749, 1719, 1614, 1439, 1389, 1249, 1226, 1200, 1270, 1135, 1103, 
1025, 950, 834, 769, 709, 688; HRMS (ESI+) Calcd for C12H12O4 (M+Na
+
) 243.0628, Found 
243.0636. 
1. Palladium-Catalyzed Oxirane-Openning Reaction with Arenes via C-H Activation 
47 
 
 
3–Benzyl–6–methylisochroman–1–one (5b). 36.3 mg, 72%, yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 7.97 (d, J = 7.9 Hz, 1H), 7.38–7.24 (m, 5H), 
7.17 (d, J = 7.9 Hz, 1H), 6.98 (s, 1H), 4.78–4.66 (m, 1H), 3.25 (dd, J = 13.7, 
5.6 Hz, 1H), 3.01 (dd, J = 13.7, 7.7 Hz, 1H), 2.91 (dd, J = 16.2, 11.2 Hz, 1H), 2.79 (dd, J = 16.2, 3.0 
Hz, 1H), 2.37 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 165.8, 144.9, 139.1, 136.4, 130.6, 129.8, 
128.9, 128.8, 128.2, 127.2, 122.7, 79.3, 41.5, 32.5, 22.0; IR (KBr, ν / cm–1) 3648, 3029, 2918, 1721, 
1614, 1455, 1362, 1278, 1247, 1158, 1134, 1079, 1014, 911, 838, 752, 700; HRMS (ESI+) Calcd 
for C17H16O2 (M+Na
+
) 275.1043, Found 275.1045. 
 
6–Methyl–3–(phenoxymethyl)isochroman–1–one (5c). 40.2 mg, 75%, 
yellow solid;
 1
H NMR (500 MHz, CDCl3) δ 8.16 (d, J = 7.9 Hz, 1H), 7.51–
7.41 (m, 2H), 7.38 (d, J = 7.9 Hz, 1H), 7.30–7.24 (m, 1H), 7.15 (t, J = 7.3 
Hz, 1H), 7.09 (d, J = 8.1 Hz, 2H), 5,13–5.02 (m, 1H), 4.46 (dd, J = 9.8, 4.6 Hz, 1H), 4.36 (dd, J = 
9.8, 5.9 Hz, 1H), 3.39 (dd, J = 16.2, 11.3 Hz, 1H), 3.24 (dd, J = 16.3, 3.3 Hz, 1H), 2.58 (s, 3H); 
13
C 
NMR (125 MHz, CDCl3) δ 165.1, 158.4, 145.3, 138.7, 130.7, 129.8, 129.0, 128.4, 122.5, 121.7, 
114.8, 76.3, 68.9, 30.4, 22.0; IR (KBr, ν / cm–1) 3445, 3061, 3040, 2924, 1721, 1614, 1600, 1541, 
1497, 1456, 1377, 1281, 1243, 1140, 1118, 1081, 1039, 1172, 1081, 839, 775, 755, 691; HRMS 
(ESI+) Calcd for C17H16O3 (M+Na
+
) 291.0992, Found 291.0983. 
 
2–((6–Methyl–1–oxoisochroman–3–yl)methyl)isoindoline–1,3–
dione (5d).
 
56.0 mg, 58%, yellow solid;
 1
H NMR (500 MHz, CDCl3) 
δ 7.96 (d, J = 7.9 Hz, 1H), 7.87 (dd, J = 5.1, 3.1 Hz, 2H), 7.74 (dd, J 
= 5.1, 3.1 Hz, 2H), 7.18 (d, J = 7.9 Hz, 1H), 7.04 (s, 1H), 4.96–4.83 
(m, 1H), 4.18 (dd, J = 14.1, 7.5 Hz, 1H), 3.93 (dd, J = 14.1, 5.4 Hz, 1H), 3.12–2.97 (m, 2H), 2.39 (s, 
3H); 
13
C NMR (125 MHz, CDCl3) δ 168.3, 164.6, 145.2, 138.0, 134.5, 132.2, 130.7, 129.1, 128.3, 
123.8, 122.5, 75.1, 41.4, 31.2, 22.0; IR (KBr, ν / cm–1) 3424, 3051, 2925, 1773, 1716, 1614, 1428, 
1396, 1273, 1238, 1125, 1078, 1018, 976, 911, 839, 774, 725, 715; HRMS (ESI+) Calcd for 
C19H15NO4 (M+Na
+
) 344.0893, Found 344.0882.
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1–Phenoxy–3–(2–(2–pyridinyl)phenyl)–2–propanol–d5 (3a–d). 57.5 
mg, 93%, yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 8.62 (dd, J = 4.2, 
1.0 Hz, 1H), 7.96 (brs, 1H), 7.86 (ddd, J = 7.8, 7.8, 1.7 Hz, 1H), 7.57 (d, J 
= 7.9 Hz, 1H), 7.37–7.27 (m, 3H), 7.00–6.93 (m, 3H), 4.31 (s, 1H), 4.14 
(dd, J = 9.2, 4.6 Hz, 1H), 3.97 (dd, J = 9.1, 6.9 Hz, 1H), 3.06 (dd, J = 13.7, 
4.0 Hz, 1H), 3.01 (dd, J = 13.7, 8.7 Hz, 1H);
 13
C NMR (125 MHz, CDCl3) δ 158.9, 147.4, 139.8, 
138.1, 137.3, 129.6, 125.0, 122.4, 121.2, 120.9, 114.9, 72.1, 71.4, 36.8; IR (KBr, ν / cm–1) 3444, 
2923, 2857, 2755, 1734, 1636, 1599, 1496, 1475, 1456, 1435, 1399, 1291, 1173, 1172, 1153, 1043, 
1018, 997, 911, 880, 855, 814, 798, 754, 692, 631; HRMS (ESI+) Calcd for C20H15D4NO2 (M+Na
+
) 
332.1559，Found 332.1556. 
 
KIE experiments. Coupling reactions were carried out under the reaction conditions which are 
described in Figures S1 and S2, stopped at arbitrary reaction times, and analyzed by 
1
H NMR 
spectroscopy (Figures S1 and S2). As a result, the slope values of two graphs were 0.0013 mM/min 
and 0.0005 mM/min, respectively, and thus the KIE value was 2.6. The KIE value suggested that 
C–H bond activation step was the rate–determining step. 
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Figure S1-1. Determination of a reaction rate using 1a as a substrate. 
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Figure S1-2. Determination of a reaction rate using 1a–d5 as a substrate. 
 
Coupling Reactions Using Chiral Oxiranes. The enantiomeric excess of (S)–3v was 
determined by HPLC (chiral column: CHIRALPAK AD–H; solvent: hexane/2–propanol = 9/1; 
flow rate: 1.0 mL/min; detection: at 254 nm) analysis in comparision with authentic racemic 
material: Retention time = 19.9 min (R) and 28.0 min (S). 
 
 
 
The enantiomeric excess of (R)–3w was determined by HPLC (chiral column: CHIRALPAK 
AD–H; Mobile phase: hexane/2–propanol = 9/1; flow rate: 1.0 mL/min; detection at 254 nm) 
analysis in comparision with authentic racemic material: Retention time = 12.8 min (R) and 21.1 
min (S). 
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2. Copper–Catalyzed Intramolecular C(sp
3
)–H and C(sp
2
)–H 
Amidation by Oxidative Cyclization 
2.1. Introduction 
β–Lactams (cyclic amides) and related compounds are important partial structures of natural 
products and drug molecules, such as penicillin and cephalosporin, ezetimibe,
1
 and piperacillin
2
 
(–lactam antibiotics) (Figure 2-1). There are a lot of classic methods that can be used to prepare 
–lactams, such as, Beckmann rearrangement,3 Schmidt reaction,4 cyclization of amino acids,5 
and iodolactamization
6
. However, there are several drawbacks for these reactions, such as using 
highly activated intermediates, harsh reaction conditions, and production of a lot of side products. 
If we can develop a method catalyzed by the earth aboudance first row transition metals based on 
C–H activation, it is very useful for the preparation of –lactams. I selected copper as a catalyst 
and a direct intramolecular C–H amidation as an alternative synthetic method. Although there are 
several reports of intramolecular C(sp
2
)–H amidation,7 however, these reactions used precious 
second or third row transition metals, such as rhodium or palladium. Examples of intramolecular 
C(sp
3
)–H amidation are still rare. The few examples include: (a) rhodium–catalyzed C(sp3)–H 
amidation at internal positions of alkyl chains, such as benzylic and tertiary positions (Figure 
2-2a);
8
 and (b) palladium–catalyzed allylic C(sp3)–H amidation (Figure 2-2b);9 and (c) 
palladium–catalyzed C(sp3)–H amidation at terminal and internal positions (Figure 2-2c).10 
Intramolecular C(sp
3
)–H amidation using first row transition metal catalysts, however, has not 
been reported. Actually, there is no reports on first row transition metal–catalyzed carbon–
heteroatom bond formation via C(sp
3
)–H activation, which mainly attribute to strong bonds 
between highly covalent first row transition metals and heteroatoms. I realized the first copper–
catalyzed intramolecular C(sp
3
)–H (and C(sp2)–H) amidation uisng a bidentate directing group 
(aninoquinonyl group).
11
 The amidation reaction proceeded at both terminal and internal C(sp
3
)–
H bonds with broad substrate generality.  
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2.2. Optimization Studies 
Considering the small radius of a copper atom, I chose a quatenary amide as a starting 
material to investigate the desired reaction. Treatment of amide 1a with a catalytic amount of 
CuCl and Ag2CO3 as an oxidant in dimethyl sulfoxide at 140 °C for 24 h gave –lactam 2a in 
only 17% yield (Table 2-1, entry 1). To improve the yield of 2a, several solvents and catalysts 
were investigated (Table 2-1). I found that the reaction worked better in low polar solvents rather 
than high polar solvents (entries 1-10). This phenomenon manily attributed to the Cu(III) center 
was stabilized by the heteroatom of high polar solvent, in contrast, copper is unsaturated 
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coordination in low polar solvent which can accelerate the reductive elimination step (see the 
proposed reaction mechanism, Scheme 2-1). The best solvent and catalyst were 1,2–
dichloroethane and CuSCN (or Cu(OAc)2), respectively (entries 14 and 18). In this reaction, –
lactam formation through C–H amidation at the terminal methyl group was predominant, and –
lactam through internal methylene C–H amidation was not detected at all. 
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2.3. Substrate Scope and Mechanism Research 
With the best reaction conditions in hand, I investigated the substrate scope. Although 
CuSCN was more reactive than Cu(OAc)2 for amide 1a (Table 2-1), its applicability to other 
substrates was unsatisfactory. Therefore, I investigated the substrate scope using Cu(OAc)2 as the 
catalyst (Table 2-2). For substrates 1b–1g, the amidation reaction proceeded selectively at a 
methyl group rather than methylene group (entries 1–6). For phenacyl amide substrate 1h, which 
possesses competitive positions at methyl and phenyl groups, the reaction proceeded at both 
C(sp
3
)–H and C(sp2)–H bonds, affording a mixture of –lactam 2h and 2–indolinone 3h, with 2h 
as the preferred product (entry 7). The reaction also proceeded selectively at an internal benzylic 
C(sp
3
)–H bond (entries 8–17). The selectivity between methyl C–H and benzyl C–H bonds was 
moderate and the product distribution was not affected by the substituents on the phenyl ring (ca. 
1:2, entries 8–15). I concluded that the reaction was affected by the acidity of C–H bonds rather 
than the steric effect. When the benzylic and methylene positions were the competitive sites, 
benzylic C–H amidation was the predominant pathway affording strained bicyclic compounds 
(entries 16 and 17). One of disadvantages of animoquinolyl group-directed C–H transformations 
is removal of the directing group after the reactions. Therefore, I used a removable directing 
group, 5–methoxyquinolyl group,17 and the reaction also proceeded using an amide with the 
directing group producing –lactam 2s in high yield (entry 18). 
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Considering the beneficial effects of acetate anions on reactivity (Table 2-1), I propose the 
following mechanism for the formation of –lactams (Scheme 2-1): (1) oxidation of a copper salt 
Cu(OAc)2 with Ag2CO3;
12
 (2) formation of a copper–amide intermediate I via elimination of 
acetic acid;
13
 (3) formation of a metalacyclic intermediate II via a concerted metalation–
deprotonation (CMD) pathway (C(sp
3
)–H bond activation);14 (4) reaction between the 
metalacyclic intermediate II and acetic acid to give an intermediate III by the elimination of CO2 
and H2O; (5) reductive elimination to give a –lactam 2 and copper species CuOAc; and (6) 
oxidation of the CuOAc species with Ag2CO3 to regenerate Cu(OAc)(CO3).
12 
After the first cycle, 
the reaction proceeds via steps (2) to (6). 
 
 
 
Next, I performed a deuterium–labeling experiment to gain insight into the rate–determining 
step for the formation of –lactams. Treatment of amide 1d or deuterated amide 1d–D with a 
copper catalyst and oxidant gave the corresponding –lactams 2d and 2d–D in 16% and 5.6% 
yields, respectively, after 1 h (eqs 2-1 and 2-2). The kinetic isotope effect value was 2.6, 
supporting our assumption that C–H bond activation is the rate–determining step.15  
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The reaction could be performed in gram–scale without significantly changing the efficiency 
(eq 2-3). Thus, treatment of 1.50 g of 1f with Cu(OAc)2 and Ag2CO3 gave 1.22 g of 2f in 81% 
yield, comparable to the yield shown in Table 2-2, entry 5 (1f: 33.2 mg). 
 
 
 
A residual directing group in the products decreases the practicality of the transformation. 
According to Chen’s finding, the 5–methoxyquinolyl group can be cleaved under oxidative 
conditions (eq 2-4).
16
 Treatment of –lactam 2s with ceric ammonium nitrate afforded 
deprotected –lactam 4 in 67% yield without opening the sensitive –lactam scaffold (eq 2-4). 
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In my retrosynthesis of duocarmycin, the desired reaction is formation of 5–membered 
aromatic amides via C(sp
2
)–H activation. So I tried to realize intramolecular C(sp2)-H amidation 
even in the presence of both C(sp
2
)–H and C(sp3)–H bonds. Interestingly, the reaction of 1h 
occurred at the C(sp
2
)–H bond selectively when the reaction conditions were slightly modified 
(eq 2-5). Thus, treatment of 1h in the presence of CuCl2 catalyst and Ag2CO3 in dimethyl 
sulfoxide under an O2 atmosphere at 140 °C for 24 h produced 2–indolinone 3h and –lactam 2h 
in 89% and 4% yields, respectively. This result is in sharp contrast to the result shown in Table 
2-2, entry 7, where C(sp
3
)–H amidation was the preferred reaction pathway. This result may be 
due to that the copper(III) species can be stabilized by DMSO, but I think that the reaction must 
proceeded in a different mechanism under this conditions and SET will be the main mechanism 
for this reaction and the high polar transition state is stabilized by DMSO. 
 
 
 
2.4. Summary 
 In summary, I succeeded in intramolecular C(sp
3
)–H and C(sp2)–H amidation under copper 
catalysis. Although there are a few examples of palladium–catalyzed intramolecular C–H 
amidation, this is the first example of copper–catalyzed C(sp3)–H amidation, and this is the first 
example of first row transition–metal–catalyzed carbon–heteroatom bond formation. The reaction 
proceeded at a terminal methyl group, as well as at the internal benzylic position of an alkyl chain. 
If methyl and benzyl sites locate at competitive positions, the reaction mainly proceeded at the 
more acidic benzylic positions. The electronic effect determines the distribution of products 
rather than the steric effect. This reaction has broad substrate scope, and –lactams were obtained 
in high yields, even in gram–scale. 2–Indolinone was also synthesized via C(sp2)–H amidation by 
slightly modifying the optimized conditions for C(sp
3
)–H amidation. Because the 5–
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methoxyquinolyl directing group can be removed by oxidation, this reaction becomes a useful 
method for the synthesis of –lactams and 2–indolinones. Attempts to improve the position 
selectivity and catalyst activity are ongoing in our group, On the other hand, I am trying to use 
this method to the synthesis of duocarmycim.. 
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2.6. Experimental 
General. All reactions were carried out in a dry solvent under argon atmosphere unless otherwise 
noted. Cu(OAc)2 (99.999%) and Cu(SCN) (99%) were purchased from Aldrich. Methanol, N,N–
dimethylformamide, dichloromethane (DCE), and THF were purchased from Wako Pure 
Chemical Industries, and were dried and degassed before use. Lithium diisopropylamide (LDA) 
was purchased from Aldrich. NMR spectra were recorded on JEOL ECX500 (500 MHz for 
1
H 
NMR and 125 MHz for 
13
C NMR) spectrometer. Proton chemical shifts are reported relative to 
residual solvent peak (CDCl3 at 7.26 ppm). Carbon chemical shifts are reported relative to 
residual solvent peak (CDCl3 at 77.3 ppm). The following abbreviations are used to designate 
multiplicities: s = singlet, d = doublet, t = triplet, q = quartet, quint = quintet, m = multiplet, br = 
broad. IR spectra were recorded on a JASCO FT/IR–410. High–resolution mass spectra (HRMS) 
were measured on a JEOL JMS–T100LC AccuTOF spectrometer (for HRMS). 
 
Preparation of amides 1a and 1b. To a solution of an acid chloride (11.0 mmol) in 
dichloromethane (40 mL), a solution of 8–aminoquinoline (1.44 g, 10.0 mmol) and NEt3 (1.01 g, 
11.0 mmol) in dichloromethane (10 mL) was added dropwise. The resulting mixture was stirred 
at 25 °C for 30 min. Then, the mixture was quenched with saturated aq. NaHCO3 (50 mL), and 
was extracted with dichloromethane for three times (3 x 50 mL). The organic layer was dried 
over Na2SO4. After filtration and evaporation, an amide was purified by column chromatography 
on silica gel (hexane/ethyl acetate = 10:1). 
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2,2–Dimethyl–N–(8–quinolinyl)butanamide (1a). 1.94 g, 91% yield, 
yellow oil; 
1
H NMR (500 MHz, CDCl3) δ 10.24 (s, 1H), 8.91–8.72 (m, 
2H), 8.14 (dd, J = 8.2, 1.5 Hz, 1H), 7.53 (dd, J = 8.0, 8.0 Hz, 1H), 7.48 
(dd, J = 8.0, 1.5 Hz, 1H), 7.44 (dd, J = 8.2, 4.2 Hz, 1H), 1.77 (q, J = 7.5 Hz, 2H), 1.39 (s, 6H), 
0.96 (t, J = 7.5 Hz, 3H); 
13
C NMR (126 MHz, CDCl3) δ 176.9, 148.4, 138.9, 136.6, 134.9, 128.2, 
127.7, 121.7, 121.4, 116.5, 44.3, 34.3, 25.3, 9.5; IR (KBr, ν / cm–1) 3367, 2967, 2877, 2359, 1677, 
1530, 1486, 1423, 1383, 1325, 1155, 826, 791, 756, 681, 617; HRMS (ESI
+
) Calcd for 
C15H18N2O (M+Na
+
) 265.1311, Found 265.1311. 
 
N–(8–quinolinyl)pivalamide (1b). 1.90 g, 99% yield, yellow oil; 1H NMR 
(500 MHz, CDCl3) δ 10.27 (s, 1H), 8.85–8.74 (m, 2H), 8.13 (dd, J = 8.0, 
1.4 Hz, 1H), 7.52 (dd, J = 8.2, 8.2 Hz, 1H), 7.47 (dd, J = 8.2, 1.4 Hz, 1H), 
7.42 (dd, J = 8.2, 4.2 Hz, 1H), 1.43 (s, 9H); 
13
C NMR (126 MHz, CDCl3) δ 177.4, 148.4, 139.0, 
136.5, 134.9, 128.1, 127.6, 121.7, 121.4, 116.4, 40.6, 28.0; IR (KBr, ν / cm–1) 3365, 3047, 2962, 
2869, 1681, 1528, 1486, 1424, 1383, 1366, 1325, 1159, 922, 826, 791, 754, 680, 620; HRMS 
(ESI
+
) Calcd for C14H16N2O (M+Na
+
) 251.1155, Found 251.1146. 
 
Preparation of amides 1c, 1g, and 1h. To a solution of a carboxylic acid (11.0 mmol) in 
THF (20 mL), SOCl2 (1.57 g, 13.2 mmol) was added dropwise. The resulting mixture was stirred 
at 25 °C for 1 h. The reaction mixture was concentrated in vacuo to give an acid chloride, which 
was used without purification. To a solution of the prepared acid chloride in dichloromethane (20 
mL), a solution of 8–aminoquinoline (1.44 g, 10.0 mmol) and Et3N (1.01 g, 11.0 mmol) in 
dichloromethane (10 mL) was added dropwise. The resulting mixture was stirred at 25 °C for 30 
min, was quenched with saturated aq. NaHCO3 (30 mL), and was extracted with dichloromethane 
(3 x 100 mL) for three times. The organic layer was dried over Na2SO4. After filtration and 
evaporation, the obtained amide was purified by column chromatography on silica gel 
(hexane/ethyl acetate = 10:1). 
 
3,3,3–Trifluoro–2,2–dimethyl–N–(8–quinolinyl)propanamide (1c). 1.24 g, 82% yield, yellow 
oil; 
1
H NMR (500 MHz, CDCl3) δ 10.54 (s, 1H), 8.95–8.67 (m, 2H), 8.14 (d, J = 8.2 Hz, 1H), 
7.53 (m, 2H), 7.45 (dd, J = 8.2, 4.2 Hz, 1H), 1.64 (s, 6H);
 13
C NMR (126 MHz, CDCl3) δ 167.7, 
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148.7, 139.0, 136.5, 134.3, 128.1, 127.5, 127.4 (q, J = 282 Hz), 122.3, 
122.0, 116.9, 49.9 (q, J = 25.3 Hz), 20.2; IR (KBr, ν / cm–1) 3348, 2989, 
2877, 1696, 1652, 1539, 1488, 1327, 1289, 1206, 1124, 908, 825, 790, 
754, 669; HRMS (ESI
+
) Calcd for C14H13F3N2O (M+Na
+
) 305.0872, Found 305.0878. 
 
1–Methyl–N–(8–quinolinyl)cyclohexanecarboxamide (1g). 2.21 g, 92% 
yield, yellow oil; 
1
H NMR (500 MHz, CDCl3) δ 10.29 (s, 1H), 8.93–8.70 
(m, 2H), 8.12 (dd, J = 8.4, 1.6 Hz, 1H), 7.65–7.37 (m, 3H), 2.26–2.14 (m, 
2H), 1.71–1.47 (m, 7H), 1.44–1.37 (m, 1H), 1.35 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 176.8, 
148.4, 139.0, 136.5, 135.0, 128.1, 127.6, 121.7, 121.3, 116.4, 44.6, 36.0, 26.8, 26.0, 23.2; IR 
(KBr, ν / cm–1) 3363, 2927, 2856, 1681, 1527, 1486, 1470, 1423, 1384, 1324, 1262, 1160, 1131, 
924, 825, 791, 754, 680; HRMS (ESI
+
) Calcd for C17H20N2O (M+Na
+
) 291.1468, Found 
291.1458. 
 
2–Methyl–2–phenyl–N–(8–quinolinyl)propanamide (1h). 5.24 g, 95% 
yield, yellow oil; 
1
H NMR (500 MHz, CDCl3) δ 9.88 (s, 1H), 8.77 (d, 
J = 7.6 Hz, 1H), 8.60 (dd, J = 4.2, 1.4 Hz, 1H), 8.08 (dd, J = 8.3, 1.4 
Hz, 1H), 7.65–7.19 (m, 8H), 1.79 (s, 6H); 13C NMR (126 MHz, CDCl3) δ 176.0, 148.3, 145.1, 
138.9, 136.3, 134.9, 129.0, 128.0, 127.5, 127.2, 126.6, 121.6, 121.5, 116.2, 48.6, 27.2; IR (KBr, ν 
/ cm
–1
) 3566, 3345, 2970, 1682, 1525, 1488, 1472, 1456, 1428, 1388, 1328, 1218, 904, 774, 742, 
770, 669; HRMS (ESI
+
) Calcd for C19H18N2O (M+Na
+
) 313.1311, Found 313.1310. 
 
Preparation of 2,2,3,3–Tetramethyl–N–(8–quinolinyl)butanamide (1e). 
Methyl 2,2,3,3–tetramethylbutanoate was prepared by alkylation of ((1–
methoxy–2–methyl–1–propen–1–yl)oxy)trimethylsilane. To a mixture of 
((1–methoxy–2–methyl–1–propen–1–yl)oxy)trimethylsilane (4.30 g, 24.7 mmol) and tert–butyl 
chloride (6.85 g, 74.0 mmol) in dichloromethane (15 mL), zinc chloride (170 mg, 1.23 mmol) 
was added under nitrogen atmosphere at 0 °C, and stirred at 25 °C for 24 h. The reaction mixture 
was diluted with dichloromethane (20 mL), and washed with 5% aq. NaHCO3 (50 mL). The 
aqueous layer was back–extracted with dichloromethane (3 x 50 mL). The combined organic 
layers were dried over MgSO4, and concentrated in vacuo to give methyl 2,2,3,3–
2. Copper–Catalyzed Intramolecular C(sp3)–H and C(sp2)–H Amidation by Oxidative Cyclization 
66 
 
tetramethylbutyrate (2.78 g, 71% yield). To a solution of 8–aminoquinoline (5.56 g, 38.5 mmol) 
in THF (100 mL), a hexane solution of n–BuLi (1.6 M, 24.1 mL, 38.6 mmol) was added 
dropwise at –78 °C. The mixture was warmed to 25 °C and stirred for 1 h. The mixture was 
added to a THF (20.0 mL) solution of the prepared ester at –78 °C, and the mixture was warmed 
to 25 °C and stirred for 12 h. After quenching with saturated aq. NaHCO3 (200 mL) at 0 °C, the 
mixture was extracted with ethyl acetate (3 x 100 mL). The combined organic layers were 
washed with brine, dried over MgSO4, and evaporated in vacuo to give the amide, which was 
purified by column chromatography on silica gel (hexane/ethyl acetate = 10:1). 1e: 3.60 g, 76% 
yield, white solid;
 1
H NMR (500 MHz, CDCl3) δ 10.26 (s, 1H), 8.81 (dd, J = 5.0, 5.0 Hz, 2H), 
8.14 (d, J = 8.1 Hz, 1H), 7.59–7.41 (m, 3H), 1.40 (s, 6H), 1.07 (s, 9H); 13C NMR (126 MHz, 
CDCl3) δ 176.0, 148.5, 139.2, 136.5, 134.8, 128.2, 127.7, 121.7, 121.3, 116.3, 49.4, 35.8, 26.6, 
21.8; IR (KBr, ν / cm–1) 3563, 3370, 2971, 2863, 1669, 1528, 1485, 1423, 1384, 1324, 1139, 939, 
901, 825, 792, 758, 669; HRMS (ESI
+
) Calcd for C17H22N2O (M+Na
+
) 293.1624, Found 
293.1631. 
 
Preparation of amides 1d, 1d–D, 1f, 1i, 1j, 1k, 1l, 1m, 1n, and 1o. To a solution of methyl 
isobutyrate (3.06 g, 30.0 mmol) in THF (100 mL), a THF solution of lithium diisopropylamide 
(1.5 M, 21.0 mL, 31.5 mmol) was added at –78 °C dropwise. The mixture was stirred at –78 °C 
for 1 h, and the corresponding alkyl halide (33.0 mmol) was added to the solution. The mixture 
was warmed to 25 °C, and was stirred for 16 h. The reaction mixture was quenched with 
saturated aq. NaHCO3 (100 mL) at 0 °C, and was extracted with ethyl acetate (3 x 100 mL). The 
combined organic layer was washed with brine, dried over MgSO4, and evaporated in vacuo to 
give an ester.  
To a solution of 8–aminoquinoline (9.52 g, 66.0 mmol) in THF (200 mL), a hexane solution of 
n–BuLi (1.6 M, 41.3 mL, 66.0 mmol) was added dropwise at –78 °C. The mixture was warmed to 
25 °C and stirred for 1 h. The reaction mixture was added to a solution of the prepared ester in 
THF at –78 °C, and the mixture was warmed to 25 °C and stirred for 12 h. After quenching with 
saturated aq. NaHCO3 (150 mL) at 0 °C, the mixture was extracted with ethyl acetate (3 x 150 
mL). The combined organic layer was washed with brine, dried over MgSO4, and evaporated in 
vacuo to give an amide, which was purified by column chromatography on silica gel 
(hexane/ethyl acetate = 10:1). 
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2,2–Dimethyl–4–phenyl–N–(8–quinolinyl)butanamide (1d). 
Synthesis of an ester from methyl 3–phenylpropanoate and methyl 
isobutyrate, 1.52 g, 65% yield, yellow oil; 
1
H NMR (500 MHz, 
CDCl3) δ 10.24 (s, 1H), 8.83–8.68 (m, 2H), 8.07 (dd, J = 8.3, 1.5 Hz, 1H), 7.57–7.35 (m, 3H), 
7.22–7.02 (m, 5H), 2.69–2.44 (m, 2H), 2.04–1.89 (m, 2H), 1.40 (s, 6H); 13C NMR (126 MHz, 
CDCl3) δ 176.4, 148.5, 142.5, 139.1, 136.6, 134.8, 128.63, 128.55, 128.2, 127.7, 126.0, 121.8, 
121.5, 116.5, 44.1, 44.0, 31.8, 26.0; IR (KBr, ν / cm–1) 3564, 3363, 3025, 2961, 2863, 1681, 1526, 
1486, 1455, 1423, 1384, 1325, 1057, 924, 826, 792, 753, 699; HRMS (ESI
+
) Calcd for 
C21H22N2O (M+Na
+
) 341.1624, Found 341.1621. 
 
2,2–Dimethyl–4–phenyl–N–(8–quinolinyl)butanamide–d6 (1d–D). 
Synthesis of an ester from methyl 3–phenylpropanoate and CD3I, 
1.02 g, 61% yield, yellow oil; 
1
H NMR (500 MHz, CDCl3) δ 10.34 
(s, 1H), 8.95–8.80 (m, 2H), 8.17 (dd, J = 8.2, 1.3 Hz, 1H), 7.61–7.43 (m, 3H), 7.35–7.13 (m, 5H), 
2.76–2.65 (m, 2H), 2.17–1.98 (m, 2H); 13C NMR (126 MHz, CDCl3) δ 176.4, 148.5, 142.5, 139.0, 
136.5, 134.8, 128.6, 128.5, 128.2, 127.7, 126.0, 121.8, 121.5, 116.5, 43.8, 43.7, 31.7 [A signal of 
CD3 groups could not be observed. This is supposed to be heptet, which is too weak to observe in 
13
C NMR.]; IR (KBr, ν / cm–1) 3565, 3443, 3060, 1683, 1523, 1487, 1423, 1384, 1326, 1034, 895, 
825, 791, 753, 668, 617; HRMS (ESI
+
) Calcd for C21H16D6N2O (M+Na
+
) 347.2001, Found 
347.1995. 
 
2–Ethyl–2–methyl–4–phenyl–N–(8–quinolinyl)butanamide (1f). 
Synthesis of an ester from (2–iodoethyl)benzene and 2–
methylbutanoate, 2.31 g, 71% yield, yellow oil; 
1
H NMR (500 MHz, 
CDCl3) δ 10.22 (s, 1H), 8.84–8.69 (m, 2H), 8.06 (dd, J = 8.4, 1.6 Hz, 1H), 7.51–7.34 (m, 3H), 
7.25–7.01 (m, 5H), 2.69–2.43 (m, 2H), 2.16–2.05 (m, 1H), 1.94–1.71 (m, 2H), 1.62 (dt, J = 14.7, 
7.4 Hz, 1H), 1.38 (s, 3H), 0.90 (t, J = 7.4 Hz, 3H); 
13
C NMR (126 MHz, CDCl3) δ 175.8, 148.5, 
142.6, 139.0, 136.5, 134.8, 128.6, 128.5, 128.2, 127.7, 126.0, 121.8, 121.5, 116.5, 47.9, 42.4, 
33.3, 31.5, 21.1, 9.2; IR (KBr, ν / cm–1) 3566, 3362, 3061, 2965, 2826, 2863, 1682, 1525, 1486, 
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1473, 1456, 1422, 1386, 1324, 1259, 1163, 825, 791, 756, 698, 669; HRMS (ESI
+
) Calcd for 
C22H24N2O (M+Na
+
) 355.1781, Found 355.1774. 
 
3–(4–Methoxyphenyl)–2,2–dimethyl–N–(8–
quinolinyl)propanamide (1i). Synthesis of an ester from 1–
(chloromethyl)–4–methoxybenzene and isobutyrate, 2.20 g, 
61% yield, yellow oil; 
1
H NMR (500 MHz, CDCl3) δ 10.15 (s, 
1H), 8.83 (dd, J = 7.6, 1.5 Hz, 1H), 8.74 (dd, J = 4.2, 1.5 Hz, 1H), 8.13 (dd, J = 8.2, 1.6 Hz, 1H), 
7.56–7.38 (m, 3H), 7.15–7.07 (m, 2H), 6.76–6.68 (m, 2H), 3.70 (s, 3H), 2.98 (s, 2H), 1.41 (s, 6H); 
13
C NMR (126 MHz, CDCl3) δ 176.3, 158.4, 148.4, 139.0, 136.4, 134.7, 131.4, 130.2, 128.1, 
127.6, 121.7, 121.5, 116.5, 113.6, 55.3, 46.3, 45.3, 25.4; IR (KBr, ν / cm–1) 3362, 2962, 2877, 
1682, 1651, 1525, 1487, 1324, 1246, 1178, 1034, 918, 827, 791, 756, 682; HRMS (ESI
+
) Calcd 
for C21H22N2O2 (M+Na
+
) 357.1573, Found 357.1571. 
 
2,2–Dimethyl–N–(8–quinolinyl)–3–(p–tolyl)propanamide (1j). 
Synthesis of an ester from 1–(bromomethyl)–4–methylbenzene 
and isobutyrate, 1.20 g, 67% yield, yellow oil; 
1
H NMR (500 
MHz, CDCl3) δ 10.17 (s, 1H), 8.83 (d, J = 7.6 Hz, 1H), 8.75 (dd, J = 4.2, 1.3 Hz, 1H), 8.14 (dd, J 
= 8.2, 1.3 Hz, 1H), 7.59–7.39 (m, 3H), 7.08 (d, J = 7.8 Hz, 2H), 7.00 (d, J = 7.8 Hz, 2H), 3.01 (s, 
2H), 2.24 (s, 3H), 1.40 (s, 6H);
 13
C NMR (126 MHz, CDCl3) δ 176.4, 148.4, 139.0, 136.5, 136.0, 
135.0, 134.8, 130.4, 128.9, 128.1, 127.7, 121.7, 121.5, 116.5, 46.7, 45.2, 25.5, 21.2; IR (KBr, /ν / 
cm
–1
) 3564, 2355, 1682, 1539, 1523, 1487, 1472, 1386, 825, 792; HRMS (ESI
+
) Calcd for 
C21H22N2O (M+Na
+
) 341.1624, Found 341.1626. 
 
2,2–Dimethyl–3–phenyl–N–(8–quinolinyl)propanamide (1k). 
Synthesis of an ester from benzyl bromide and isobutyrate, 1.80 g, 
77% yield, yellow oil; 
1
H NMR (500 MHz, CDCl3) δ 10.18 (s, 1H), 
8.85 (d, J = 7.7 Hz, 1H), 8.74 (d, J = 4.2 Hz, 1H), 8.13 (d, J = 8.2 Hz, 1H), 7.58–7.37 (m, 3H), 
7.23–7.12 (m, 5H), 3.06 (s, 2H), 1.43 (s, 6H); 13C NMR (126 MHz, CDCl3) δ 176.2, 148.4, 139.0, 
138.2, 136.4, 134.7, 130.5, 128.2, 128.1, 127.6, 126.6, 121.7, 121.5, 116.5, 47.1, 45.2, 25.5; IR 
(KBr, ν / cm–1) 3363, 3027, 2963, 1672, 1527, 1486, 1455, 1423, 1385, 1325, 1259, 1147, 917, 
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825, 791, 752, 721, 701; HRMS (ESI
+
) Calcd for C20H20N2O (M+Na
+
) 327.1468, Found 
327.1465. 
 
3–(4–Bromophenyl)–2,2–dimethyl–N–(8–
quinolinyl)propanamide (1l). Synthesis of an ester from 1–
bromo–4–(bromomethyl)benzene and isobutyrate, 1.43 g, 66% 
yield, yellow oil;
 1
H NMR (500 MHz, CDCl3) δ 10.12 (s, 1H), 8.87–8.69 (m, 2H), 8.14 (dd, J = 
8.2, 1.5 Hz, 1H), 7.57–7.43 (m, 2H), 7.43 (dd, J = 8.2, 4.2 Hz, 1H), 7.30 (d, J = 8.4 Hz, 2H), 7.06 
(d, J = 8.4 Hz, 2H), 2.98 (s, 2H), 1.41 (s, 6H);
 13
C NMR (126 MHz, CDCl3) δ 175.8, 148.5, 139.0, 
137.2, 136.5, 134.6, 132.1, 131.3, 128.1, 127.6, 121.8, 121.7, 120.7, 116.5, 46.5, 45.1, 25.5; IR 
(KBr, ν / cm–1) 3363, 3123, 1683, 1508, 1487, 1473, 1420, 1396, 1325, 1259, 1010, 917, 825, 
791; HRMS (ESI
+
) Calcd for C20H19BrN2O (M+Na
+
) 405.0573, Found 405.0566.  
 
3–(4–Chlorophenyl)–2,2–dimethyl–N–(8–quinolinyl)propanamide (1m). Synthesis of an ester 
from 1–chloro–4–(bromomethyl)benzene and isobutyrate, 1.53 
g, 71% yield, yellow oil; 
1
H NMR (500 MHz, CDCl3) δ 10.12 (s, 
1H), 8.87–8.70 (m, 2H), 8.15 (dd, J = 8.3, 1.6 Hz, 1H), 7.61–
7.39 (m, 3H), 7.20–7.07 (m, 4H), 3.00 (s, 2H), 1.41 (s, 6H); 13C 
NMR (126 MHz, CDCl3) δ 175.9, 148.5, 139.0, 136.7, 136.5, 134.6, 132.5, 131.8, 128.4, 128.2, 
127.6, 121.8, 121.7, 116.6, 46.5, 45.2, 25.5; IR (KBr,ν / cm–1) 3375, 3356, 2358, 1682, 1557, 
1507, 1487, 1473, 1386, 1325, 1090, 826, 790; HRMS (ESI
+
) Calcd for C20H19ClN2O (M+Na
+
) 
361.1078, Found 361.1078. 
 
3–(4–Fluorophenyl)–2,2–dimethyl–N–(8–
quinolinyl)propanamide (1n). Synthesis of an ester from 1–
(bromomethyl)–4–fluorobenzene and isobutyrate, 1.59 g, 61% 
yield, yellow oil; 
1
H NMR (500 MHz, CDCl3) δ 10.14 (s, 1H), 
8.86–8.71 (m, 2H), 8.13 (dd, J = 8.3, 1.6 Hz, 1H), 7.58–7.39 (m, 3H), 7.18–7.10 (m, 2H), 6.93–
6.81 (m, 2H), 3.01 (s, 2H), 1.41 (s, 6H); 
13
C NMR (126 MHz, CDCl3) δ 176.0, 161.9 (d, J = 244 
Hz), 148.4, 139.0, 136.5, 134.6, 133.6 (d, J = 3.4 Hz), 131.5 (d, J = 7.8 Hz), 128.1, 127.6, 121.8, 
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121.7, 116.5, 114.7 (d, J = 21.1 Hz), 46.3, 45.0 (d, J = 1.1 Hz), 25.5; IR (KBr,ν / cm–1) 3358, 
3048, 2968, 1682, 1526, 1508, 1487, 1423, 1386, 1325, 1221, 1158, 919, 825, 791, 758, 668; 
HRMS (ESI
+
) Calcd for C20H19FN2O (M+Na
+
) 345.1374, Found 345.1363. 
 
2,2–Dimethyl–N–(8–quinolinyl)–3–(4–(trifluoromethyl)phenyl)propanamide (1o). Synthesis 
of an ester from 1–(bromomethyl)–4–
(trifluoromethyl)benzene and isobutyrate, 1.69 g, 63% yield, 
yellow oil; 
1
H NMR (500 MHz, CDCl3) δ 10.12 (s, 1H), 8.89–
8.67 (m, 2H), 8.14 (d, J = 8.2 Hz, 1H), 7.59–7.49 (m, 2H), 7.43 (d, J = 8.0 Hz, 3H), 7.34–7.19 (m, 
2H), 3.09 (s, 2H), 1.44 (s, 6H);
 13
C NMR (126 MHz, CDCl3) δ 175.6, 148.5, 142.4, 139.0, 136.5, 
134.5, 130.7, 128.9 (q, J = 32.4 Hz), 128.1, 127.6, 125.1 (q, J = 3.8 Hz), 125.1, 124.5 (q, J = 273 
Hz), 121.8, 116.6, 46.9, 45.2, 25.6; IR (KBr,ν / cm–1) 3359, 3027, 1682, 1557, 1552, 1456, 
1419, 1386, 1325, 1163, 859, 825, 791, 669; HRMS (ESI
+
) Calcd for C21H19F3N2O (M+Na
+
) 
395.1342, Found 395.1335. 
 
2–Benzyl–2–methyl–N–(8–quinolinyl)butanamide (1p). Synthesis of 
an ester from benzyl bromide and methyl 2–methylbutanoate, 1.09 g, 
65% yield, yellow oil; 
1
H NMR (500 MHz, CDCl3) δ 10.14 (s, 1H), 
8.95–8.67 (m, 2H), 8.14 (dd, J = 8.3, 1.6 Hz, 1H), 7.61–7.37 (m, 3H), 7.23–7.04 (m, 5H), 3.26 (d, 
J = 13.3 Hz, 1H), 2.83 (d, J = 13.3 Hz, 1H), 2.05 (m, 7.4 Hz, 1H), 1.71–1.52 (m, 1H), 1.35 (s, 
3H), 1.00 (t, J = 7.5 Hz, 3H);
 13
C NMR (126 MHz, CDCl3) δ 175.5, 148.4, 139.0, 138.1, 136.4, 
134.7, 130.5, 128.2, 128.1, 127.7, 126.5, 121.7, 121.5, 116.5, 49.2, 46.2, 33.0, 20.5, 9.4; IR (KBr, 
ν / cm–1) 3566, 3365, 2967, 2924, 1671, 1653, 1526, 1487, 1457, 1423, 1385, 1324, 1082, 915, 
825, 791, 767, 719, 700; HRMS (ESI
+
) HRMS (ESI
+
) Calcd for C21H22N2O (M+Na
+
) 341.1624, 
Found 341.1622. 
 
1–Benzyl–N–(8–quinolinyl)cyclopentanecarboxamide (1q). 
Synthesis of an ester from benzyl bromide and methyl 
cyclopentanecarboxylate, 1.79 g, 73% yield, yellow oil; 
1
H NMR (500 
MHz, CDCl3) δ 10.03 (s, 1H), 8.80 (d, J = 4.2 Hz, 1H), 8.72 (dd, J = 4.2, 1.6 Hz, 1H), 8.12 (dd, J 
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= 8.2, 1.6 Hz, 1H), 7.57–7.36 (m, 3H), 7.23–7.05 (m, 5H), 3.13 (s, 2H), 2.24–2.27 (m, 2H), 1.81–
1.89 (m, 6H); 
13
C NMR (126 MHz, CDCl3) δ 175.8, 148.3, 138.9, 138.6, 136.4, 134.8, 129.9, 
128.3, 128.1, 127.6, 126.5, 121.7, 121.4, 116.4, 57.8, 44.9, 35.6, 24.2; IR (KBr, ν / cm–1) 3566, 
3356, 3027, 2954, 2871, 2359, 1671, 1524, 1485, 1455, 1423, 1384, 1324, 1239, 1164, 915, 825, 
791, 742, 700; HRMS (ESI
+
) Calcd for C22H22N2O (M+Na
+
) 353.1624, Found 353.1613. 
 
1–Benzyl–N–(8–quinolinyl)cyclohexanecarboxamide (1r). Synthesis of an ester from benzyl 
bromide and methyl cyclohexanecarboxylate, 0.99 g, 66% yield, yellow 
oil; 
1
H NMR (500 MHz, CDCl3) δ 10.05 (s, 1H), 8.95–8.63 (m, 2H), 
8.12 (dd, J = 8.1, 0.9 Hz, 1H), 7.63–7.37 (m, 3H), 7.19–7.02 (m, 5H), 
2.98 (s, 2H), 2.26 (d, J = 10.3 Hz, 2H), 1.80–1.71 (m, 2H), 1.69–1.52 
(m, 5H), 1.34 (s, 1H);
 13
C NMR (126 MHz, CDCl3) δ 174.8, 148.3, 139.0, 137.4, 136.4, 134.7, 
130.4, 128.1, 128.0, 127.7, 126.5, 121.6, 121.4, 116.5, 49.8, 47.5, 34.4, 26.2, 23.4; IR (KBr,ν / 
cm–1) 3566, 2826, 2863, 1682, 1523, 1487, 1472, 1456, 1420, 1386, 1323, 1082, 912, 825, 791, 
738, 701; HRMS (ESI
+
) Calcd for C23H24N2O (M+Na
+
) 367.1781, Found 367.1777. 
 
2–Ethyl–N–(5–methoxy–8–quinolinyl)–2–methyl–4–phenylbutanamide (1s). To a solution of 
methyl 2–methylbutanoate (3.00 g, 25.8 mmol) in THF, a THF 
solution of lithium diisopropylamide (1.5 M, 18.1 mL, 27.2 mmol) 
was added dropwise at –78 °C, and the mixture was stirred at –
78 °C for 1 h. (2–Iodoethyl)benzene (6.59 g, 28.4 mmol) was added to the solution, and the 
mixture was warmed to 25 °C and stirred for 16 h. After quenching with saturated aq. NaHCO3 
(100 mL) at 0 °C, the mixture was extracted with ethyl acetate (3 x 150 mL), and the combined 
organic layers were washed with brine, dried over MgSO4, and evaporated in vacuo to give 
methyl 2–ethyl–2–methyl–4–phenylbutanoate. To a solution of 5–methoxy–8–quinolinamine 
(9.89 g, 56.8 mmol) in THF (100 mL), a hexane solution of n–BuLi (1.6 M, 35.5 mL, 56.8 mmol) 
was added dropwise at –78 °C. The mixture was warmed to 25 °C and stirred for 1 h. The 
reaction mixture was added to a solution of methyl 2–ethyl–2–methyl–4–phenylbutanoate (5.59 g, 
27.1 mmol) in THF (20.0 mL) at –78 °C, and the mixture was warmed to 25 °C and stirred for 12 
h. After quenching with saturated aq. NaHCO3 (150 mL) at 0 °C, the mixture was extracted with 
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ethyl acetate (3 x 150 mL). The combined organic layers were washed with brine, dried over 
MgSO4, and evaporated in vacuo to give amide 1s, which was purified by column 
chromatography on silica gel (hexane/ethyl acetate = 5:1). 1s: 5.90 g, 63%, brown solid; 
1
H 
NMR (500 MHz, CDCl3) δ 9.97 (s, 1H), 8.72 (m, 2H), 8.50 (d, J = 8.4 Hz, 1H), 7.37 (dd, J = 8.4, 
4.2 Hz, 1H), 7.12 (m, 5H), 6.77 (d, J = 8.4 Hz, 1H), 3.91 (s, 3H), 2.58 (m, 2H), 2.08 (m, 1H), 
1.97–1.73 (m, 2H), 1.70–1.53 (m, 1H), 1.38 (s, 3H), 0.90 (t, J = 7.4 Hz, 3H); 13C NMR (126 
MHz, CDCl3) δ 175.3, 150.4, 148.9, 142.7, 139.7, 131.5, 128.7, 128.5, 128.3, 126.0, 120.9, 120.7, 
116.6, 104.6, 56.0, 47.8, 42.5, 33.3, 31.5, 21.1, 9.2; IR (KBr,ν / cm–1) 3565, 3374, 2967, 2860, 
1669, 1527, 1494, 1456, 1269, 1244, 1154, 1091, 820, 789, 742, 669; HRMS (ESI
+
) Calcd for 
C23H26N2O2 (M+Na
+
) 385.1883, Found 385.1881. 
 
Typical procedure for Copper–Catalyzed Intramolecular C(sp3)–H and C(sp2)–H 
Amidation. A mixture of 2,2–dimethyl–N–(8–quinolinyl)butanamide (1a, 24.2 mg, 0.100 mmol), 
Cu(OAc)2 (3.63 mg, 20.0 mol), and 1,2–dichloroethane (1.0 mL) was stirred at 140 °C for 24 h 
under argon atmosphere. Then, the reaction mixture was cooled to room temperature, and was 
subjected to column chromatography on silica gel (hexane/ethyl acetate = 8:1) to give 2a. 
2a, 19.8 mg, 82% yield, yellow solid,; 
1
H NMR (500 MHz, CDCl3) δ 8.80 
(dd, J = 3.9, 2.2 Hz, 1H), 8.49 (dd, J = 6.1, 3.0 Hz, 1H), 8.10 (ddd, J = 8.0, 
2.2, 2.2 Hz, 1H), 7.57–7.46 (m, 2H), 7.37 (ddd, J = 7.5, 3.9, 3.9 Hz, 1H), 
4.40 (d, J = 7.3 Hz, 1H), 4.24 (d, J = 7.3 Hz, 1H), 1.93–1.72 (m, 2H), 1.44 
(s, 3H), 1.07 (t, J = 7.4 Hz, 3H);
 13
C NMR (126 MHz, CDCl3) δ 173.6, 148.7, 140.7, 136.1, 135.4, 
129.2, 127.0, 122.9, 121.4, 119.7, 58.4, 56.1, 28.0, 19.4, 9.4; IR (KBr,ν / cm–1) 3651, 3567, 
2969, 1735, 1685, 1506, 1474, 1457, 1398, 1348, 1188, 1149, 1105, 842, 790, 753; HRMS (ESI
+
) 
Calcd for C15H16N2O (M+Na
+
) 263.1155, Found 263.1153. 
 
3,3–Dimethyl–1–(8–quinolinyl)–2–azetidinone (2b). 19.5 mg, 86% yield, 
yellow oil; 
1
H NMR (500 MHz, CDCl3) δ 8.79 (dd, J = 4.0, 1.7 Hz, 1H), 8.49 
(dd, J = 6.3, 2.6 Hz, 1H), 8.09 (dd, J = 8.5, 1.7 Hz, 1H), 7.54–7.46 (m, 2H), 
7.37 (dd, J = 8.5, 4.0 Hz, 1H), 4.34 (s, 2H), 1.45 (s, 6H);
 13
C NMR (126 MHz, 
CDCl3) δ 173.9, 148.7, 140.6, 136.1, 135.4, 129.2, 127.0, 123.0, 121.4, 119.7, 61.0, 51.7, 21.7; 
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IR (KBr,ν / cm–1) 3460, 2962, 2926, 2890, 1737, 1505, 1474, 1426, 1402, 1365, 1349, 1194, 
1151, 1106, 1041, 980, 825, 189, 758, 637; HRMS (ESI
+
) Calcd for C14H14N2O (M+Na
+
) 
249.0998, Found 249.0992. 
 
3–Methyl–1–(8–quinolinyl)–3–(trifluoromethyl)–2–azetidinone (2c). 24.9 mg, 
89% yield, white solid; 
1
H NMR (500 MHz, CDCl3) δ 8.81 (dd, J = 4.0, 4.0 Hz, 
1H), 8.45 (d, J = 4.0 Hz, 1H), 8.13 (d, J = 8.3 Hz, 1H), 7.58 (d, J = 7.3 Hz, 1H), 
7.52 (d, J = 7.3 Hz, 1H), 7.41 (dd, J = 8.3, 4.1 Hz, 1H), 4.78 (d, J = 8.0 Hz, 1H), 
4.48 (d, J = 8.0 Hz, 1H), 1.71 (s, 3H);
 13
C NMR (126 MHz, CDCl3) δ 163.4, 
149.1, 140.5, 136.3, 134.1, 128.0 (d, J = 284 Hz), 126.9, 126.7, 124.1, 121.7, 120.1, 59.0 (d, J = 
28.9 Hz), 54.4, 14.3; IR (KBr,ν / cm–1) 3455, 2972, 2883, 1760, 1636, 1506, 1477, 1409, 
1370, 1320, 1199, 1177, 1146, 1112, 1033, 826, 790, 757, 635; HRMS (ESI
+
) Calcd for 
C14H11F3N2O (M+Na
+
) 303.0716, Found 303.0718. 
 
3–Methyl–3–phenethyl–1–(8–quinolinyl)–2–azetidinone (2d). 27.2 
mg, 86% yield, yellow oil; 
1
H NMR (500 MHz, CDCl3) δ 8.84 (d, J = 
4.0 Hz, 1H), 8.53 (d, J = 6.5 Hz, 1H), 8.13 (d, J = 8.3 Hz, 1H), 7.64–
7.47 (m, 2H), 7.41 (dd, J = 8.3, 4.0 Hz, 1H), 7.34–7.07 (m, 5H), 4.49 
(d, J = 7.3 Hz, 1H), 4.33 (d, J = 7.3 Hz, 1H), 3.06–2.64 (m, 2H), 2.21–1.93 (m, 2H), 1.56 (s, 3H); 
13
C NMR (126 MHz, CDCl3) δ 173.1, 148.7, 142.1, 140.7, 136.2, 135.3, 129.2, 128.7, 128.6, 
127.0, 126.2, 123.1, 121.4, 119.8, 58.8, 55.5, 37.3, 31.5, 19.9; IR (KBr,ν / cm–1) 3650, 2991, 
1736, 1685, 1654, 1559, 1506, 1474, 1400, 1346, 1151, 1101, 824, 790, 752, 698; HRMS (ESI
+
) 
Calcd for C21H20N2O (M+Na
+
) 339.1468, Found 339.1459. 
 
3–Methyl–3–phenethyl–1–(8–quinolinyl)–2–azetidinone–d5 (2d–D).
 
29.3 mg, 91% yield, yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 8.81 
(dd, J = 4.0, 1.7 Hz, 1H), 8.51 (dd, J = 6.4, 2.4 Hz, 1H), 8.11 (dd, J = 
8.5, 1.7 Hz, 1H), 7.55–7.47 (m, 2H), 7.39 (dd, J = 8.3, 4.1 Hz, 1H), 
7.32–7.14 (m, 5H), 2.93–2.63 (m, 2H), 2.21–2.02 (m, 2H); 13C NMR (126 MHz, CDCl3) δ 173.2, 
148.7, 142.1, 140.6, 136.2, 135.2, 129.2, 128.7, 128.6, 127.0, 126.2, 123.1, 121.4, 119.7, 55.1, 
2. Copper–Catalyzed Intramolecular C(sp3)–H and C(sp2)–H Amidation by Oxidative Cyclization 
74 
 
37.2, 31.5 [Signals of CD3 and CD2 groups could not be observed. They are supposed to be 
heptet and quintet, which are too weak to observe in 
13
C NMR.]; IR (KBr,ν / cm–1) 3448, 1735, 
1505, 1474, 1397, 1348, 1255, 1096, 826, 791, 756, 700, 668; HRMS (ESI
+
) Calcd for 
C21H15D5N2O (M+Na
+
) 344.1782, Found 344.1791. 
 
3–(tert–Butyl)–3–methyl–1–(8–quinolinyl)–2–azetidinone (2e). 23.2 mg, 
93% yield, yellow solid;
 1
H NMR (500 MHz, CDCl3) δ 8.81 (dd, J = 4.1, 
1.7 Hz, 1H), 8.50 (dd, J = 6.2, 2.8 Hz, 1H), 8.10 (dd, J = 8.2, 1.7 Hz, 1H), 
7.49 (m, 2H), 7.37 (dd, J = 8.2, 4.1 Hz, 1H), 4.50 (d, J = 7.5 Hz, 1H), 4.10 
(d, J = 7.5 Hz, 1H), 1.46 (s, 3H), 1.10 (s, 9H);
 13
C NMR (126 MHz, CDCl3) δ 173.2, 148.7, 140.7, 
136.1, 135.2, 129.2, 127.0, 122.9, 121.4, 119.6, 62.3, 56.8, 33.3, 26.1, 16.8; IR (KBr,ν / cm–1) 
3456, 2962, 2883, 1739, 1637, 1505, 1474, 1401, 1347, 1202, 1152, 825, 629; HRMS (ESI
+
) 
Calcd for C17H20N2O (M+Na
+
) 291.1468, Found 291.1464. 
 
3–Ethyl–3–phenethyl–1–(8–quinolinyl)–2–azetidinone (2f). 29.7 
mg, 90% yield, yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 8.74 (dd, 
J = 4.1, 1.6 Hz, 1H), 8.43 (dd, J = 6.8, 2.3 Hz, 1H), 8.02 (dd, J = 8.3, 
1.6 Hz, 1H), 7.46–7.38 (m, 2H), 7.30 (dd, J = 8.3, 4.1 Hz, 1H), 7.23–
7.06 (m, 5H), 4.32 (d, J = 7.6 Hz, 1H), 4.29 (d, J = 7.6 Hz, 1H), 2.86–2.59 (m, 2H), 2.13–1.94 (m, 
2H), 1.83 (m, 2H), 1.03 (t, J = 7.4 Hz, 3H); 
13
C NMR (126 MHz, CDCl3) δ 172.6, 148.7, 142.2, 
140.7, 136.1, 135.1, 129.2, 128.7, 128.6, 127.0, 126.2, 123.1, 121.4, 119.7, 60.0, 55.9, 35.2, 31.3, 
26.3, 9.2; IR (KBr,ν / cm–1) 3453, 2981, 2903, 1737, 1652, 1505, 1473, 1457, 1401, 1152, 826, 
790, 699; HRMS (ESI
+
) Calcd for C22H22N2O (M+Na
+
) 353.1624, Found 353.1623. 
 
2–(8–Quinolinyl)–2–azaspiro[3.5]–1–nonanone (2g). 20.5 mg, 77% yield, 
yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 8.80 (dd, J = 4.0, 1.7 Hz, 1H), 
8.50 (dd, J = 5.4, 3.6 Hz, 1H), 8.09 (dd, J = 8.1, 1.7 Hz, 1H), 7.51–7.45 (m, 
2H), 7.36 (dd, J = 8.4, 4.1 Hz, 1H), 4.33 (s, 2H), 1.93–1.85 (m, 6H), 1.75–
1.35 (m, 4H);
 13
C NMR (126 MHz, CDCl3) δ 173.9, 148.6, 140.5, 136.1, 135.5, 129.2, 127.0, 
122.8, 121.4, 119.5, 59.5, 57.2, 31.4, 25.5, 23.6; IR (KBr,ν / cm–1) 3457, 2927, 2851, 1738, 1505, 
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1474, 1401, 1369, 1342, 1202, 1152, 1133, 1107, 968, 825, 789, 755, 627; HRMS (ESI
+
) Calcd 
for C17H18N2O (M+Na
+
) 289.1311, Found 289.1302.  
 
3–Methyl–3–phenyl–1–(8–quinolinyl)–2–azetidinone (2h). 18.7 mg, 65% 
yield, yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 8.81 (dd, J = 3.9, 1.3 Hz, 1H), 
8.56 (dd, J = 6.5, 2.4 Hz, 1H), 8.10 (dd, J = 8.2, 1.3 Hz, 1H), 7.53 (m, 4H), 
7.41–7.35 (m, 3H), 7.28 (d, J = 7.5 Hz, 1H), 4.83 (d, J = 7.2 Hz, 1H), 4.68 (d, J 
= 7.2 Hz, 1H), 1.83 (s, 3H); 
13
C NMR (126 MHz, CDCl3) δ 171.4, 148.8, 141.5, 
140.7, 136.2, 135.2, 129.2, 128.9, 127.3, 127.0, 126.4, 123.2, 121.5, 119.9, 61.1, 
59.4, 24.0; IR (KBr,ν / cm–1) 3455, 2961, 1737, 1647, 1540, 1505, 1474, 1402, 1349, 1154, 825, 
789, 763, 700; HRMS (ESI
+
) Calcd for C19H16N2O (M+Na
+
) 311.1155, Found 311.1158. 
 
3,3–Dimethyl–1–(8–quinolinyl)–2–indolinone (3h). 8.9 mg, 31% yield, 
yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 8.82 (dd, J = 4.0, 1.3 Hz, 1H), 
8.22 (dd, J = 8.3, 1.3 Hz, 1H), 7.94 (d, J = 8.3 Hz, 1H), 7.78 (d, J = 7.1 Hz, 
1H), 7.68 (d, J = 8.0 Hz, 1H), 7.42 (dd, J = 8.0, 4.0 Hz, 1H), 7.35–7.29 (m, 
1H), 7.08 (m, 2H), 6.38 (d, J = 7.1 Hz, 1H), 1.65 (s, 3H), 1.58 (s, 3H); 
13
C 
NMR (126 MHz, CDCl3) δ 182.1, 151.2, 144.6, 144.4, 136.3, 135.8, 132.9, 130.1, 129.9, 129.3, 
127.6, 126.6, 122.7, 122.6, 122.1, 109.9, 44.9, 25.5, 24.7; IR (KBr,ν / cm–1) 3649, 2969, 2894, 
1718, 1610, 1507, 1490, 1458, 1395, 1298, 1198, 1090, 830, 793, 758, 628; HRMS (ESI
+
) Calcd 
for C19H16N2O (M+Na
+
) 311.1155, Found 311.1151. 
 
3–(4–Methoxybenzyl)–3–methyl–1–(8–quinolinyl)–2–azetidinone (2i). 8.3 mg, 25% yield, 
yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 8.77 (dd, J = 4.1, 1.7 
Hz, 1H), 8.41 (dd, J = 6.9, 2.1 Hz, 1H), 8.08 (dd, J = 8.3, 1.7 Hz, 
1H), 7.54–7.43 (m, 2H), 7.35 (dd, J = 8.3, 4.1 Hz, 1H), 7.22 (d, J = 
8.6 Hz, 2H), 6.83 (d, J = 8.6 Hz, 2H), 4.40 (d, J = 7.3 Hz, 1H), 4.29 
(d, J = 7.3 Hz, 1H), 3.76 (s, 3H), 3.13 (d, J = 14.1 Hz, 1H), 2.89 (d, 
J = 14.1 Hz, 1H), 1.45 (s, 3H);
 13
C NMR (126 MHz, CDCl3) δ 
173.2, 158.6, 148.7, 140.7, 136.1, 135.1, 131.2, 129.6, 129.2, 126.9, 123.1, 121.4, 119.8, 114.0, 
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58.0, 56.3, 55.4, 40.2, 20.1; IR (KBr,ν / cm–1) 3444, 2962, 2893, 1735, 1652, 1558, 1507, 
1473, 1400, 1349, 1249, 1152, 1034, 825, 791; HRMS (ESI
+
) Calcd for C21H20N2O2 (M+Na
+
) 
355.1417, Found 355.1408. 
 
4–(4–Methoxyphenyl)–3,3–dimethyl–1–(8–quinolinyl)–2–azetidinone (2iʹ). 17.3 mg, 52% 
yield, yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 8.57 (dd, J = 4.2, 1.6 Hz, 
1H), 8.27 (dd, J = 6.4, 2.0 Hz, 1H), 7.92 (dd, J = 8.0, 2.0 Hz, 1H), 7.51–
7.40 (m, 2H), 7.17 (dd, J = 8.7, 4.2 Hz, 1H), 7.05 (d, J = 8.6Hz, 2H), 6.65 
(d, J = 8.6 Hz, 2H), 5.93 (s, 1H), 3.61 (s, 3H), 1.56 (s, 3H), 0.85 (s, 3H);
 13
C 
NMR (126 MHz, CDCl3) δ 173.9, 158.9, 149.0, 141.4, 135.9, 133.7, 130.9, 
129.2, 127.7, 126.8, 124.4, 122.4, 121.4, 113.8, 71.4, 56.3, 55.3, 23.6, 18.8; 
IR (KBr,ν / cm–1) 3446, 2961, 1745, 1614, 1513, 1505, 1473, 1399, 1344, 1249, 1177, 1128, 
1098, 1033, 829, 790, 636; HRMS (ESI
+
) Calcd for C21H20N2O2 (M+Na
+
) 355.1417, Found 
355.1418. 
 
3–Methyl–3–(4–methylbenzyl)–1–(8–quinolinyl)–2–azetidinone (2j). 12.1 mg, 38% yield, 
yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 8.77 (dd, J = 5.4, 1.7 Hz, 
1H), 8.43 (dd, J = 5.4, 2.2 Hz, 1H), 8.07 (dd, J = 8.2, 1.7 Hz, 1H), 7.47 
(m, 2H), 7.35 (d, J = 9.6, 4.0 Hz, 1H), 7.19 (d, J = 7.1 Hz, 2H), 7.10 (d, 
J = 7.1 Hz, 2H), 4.43 (d, J = 7.3 Hz, 1H), 4.29 (d, J = 7.3 Hz, 1H), 
3.15 (d, J = 13.9 Hz, 1H), 2.92 (d, J = 13.9 Hz, 1H), 2.29 (s, 3H), 1.45 
(s, 3H); 
13
C NMR (126 MHz, CDCl3) δ 173.2, 148.7, 140.7, 136.3, 136.1, 135.2, 134.4, 130.1, 
129.3, 129.2, 126.9, 123.1, 121.4, 119.8, 58.2, 56.2, 40.6, 21.3, 20.1; IR (KBr,ν / cm–1) 3327, 
2969, 2813, 1736, 1506, 1474, 1399, 1348, 824, 788; HRMS (ESI
+
) Calcd for C21H20N2O 
(M+Na
+
) 339.1468, Found 339.1457. 
 
3,3–Dimethyl–1–(8–quinolinyl)–4–(p–tolyl)–2–azetidinone (2jʹ). 16.1 
mg, 51% yield, yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 8.65 (d, J = 4.2 
Hz, 1H), 8.36 (dd, J = 5.9, 3.1 Hz, 1H), 8.01 (d, J = 8.7 Hz, 1H), 7.64–7.48 
(m, 2H), 7.25 (dd, J = 8.7, 4.2 Hz, 1H), 7.10 (d, J = 7.9 Hz, 2H), 7.00 (d, J = 
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7.9 Hz, 2H), 6.04 (s, 1H), 2.23 (s, 3H), 1.65 (s, 3H), 0.93 (s, 3H);
 13
C NMR (126 MHz, CDCl3) δ 
173.8, 149.0, 141.4, 137.0, 135.9, 135.8, 133.8, 129.2, 129.1, 126.8, 126.4, 124.4, 122.4, 121.4, 
71.6, 56.3, 23.6, 21.3, 18.8; IR (KBr,ν / cm–1) 3447, 2962, 2853, 1747, 1636, 1505, 1473, 1343, 
1206, 1162, 1128, 1099, 1042, 788; HRMS (ESI
+
) Calcd for C21H20N2O (M+Na
+
) 339.1468, 
Found 339.1458. 
 
3–Benzyl–3–methyl–1–(8–quinolinyl)–2–azetidinone (2k). 7.56 mg, 
25% yield, yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 8.70 (d, J = 4.0 
Hz, 1H), 8.34 (d, J = 6.9 Hz, 1H), 8.00 (d, J = 8.2 Hz, 1H), 7.44–7.37 
(m, 2H), 7.28 (dd, J = 8.2, 4.0 Hz, 1H), 7.26–7.19 (m, 4H), 7.16–7.09 
(m, 1H), 4.36 (d, J = 7.3 Hz, 1H), 4.23 (d, J = 7.3 Hz, 1H), 3.12 (d, J = 
13.9 Hz, 1H), 2.89 (d, J = 13.9 Hz, 1H), 1.39 (s, 3H);
 13
C NMR (126 MHz, CDCl3) δ 173.1, 
148.7, 140.7, 137.6, 136.1, 135.1, 130.2, 129.2, 128.6, 126.9, 126.8, 123.1, 121.4, 119.9, 58.1, 
56.2, 41.1, 20.1; IR (KBr,ν / cm–1) 3406, 2966, 2902, 1737, 1568, 1505, 1474, 1426, 1401, 1349, 
1197, 1152, 1098, 1032, 825, 789, 700, 668; HRMS (ESI
+
) Calcd for C20H18N2O (M+Na
+
) 
325.1311, Found 325.1304. 
 
3,3–Dimethyl–4–phenyl–1–(8–quinolinyl)–2–azetidinone (2kʹ). 19.4 mg, 
64% yield, yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 8.55 (d, J = 5.5 Hz, 
1H), 8.32 (dd, J = 5.7, 3.2 Hz, 1H), 7.94 (dd, J = 8.1, 1.5 Hz, 1H), 7.51–7.44 
(m, 2H), 7.20–7.04 (m, 6H), 6.01 (s, 1H), 1.58 (s, 3H), 0.84 (s, 3H); 13C 
NMR (126 MHz, CDCl3) δ 173.7, 148.9, 141.3, 139.0, 135.8, 133.8, 129.2, 
128.4, 127.3, 126.8, 126.4, 124.4, 122.2, 121.4, 71.8, 56.4, 23.6, 18.8; IR (KBr,ν / cm–1) 3567, 
2964, 2925, 1747, 1504, 1474, 1425, 1399, 1364, 1342, 1206, 978, 827, 789, 756, 701, 668, 637; 
HRMS (ESI
+
) Calcd for C20H18N2O (M+Na
+
) 325.1311, Found 325.1308. 
 
3–(4–Bromobenzyl)–3–methyl–1–(8–quinolinyl)azetidin–2–one (2l). 9.2 mg, 24% yield, 
yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 8.77 (dd, J = 4.2, 1.7 Hz, 1H), 8.40 (dd, J = 7.3, 1.7 
Hz, 1H), 8.09 (dd, J = 8.3, 1.7 Hz, 1H), 7.53–7.45 (m, 2H), 7.41 (d, J = 8.3 Hz, 2H), 7.36 (dd, J = 
8.3, 4.2 Hz, 1H), 7.19 (d, J = 8.3 Hz, 2H), 4.38 (d, J = 7.3 Hz, 1H), 4.29 (d, J = 7.3 Hz, 1H), 3.13 
(d, J = 14.0 Hz, 1H), 2.91 (d, J = 14.0 Hz, 1H), 1.45 (s, 3H); 
13
C NMR (126 MHz, CDCl3) δ 
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172.7, 148.8, 140.7, 136.5, 136.2, 134.9, 131.9, 131.7, 129.2, 126.9, 
123.3, 121.4, 120.9, 119.9, 57.9, 55.9, 40.5, 20.2; IR (KBr,ν / cm–1) 
3455, 2962, 1737, 1628, 1505, 1474, 1402, 1350, 1223, 1152, 1072, 
663; HRMS (ESI
+
) Calcd for C20H17BrN2O (M+Na
+
) 403.0416, 
Found 403.0416. 
 
4–(4–Bromophenyl)–3,3–dimethyl–1–(8–quinolinyl)–2–azetidinone (2lʹ). 
22.9 mg, 60% yield, yellow solid;
1
H NMR (500 MHz, CDCl3) δ 8.51 (dd, J 
= 3.9, 1.7 Hz, 1H), 8.34 (dd, J = 6.3, 2.7 Hz, 1H), 7.94 (dd, J = 8.5, 1.7 Hz, 
1H), 7.51–7.43 (m, 2H), 7.24 (d, J = 8.4 Hz, 2H), 7.18 (dd, J = 8.5, 3.9 Hz, 
1H), 7.00 (d, J = 8.4 Hz, 2H), 5.96 (s, 1H), 1.56 (s, 3H), 0.84 (s, 3H); 
13
C 
NMR (126 MHz, CDCl3) δ 173.4, 148.9, 140.9, 138.2, 136.0, 133.5, 131.6, 129.2, 128.1, 126.9, 
124.4, 121.8, 121.5, 121.2, 71.3, 56.5, 23.5, 18.9; IR (KBr,ν / cm–1) 3448, 2964, 2925, 1748, 
1504, 1474, 1400, 1342, 1281, 1206, 1161, 1127, 1098, 1009, 827, 789, 756, 668, 635; HRMS 
(ESI
+
) Calcd for C20H17BrN2O (M+Na
+
) 403.0416, Found 403.0410. 
 
3–(4–Chlorobenzyl)–3–methyl–1–(8–quinolinyl)–2–azetidinone (2m). 8.4 mg, 25% yield, 
yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 8.78 (dd, J = 4.1, 1.5 Hz, 
1H), 8.41 (dd, J = 7.3, 1.5 Hz, 1H), 8.09 (dd, J = 8.3, 1.5 Hz, 1H), 
7.57–7.45 (m, 2H), 7.37 (dd, J = 8.3, 4.1 Hz, 1H), 7.31–7.21 (m, 4H), 
4.39 (d, J = 7.3 Hz, 1H), 4.30 (d, J = 7.3 Hz, 1H), 3.16 (d, J = 14.0 
Hz, 1H), 2.94 (d, J = 14.0 Hz, 1H), 1.47 (s, 3H); 
13
C NMR (126 MHz, 
CDCl3) δ 172.4, 148.5, 140.4, 135.9, 135.7, 134.6, 132.5, 131.3, 
128.9, 128.4, 126.6, 123.0, 121.2, 119.6, 57.6, 55.7, 40.2, 19.9; IR (KBr,ν / cm–1) 3649, 2982, 
1735, 1685, 1654, 1559, 1398, 1348, 1091, 828, 639; HRMS (ESI
+
) Calcd for C20H17ClN2O 
(M+Na
+
) 359.0922, Found 359.0918. 
 
4–(4–Chlorophenyl)–3,3–dimethyl–1–(8–quinolinyl)–2–azetidinone (2mʹ). 20.9 mg, 62% 
yield, yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 8.61 (dd, J = 4.1, 1.7 Hz, 1H), 8.43 (dd, J = 
5.5, 3.3 Hz, 1H), 8.04 (dd, J = 8.4, 1.7 Hz, 1H), 7.59–7.54 (m, 2H), 7.28 (dd, J = 5.5, 3.3 Hz, 1H), 
7.21–7.12 (m, 4H), 6.07 (s, 1H), 1.66 (s, 3H), 0.94 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 173.4, 
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148.9, 140.9, 137.7, 136.0, 133.6, 133.1, 129.2, 128.7, 127.7, 126.9, 124.4, 
121.9, 121.5, 71.3, 56.5, 23.5, 18.8; IR (KBr, ν / cm–1) 3649, 2965, 2925, 
1748, 1636, 1504, 1493, 1473, 1399, 1342, 1206, 1097, 788, 701, 637; 
HRMS (ESI
+
) Calcd for C20H17ClN2O (M+Na
+
) 359.0922, Found 359.0911. 
 
3–(4–Fluorobenzyl)–3–methyl–1–(8–quinolinyl)–2–azetidinone (2n). 9.6 mg, 30% yield, 
yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 8.77 (dd, J = 4.1, 1.7 Hz, 
1H), 8.39 (dd, J = 7.3, 1.7 Hz, 1H), 8.08 (dd, J = 8.3, 1.7 Hz, 1H), 
7.54–7.41 (m, 2H), 7.36 (dd, J = 8.3, 4.1 Hz, 1H), 7.32–7.22 (m, 2H), 
7.02–6.92 (m, 2H), 4.38 (d, J = 7.3 Hz, 1H), 4.29 (d, J = 7.3 Hz, 1H), 
3.15 (d, J = 14.1 Hz, 1H), 2.93 (d, J = 14.1 Hz, 1H), 1.46 (s, 3H); 
13
C 
NMR (126 MHz, CDCl3) δ 172.8, 162.0 (d, J = 244 Hz), 148.7, 140.7, 
136.1, 135.0, 133.2 (d, J = 3.5 Hz), 131.6 (d, J = 9.4 Hz), 129.2, 126.9, 123.2, 121.4, 119.9, 115.4 
(d, J = 21.1 Hz), 57.8, 56.2, 40.3, 20.2; IR (KBr,ν / cm–1) 3649, 3421, 2991, 2903, 1735, 1652, 
1558, 1540, 1507, 1473, 1401, 1349, 1221, 1154, 825, 789; HRMS (ESI
+
) Calcd for C20H17FN2O 
(M+Na
+
) 343.1217, Found 343.1211. 
 
4–(4–Fluorophenyl)–3,3–dimethyl–1–(8–quinolinyl)–2–azetidinone (2nʹ). 
19.2 mg, 60% yield, yellow solid;
 1
H NMR (500 MHz, CDCl3) δ 8.63 (dd, J 
= 4.0, 1.7 Hz, 1H), 8.42 (dd, J = 6.3, 2.7 Hz, 1H), 8.04 (dd, J = 8.4, 1.7 Hz, 
1H), 7.61–7.50 (m, 2H), 7.27 (dd, J = 8.4, 4.0 Hz, 1H), 7.22–7.09 (m, 2H), 
7.00–6.83 (m, 2H), 6.07 (s, 1H), 1.66 (s, 3H), 0.94 (s, 3H); 13C NMR (126 
MHz, CDCl3) δ 173.5, 162.2 (d, J = 246 Hz), 148.9, 141.1, 135.9, 134.8 (d, J = 3.4 Hz), 133.6, 
129.2, 127.9 (d, J = 7.9 Hz), 126.8, 124.4, 122.0, 121.4, 115.4 (d, J = 22.0 Hz), 71.2, 56.4, 23.5, 
18.8; IR (KBr,ν / cm–1) 3738, 2959, 2893, 1746, 1506, 1473, 1399, 1341, 1222, 1158, 1098, 
1146, 816, 788, 759; HRMS (ESI
+
) Calcd for C20H17FN2O (M+Na
+
) 343.1217, Found 343.1205. 
 
3–Methyl–1–(8–quinolinyl)–3–(4–(trifluoromethyl)benzyl)–2–azetidinone (2o). 7.8 mg, 21% 
yield, yellow solid;
 1
H NMR (500 MHz, CDCl3) δ 8.77 (d, J = 2.5 Hz, 1H), 8.38 (d, J = 7.1 Hz, 
1H), 8.09 (d, J = 8.3 Hz, 1H), 7.60–7.41 (m, 6H), 7.37 (dd, J = 8.3, 4.0 Hz, 1H) , 4.42 (d, J = 7.3 
Hz, 1H), 4.31 (d, J = 7.3 Hz, 1H), 3.23 (d, J = 13.9 Hz, 1H), 3.04 (d, J = 13.9 Hz, 1H), 1.56 (s, 
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3H);
 13
C NMR (126 MHz, CDCl3) δ 172.4, 148.8, 141.7, 136.2, 
134.8, 130.5, 129.4 (q, J = 32.5 Hz), 129.2, 126.9, 125.5 (q, J = 274 
Hz), 125.5 (q, J = 3.6 Hz), 123.4, 121.7, 121.5, 120.0, 58.0, 55.9, 
40.9, 20.2; IR (KBr,ν / cm–1) 3629, 1735, 1700, 1685, 1541, 1507, 
1474, 1457, 1324, 1122, 668; HRMS (ESI
+
) Calcd for C21H17F3N2O 
(M+Na
+
) 393.1185, Found 393.1189. 
 
4–(4–(Trifluoromethyl)phenyl)–3,3–dimethyl–1–(8–quinolinyl)–2–azetidinone (2oʹ). 21.5 mg, 
58% yield, yellow solid;
 1
H NMR (500 MHz, CDCl3) δ 8.58 (dd, J = 4.9, 1.7 
Hz, 1H), 8.47 (dd, J = 4.9, 3.3 Hz, 1H), 8.05 (dd, J = 8.2, 1.7 Hz, 1H), 7.61–
7.55 (m, 2H), 7.48 (d, J = 8.2 Hz, 2H), 7.33 (d, J = 8.2 Hz, 2H), 7.28 (d, J = 
4.0 Hz, 1H), 6.17 (s, 1H), 1.68 (s, 3H), 0.93 (s, 3H); 
13
C NMR (126 MHz, 
CDCl3) δ 173.2, 148.9, 143.4, 140.8, 136.0, 133.5, 130.5, 129.7, 129.3 (q, J = 
32.5 Hz), 129.2, 126.9, 125.51 (q, J = 273 Hz), 125.46 (q, J = 3.6 Hz), 121.7, 121.5, 71.4, 56.8, 
23.5, 18.9; IR (KBr,ν / cm–1) 3481, 2966, 1748, 1647, 1505, 1473, 1421, 1399, 1364, 1325, 1164, 
1125, 1067, 1017, 852, 827, 789, 756, 637; HRMS (ESI
+
) Calcd for C21H17F3N2O (M+Na
+
) 
393.1185, Found 393.1178. 
 
3–Benzyl–3–ethyl–1–(8–quinolinyl)–2–azetidinone (2p). 9.5 mg, 30% 
yield, yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 8.69 (dd, J = 3.9, 1.7 Hz, 
1H), 8.30 (dd, J = 7.0, 1.6 Hz, 1H), 8.02–7.93 (m, 1H), 7.38 (d, J = 3.9 Hz, 
2H), 7.30–7.15 (m, 5H), 7.10 (dd, J = 10.8, 3.6 Hz, 1H), 4.31 (d, J = 7.4 
Hz, 1H), 4.21 (d, J = 7.4 Hz, 1H), 3.13 (d, J = 14.0 Hz, 1H), 2.92 (d, J = 
14.0 Hz, 1H), 1.85–1.65 (m, 2H), 1.04 (t, J = 7.4 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 172.4, 
148.7, 140.8, 137.5, 136.1, 134.9, 130.3, 129.2, 128.5, 126.9, 126.8, 123.1, 121.4, 119.9, 60.7, 
54.8, 39.5, 26.5, 9.3; IR (KBr,ν / cm–1) 3446, 2987, 1735, 1647, 1558, 1541, 1506, 1473, 1398, 
1349, 1153, 790, 758, 636; HRMS (ESI
+
) Calcd for C21H20N2O (M+Na
+
) 339.1468, Found 
339.1460.  
 
3–Ethyl–3–methyl–4–phenyl–1–(8–quinolinyl)–2–azetidinone (2pʹ). 19.0 mg, 60% yield, 
yellow solid;
 1
H NMR (500 MHz, CDCl3) δ 8.55–8.53 (m, 1H, major + minor), 8.35–8.31 (m, 1H, 
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major), 8.31–8.27 (m, 1H, minor), 8.01–7.81 (m, 1H, major + minor), 
7.53–7.38 (m, 2H, major + minor), 7.22–6.87 (m, 6H, major + minor), 
6.08 (s, 1H, major), 5.98 (s, 1H, minor), 1.99–1.89 (m, 2H, major), 1.57 (s, 
3H, minor), 1.49–1.45 (m, 2H, minor), 1.22–1.16 (m, 3H, minor), 1.13 (t, 
J = 7.4 Hz, 3H, major), 0.83 (s, 3H, major), 0.69 (t, J = 7.5 Hz, 3H, minor);
 13
C NMR (126 MHz, 
CDCl3) δ 173.4, 148.89, 148.85, 141.3, 139.1, 138.7, 135.8, 133.8, 129.2, 128.4, 128.2, 127.4, 
127.2, 126.9, 126.81, 126.78, 126.6, 124.4, 124.3, 122.4, 122.1, 121.4, 77.3, 72.0, 69.4, 60.6, 
59.8, 29.8, 25.3, 20.0, 16.2, 9.5, 8.6; IR (KBr,ν / cm–1) 3363, 2956, 1745, 1680, 1527, 1486, 
1423, 1386, 1326, 1079, 826, 791, 755, 700, 647, 638, 611; HRMS (ESI
+
) Calcd for C21H20N2O 
(M+Na
+
) 339.1468, Found 339.1458. 
 
3–Phenyl–2–(8–quinolinyl)–2–azaspiro[3.4]–1–octanone (2qʹ). 27.3 mg, 
83% yield, yellow solid;
 1
H NMR (500 MHz, CDCl3) δ 8.55 (dd, J = 4.2, 
1.7 Hz, 1H), 8.34 (dd, J = 5.9, 3.0 Hz, 1H), 7.90 (dd, J = 8.2, 1.7 Hz, 1H), 
7.48–7.41 (m, 2H), 7.13 (m, 5H), 7.08–7.03 (m, 1H), 6.05 (s, 1H), 2.33–
2.15 (m, 2H), 1.80–1.72 (m, 2H), 1.68–1.52 (m, 2H), 1.40–1.26 (m, 1H), 1.19–1.15 (m, 1H); 13C 
NMR (126 MHz, CDCl3) δ 174.0, 148.8, 141.1, 139.4, 135.8, 133.8, 129.2, 128.5, 127.4, 126.8, 
126.7, 124.1, 121.9, 121.3, 72.7, 67.2, 35.5, 29.7, 25.9, 25.5; IR (KBr,ν / cm–1) 3651, 2982, 1742, 
1636, 1542, 1504, 1398, 1348, 1319, 1153, 904, 826, 789, 761, 699; HRMS (ESI
+
) Calcd for 
C22H20N2O (M+Na
+
) 351.1468, Found 351.1464. 
 
3–Phenyl–2–(8–quinolinyl)–2–azaspiro[3.5]–1–nonanone (2rʹ). 25.7 mg, 
75% yield, yellow solid; 
1
H NMR (500 MHz, CDCl3) δ 8.54 (dd, J = 4.1, 
1.7 Hz, 1H), 8.37–8.29 (m, 1H), 7.90 (dd, J = 8.3, 1.7 Hz, 1H), 7.44 (dd, J 
= 6.8, 3.3 Hz, 2H), 7.24–6.95 (m, 6H), 5.97 (s, 1H), 2.14–2.09 (m, 1H), 
2.03–1.95 (m, 1H), 1.90–1.76 (m, 1H), 1.69–1.20 (m, 6H), 1.02–0.88 (m, 1H); 13C NMR (126 
MHz, CDCl3) δ 173.6, 148.8, 141.2, 138.6, 135.8, 133.7, 129.2, 128.2, 127.4, 127.1, 126.8, 124.2, 
122.1, 121.3, 71.6, 60.8, 34.1, 28.1, 25.6, 23.9, 22.3; IR (KBr,ν / cm–1) 3650, 3094, 2928, 2850, 
1760, 1740, 1558, 1505, 1473, 1456, 1397, 1362, 1338, 1213, 1130, 826, 788, 763, 701; HRMS 
(ESI
+
) Calcd for C23H22N2O (M+Na
+
) 365.1624, Found 365.1615. 
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3–Ethyl–1–(5–methoxy–8–quinolinyl)–3–phenethyl–2–
azetidinone (2s).
 
25.6 mg, 71% yield, yellow solid;
 1
H NMR (500 
MHz, CDCl3) δ 8.83 (dd, J = 4.2, 1.8 Hz, 1H), 8.55 (dd, J = 8.4, 1.8 
Hz, 1H), 8.32 (d, J = 8.4 Hz, 1H), 7.38 (dd, J = 8.4, 4.2 Hz, 1H), 7.27 
(m, 4H), 7.21–7.15 (m, 1H), 6.83 (d, J = 8.5 Hz, 1H), 4.28 (d, J = 7.3 
Hz, 1H), 4.26 (d, J = 7.3 Hz, 1H), 3.99 (s, 3H), 2.99–2.84 (m, 1H), 2.84–2.66 (m, 1H), 2.18–2.02 
(m, 2H), 2.00–1.85 (m, 2H), 1.11 (t, J = 7.4 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 172.2, 151.7, 
149.4, 142.4, 141.9, 130.9, 128.64, 128.59, 128.3, 126.1, 121.1, 120.63, 120.60, 104.4, 59.7, 56.1, 
55.4, 35.2, 31.3, 26.3, 9.2; IR (KBr,ν / cm–1) 3649, 3567, 2968, 1733, 1507, 1480, 1457, 1409, 
1373, 1276, 1158, 1096, 785, 700, 615; HRMS (ESI
+
) Calcd for C23H24N2O2 (M+Na
+
) 383.1730, 
Found 383.1729. 
 
3–Ethyl–3–phenethyl–2–azetidinone (4). Amide 1s (72.5 mg, 0.20 mmol) was 
dissolved in a mixture of CH3CN and H2O (5/1, 2.4 mL) at rt. CAN (329 mg, 
0.60 mmol, 3.0 equiv) was added, and the reaction mixture was stirred at rt for 3 
h. The reaction was quenched with sat. NaHCO3 (20 mL), and extracted with ethyl acetate (3 x 
30 mL). The organic layer was dried over anhydrous Na2SO4, and concentrated in vacuo. The 
resulting residue was purified by column chromatography on silica gel (hexane/ethyl acetate = 
4:1) to give amide 4 in 67% yield (27 mg) as yellow oil; 
1
H NMR (500 MHz, CDCl3) δ 7.26–
7.08 (m, 5H), 5.69 (s, 1H), 3.06 (d, J = 5.6 Hz, 1H), 3.04 (d, J = 5.6 Hz, 1H), 2.78–2.65 (m, 1H), 
2.65–2.50 (m, 1H), 1.96–1.85 (m, 2H), 1.74–1.66 (m, 2H), 0.95 (t, J = 7.4 Hz, 3H); 13C NMR 
(126 MHz, CDCl3) δ 174.0, 142.0, 128.7, 128.5, 126.2, 61.2, 46.0, 34.9, 31.1, 25.8, 9.0; IR 
(KBr,ν / cm–1) 3446, 2923, 2890, 1748, 1636, 1558, 1540, 1507, 1457, 1275, 700; HRMS (ESI+) 
Calcd for C13H17NO (M+Na
+
) 226.1202, Found 226.1201. 
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3. Copper–Mediated C(sp
3
)–H and C(sp
2
)–H Acetoxylation 
3.1. Introduction 
 
Direct C–H bond transformations are highly efficient and ideal methods for synthesizing 
organic molecules. Second– and third–row transition metal complexes or salts are often used as 
catalysts or mediators to promote direct C–H transformations. The abundance and low cost of 
first–row transition metals compared with second– and third–row transition metals, and the few 
examples of first–row transition metal–catalyzed or –mediated C–H transformations have 
recently prompted researchers to concentrate their effort on developing direct C–H (especially 
C(sp
2
)–H) transformations using first–row transition metals.1  
To date, however, there are still only a few examples of first–row transition metal–catalyzed 
or –mediated unactivated C(sp3)–H transformations: for example, Nakamura and co–workers 
reported iron–catalyzed arylation, alkenylation, and alkylation at C(sp3)–H bonds adjacent to a 
nitrogen atom;
2
 the Chatani
3
 and Ge
4
 groups independently reported nickel–catalyzed C(sp3)–H 
arylation and alkylation; however, all these first row transition–metals–catalyzed C(sp3)–H 
transformations focused on the carbon–carbon bond formation, we reported copper–catalyzed 
intramolecular C(sp
3
)–H amidation;5 and Ge’s group subsequently reported a similar C(sp3)–H 
amidation,
6
 although these two reactions are intramolecular reaction, they are first examples on 
first row transition–metal–catalyzed carbon–heteroatom bond formation. So it is necessary to 
investigate an intermolecular carbon–heteroatom bond formation using a first row transition 
metal or catalyst. Considering there are a lot of acetate anion exists in copper–catalyzed C(sp3)–H 
amidation, I chose copper–catalyzed intermolecular acetoxylation as my target reaction. On the 
other hand, organic molecules bearing acetoxy group(s) are important as natural products, drugs, 
and agricultural chemicals. For example, cytochalasin D
7
 is a cell–permeable and potent inhibitor 
of actin polymerization, and decazolin
8
 is herbicide (Figure 3-1).  
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Several tranditional methods for introducing acetoxy groups into the desired site(s) of 
organic molecules have been developed, such as the Schotten–Baumann reaction,9 the 
Tishchenko reaction,
10
 the Baeyer–Villiger oxidation,11 and the Pinner reaction.12 C(sp3)–H 
Acetoxylation is the most direct and efficient method for introducing acetoxy group(s), and 
acetoxylated products can be synthesized from simple substrates. Among them are the recently 
reported palladium–catalyzed oxidative C(sp3)–H acetoxylations;13–16 but there have been no 
report on C(sp
3
)–H acetoxylation promoted by a first–row transition metal complex or salt.17.18 I 
report herein copper–mediated unactivated C(sp3)–H acetoxylation using a chelating directing 
group.
19
 I also used this method to achieve C(sp
2
)–H acetoxylation. 
 
3.2. Optimization Studies 
 
Considering the small radius of copper atom, I chose an amide which contains a quartery 
carbon as a starting material to investigate the desired reaction, since a quartery carbon makes the 
methyl closed to copper center. In addition, I selected high polarized solvents considering the 
solubility of various salts. Because several groups reported copper–mediated C–heteroatom bond 
formation reactions via C–H activation, which were inhibited by the products, 1 equivalent of a 
copper salt was used. Treatment of amide 1a with a mixture of CuCl, AgOAc, and NaOAc in 
hexamethylphosphoric triamide (HMPA) at 145 °C for 24 h gave mono– and di–acetoxylated 
products 2a and 3a in 30% and 14% yield, respectively (Table 3-1, entry 1). In this reaction, 
acetoxylation occurred only at the terminal C(sp
3
)–H bond, and internal C(sp3)–H acetoxylation 
of the ethyl group, C(sp
2
)–H acetoxylation of the quinolyl group,20 and intramolecular C(sp3)–H 
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amidation
5,6
 did not proceed at all. This result shows that the steric effect is more important rather 
than electronic one in this reaction. Based on the screening of several copper salts (entries 2–8), 
Cu(OAc)2 was revealed as the best catalyst, and 2a and 3a were obtained in 48% and 33% yields, 
respectively (entry 8). In this reaction, sodium acetate was not indispensable; however, the yields 
of 2a and 3a decreased slightly when sodium acetate was not used (entry 9). Because HMPA is a 
carcinogen, the solvent was replaced with another solvent (entries 10–13). As a result, N–
methylpyrrolidone (NMP) exhibited the similar reactivity as HMPA (entry 13). Unfortunately, the 
yields of 2a and 3a were decreased by decreasing the amount of Cu(OAc)2 (entry 14).
21
 This 
phenomenon mainly attributed to the strong coordination ability of the products rather than the 
staring materials (the products are a tri– or tetradentate compounds and the starting materials are 
bidentate molecules). 
 
 
entry catalyst solvent Yield (%)Mono–OAc (2a) Di–OAc (3a) 
1 CuCl HMPA 30 14 
2 CuCl2 HMPA 22 15 
3 CuBr HMPA 35 32 
4 CuBr2 HMPA 26 27 
5 CuCN HMPA 21 5 
6 Cu(OH)2 HMPA 10 5 
7 Cu2(OH)2(CO3) HMPA 37 3 
8 Cu(OAc)2 HMPA 48 33 
9 Cu(OAc)2 HMPA 36 18 
10 Cu(OAc)2 DMSO 28 trace 
11 Cu(OAc)2 DMA 34 22 
12 Cu(OAc)2 DMF 34 32 
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13 Cu(OAc)2 NMP 46 32 
14 Cu(OAc)2
b
 NMP 31 18 
a
NaOAc was not added. 
b
0.50 equiv. 
 
3.3. Substrate Scope and Mechanism Research 
 
With the best reaction conditions in hand, I then investigated the substrate scope of the 
acetoxylation (Table 3-2). Amides with a tertiary alkyl group gave the corresponding mono– and 
di–acetoxylated products 2b–2e, 2g and 3b–3e, 3g, respectively (entries 1–4 and 6).22 In the case 
of substrates 1d and 1e, acetoxylation did not occur at the more acidic benzylic C(sp
3
)–H bonds 
(entries 3 and 4). This result indicated that the steric effect played a more important role than the 
electronic effect. In the case of tertiary alkyl amides 1f and 1h–1n bearing a trifluoromethyl or 
benzylic group, only mono–acetoxylated products 2f and 2h–2n were obtained in 62%–83% 
yields with high functional group tolerance (entries 5 and 7–13). The yields of the acetoxylated 
products increased with an increase of the electron–withdrawing ability of the functional group. 
The results of substrates 1o–1r revealed that the reaction occurred preferentially at the methyl 
groups, and acetoxylation did not proceed at the terminal position of the ethyl groups, methylene 
moieties (internal position), or benzylic C(sp
3
)–H bonds (entries 14–17). The corresponding 
acetoxylated product 2s was obtained in 68% yield when an amide bearing a methoxy group on 
the quinolyl group was used as a substrate (entry 18). The regioselectivity of this reaction was 
different from intramolecule C(sp
3
)-H amidation reaction (Chapter 2). I deduced that the main 
reason is that the copper center is occupied by a high polar solvent and reductive C-OAc bond 
formation is promoted in this reaction, whereas the copper center in intramolecule C(sp
3
)-H 
amidation is unsaturated because of the use of a low polar solvent. 
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Based on the researches on copper–catalyzed intramolecular amidation(project 2) and 
copper–mediated acetoxylation, the proposed mechanism for the C(sp3)–H acetoxylation is as 
follows (Scheme 3-1): (1) formation of a metallacyclic intermediate by the reaction of amide 1 
with Cu(OAc)2 and AgOAc via the elimination of 2 equivalents of acetic acid via a concerted 
metalation–deprotonation pathway (including C(sp3)–H bond activation); (2) reductive 
elimination; and (3) protonation of the formed amide–copper intermediate to give the 
acetoxylated product. 
 
 
 
I then performed kinetic isotope experiments to elucidate the rate–determining step of the 
C(sp
3
)–H acetoxylation (Scheme 3-2). Treatment of amide 1d or its deuterated substrate 1g with 
a mixture of Cu(OAc)2, AgOAc, and NaOAc in NMP at 145 °C. Based on these results, the 
kinetic isotope effect value was calculated to be 1.3, suggesting that C(sp
3
)–H bond activation 
was not involved in the rate–determining step of the acetoxylation. This is sharply different with 
the copper–catalyzed C(sp3)–H amidation, in which C(sp3)–H bond activation is the rate–
determine step. Two possible reasons were considered: the first one is that copper(III) was 
stablized by a high polar solvent; and the second one is that positive copper(III) cation forms a 
stronger copper–oxygen bond rather than copper–nitrogen bond, which caused the reductive 
elimination slower and became the reductive elimination the rate–determine step. 
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The acetoxylation also proceeded in excellent yield without the formation of regioisomers 
and loss the functional groups when a more complex molecule 4 was used as a substrate (Scheme 
3-3). This finding suggests that the C(sp
3
)–H acetoxylation is applicable to late–stage 
functionalization of complex molecules. The acetoxylation also proceeded in excellent yield 
without decreasing the yield of the product even in gram–scale (eq 3-1). By the reaction of amide 
4 with a mixture of Cu(OAc)2, AgOAc, and NaOAc, 1.10 g of acetoxylated product 5 was 
obtained in 53% yield. The yield of 5 on a large scale was comparable to that of 5 (42.9 mg, 58%) 
on a small scale. 
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When 5–methoxyquinolyl group was used as the directing group, the acetoxylation reaction 
proceeded well. The directing group could be removed by oxidation (eq 3-2).
23
 Treatment of the 
acetoxylated product 2s with ceric ammonium nitrate afforded the deprotected compound 6 in 63% 
yield without the loss of an acetoxy group.  
 
 
 
Acetoxylation also proceeded at an aromatic C(sp
2
)–H bond. Treatment of aromatic amide 
1t with a mixture of Cu(OAc)2, AgOAc, and NaOAc in NMP at 145 °C for 24 h gave an ortho–
acetoxylated product 7 and amide 8 in 40% and 32% yield, respectively (eq 3-3).
24–26
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3.4. Summary 
In conclusion, a copper–mediated intermolecular C(sp3)–H acetoxylation was realized 
(Figure 3-2). The reaction was difficult to be promoted by a catalytic amount of a copper salt. The 
main reason is that the products are tri– or tetra–dentate compounds, which can strongly 
coordinate to a small copper metal rather than bidentate starting materials. Because the reaction 
proceeded at the methyl site rather than a competitive benzylic and methylene sites, the steric 
effect played a very important role in this reaction rather than the electronic effect. The product 
distribution of this reaction was different from the copper-catalyzed intramolecular C(sp
3
)-H 
amidation (Chapter 2), which mainly attributed to the polarity of the solvent, since the 
acetoxylation reaction, copper center is saturated, whereas copper center is unsaturated in 
amidation reaction. This reaction has high functional group tolerance, and the reaction proceeded 
in excellent yield, even in gram–scale. The directing group can be removed by oxidation when 
using a 5–methoxyquinolyl group as a directing group. This acetoxylation can be applied to a 
complex molecule, which will lead to late–stage functionalization. Deuterium labeling 
experiments suggested that the C(sp
3
)–H bond activation step is not the rate–determining step, 
which is also different from copper–catalyzed intramolecular amaidation. Aromatic C(sp2)–H 
acetoxylation also proceeded under similar reaction conditions. I believe that this reaction will 
provide useful insights into C–H bond transformations. For the detailed mechanism research is 
ongoing in our lab. 
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3.6. Experimental 
  
General. All reactions were carried out in a dry solvent under argon atmosphere unless otherwise 
noted. Cu(OAc)2 (99.999%) and AgOAc (≥99.0%) were purchased from Aldrich. Sodium acetate, 
N–methyl–2–pyrrolidone, and THF were purchased from Wako Pure Chemical Industries, and 
THF was dried and degassed before use. Lithium diisopropylamide (LDA) was purchased from 
Aldrich. NMR spectra were recorded on JEOL ECS400 (400 MHz for 
1
H NMR and 100 MHz for 
13
C NMR) spectrometer. Proton chemical shifts are reported relative to residual solvent peaks 
(CDCl3 at 7.26 ppm, acetone–d6 at 2.09 ppm). Carbon chemical shifts are reported relative to 
residual solvent peaks (CDCl3 at 77.3 ppm, acetone–d6 at 206 and 30.6 ppm). The following 
abbreviations are used to designate multiplicities: s = singlet, d = doublet, t = triplet, q = quartet, 
quint = quintet, m = multiplet, br = broad. IR spectra were recorded on a JASCO FT/IR–410. 
High–resolution mass spectra (HRMS) were measured on a JEOL JMS–T100LC AccuTOF 
spectrometer (for HRMS). 
 
The spectra of amides 1a, 1b, 1d, 1f, 1g, 1h, 1i, 1j, 1k, 1l, 1m, 1n, 1o, 1p, 1r, and 1s, and 3,3–
dimethyl–1–(8–quinolinyl)–2–indolinone (ref. 26) were determined by comparison with the 
reported data.
1
 
 
Preparation of amide 1c (1e was also prepared using this mehod). To a solution of 2,2–
dimethylpentanoic acid (0.969 g, 11.0 mmol) in THF (20 mL), SOCl2 (1.57 g, 13.2 mmol) was 
added dropwise. After stirring at 25 °C for 1 h, the reaction mixture was concentrated in vacuo to 
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give an acid chloride, which was used without purification. To a solution of the prepared acid 
chloride in dichloromethane (20 mL), a solution of 8–aminoquinoline (1.44 g, 10.0 mmol) and 
Et3N (1.01 g, 11.0 mmol) in dichloromethane (10 mL) was added dropwise within 30 min. The 
resulting mixture was stirred at 25 °C for 30 min, was quenched with saturated aq. NaHCO3 (30 
mL), and was extracted with dichloromethane (3 x 100 mL). The organic layer was dried over 
Na2SO4. After filtration and evaporation, the obtained amide was purified by column 
chromatography on silica gel (hexane/ethyl acetate = 10:1).  
 
2,2–Dimethyl–N–(8–quinolinyl)pentanamide (1c). 2.68 g, 92% yield, 
white solid; 
1
H NMR (400 MHz, CDCl3) δ 10.25 (s, 1H), 8.97 – 8.61 (m, 
2H), 8.15 (dd, J = 8.3, 1.6 Hz, 1H), 7.78 – 7.36 (m, 3H), 1.95 – 1.64 (m, 
2H), 1.40 (s, 6H), 1.35 (m, 2H), 0.92 (t, J = 7.3 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 177.0, 
148.4, 139.0, 136.5, 134.9, 128.2, 127.7, 121.7, 121.4, 116.4, 44.2, 44.1, 25.9, 18.5, 14.9; IR 
(KBr, ν/cm–1) 3366, 2959, 2871, 1687, 1527, 1487, 1423, 1384, 1326, 1260, 1155, 1056, 929, 826, 
792, 756, 681; HRMS (ESI
+
) Calcd for C16H20N2O (M+Na
+
) 279.1468, Found 279.1459. 
 
3–(Benzyloxy)–2,2–dimethyl–N–(8–quinolinyl)propanamide (1e). 
1.98 g, 93% yield, yellow oil; 
1
H NMR (400 MHz, CDCl3) δ 11.05 (s, 
1H), 8.83 (dt, J = 7.6, 1.3 Hz, 1H), 8.50 (dd, J = 4.2, 1.6 Hz, 1H), 8.09 
(dd, J = 8.3, 1.6 Hz, 4H), 7.55 – 7.40 (m, 4H), 7.38 – 7.23 (m, 1H), 4.73 
(s, 2H), 3.62 (s, 2H), 1.39 (s, 6H); 
13
C NMR (100 MHz, CDCl3) δ 175.9, 148.3, 139.2, 138.4, 
136.3, 135.6, 128.5, 128.1, 127.7, 127.62, 127.59, 121.6, 121.4, 116.8, 77.0, 73.7, 44.6, 23.5; IR 
(KBr, ν/cm–1) 3420, 2966, 2867, 1672, 1527, 1488, 1457, 1423, 1385, 1326, 1260, 1155, 1096, 
1029, 923, 825, 792, 737, 697; HRMS (ESI
+
) Calcd for C21H22N2O2 (M+Na
+
) 357.1573, Found 
357.1565. 
 
Preparation of amide 1q. To a solution of methyl 4–phenylbutanoate (5.35 g, 30.0 mmol) in 
THF (100 mL), a THF solution of lithium diisopropylamide (1.5 M, 21.0 mL, 31.5 mmol) was 
added at –78 °C dropwise. The mixture was stirred at –78 °C for 1 h, and 1–(bromomethyl)–4–
(trifluoromethyl)benzene (7.89 g, 33.0 mmol) was added to the solution. The mixture was 
warmed to 25 °C, and was stirred for 16 h. The reaction mixture was quenched with saturated aq. 
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NaHCO3 (100 mL) at 0 °C, and was extracted with ethyl acetate (3 x 100 mL). The combined 
organic layer was washed with brine, dried over MgSO4, and evaporated in vacuo to give methyl 
4–phenyl–2–(4–(trifluoromethyl)benzyl)butanoate. 
To a solution of the ester in THF (100 mL), a THF solution of lithium diisopropylamide (1.5 M, 
21.0 mL, 31.5 mmol) was added at –78 °C dropwise. The mixture was stirred at –78 °C for 1 h, 
and the iodomethane (4.68 g, 33.0 mmol) was added to the solution. The mixture was warmed to 
25 °C, and was stirred for 16 h. The reaction mixture was quenched with saturated aq. NaHCO3 
(100 mL) at 0 °C, and was extracted with ethyl acetate (3 x 100 mL). The combined organic layer 
was washed with brine, dried over MgSO4, and evaporated in vacuo to give methyl 2–methyl–4–
phenyl–2–(4–(trifluoromethyl)benzyl)butanoate. 
To a solution of 8–aminoquinoline (9.52 g, 66.0 mmol) in THF (200 mL), a hexane solution of n–
BuLi (1.6 M, 41.3 mL, 66.0 mmol) was added dropwise at –78 °C. The mixture was warmed to 
25 °C and stirred for 1 h. The reaction mixture was added to a solution of the prepared ester in 
THF at –78 °C, and the mixture was warmed to 25 °C and stirred for 12 h. After quenching with 
saturated aq. NaHCO3 (150 mL) at 0 °C, the mixture was extracted with ethyl acetate (3 x 150 
mL). The combined organic layer was washed with brine, dried over MgSO4, and evaporated in 
vacuo to give an amide, which was purified by column chromatography on silica gel 
(hexane/ethyl acetate = 10:1).  
 
2–Methyl–4–phenyl–N–(8–quinolinyl)–2–(4–(trifluoromethyl)benzyl)butanamide (1q). 11.2 
g, 81% yield, yellow oil; 
1
H NMR (400 MHz, CDCl3) δ 10.08 (s, 
1H), 8.75 (dd, J = 7.5, 1.3 Hz, 1H), 8.64 (dd, J = 4.2, 1.5 Hz, 1H), 
8.06 (dd, J = 8.3, 1.3 Hz, 1H), 7.54 – 7.29 (m, 5H), 7.24 – 7.04 
(m, 7H), 3.28 (d, J = 13.2 Hz, 1H), 2.79 (d, J = 13.2 Hz, 1H), 
2.63 (m, 2H), 2.35 – 2.16 (m, 1H), 1.85 – 1.70 (m, 1H), 1.38 (s, 
3H); 
13
C NMR (100 MHz, CDCl3) δ 174.5, 148.5, 142.1, 141.9, 138.9, 136.5, 134.3, 130.8, 129.3 
(q, J = 32.4 Hz), 128.8, 128.7, 128.6, 128.1, 127.6, 126.2, 125.2 (q, J = 3.7 Hz), 124.4 (q, J = 276 
Hz), 121.9, 116.6, 49.0, 46.6, 42.8, 31.5, 21.0; HRMS (ESI
+
) Calcd for C28H25F3N2O (M+Na
+
) 
485.1811, Found 485.1816. 
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Preparation of amide 1t. To a solution of 2–methylbenzoyl chloride (11.0 mmol) in 
dichloromethane (40 mL), a solution of 8–aminoquinoline (1.44 g, 10.0 mmol) and NEt3 (1.01 g, 
11.0 mmol) in dichloromethane (10 mL) was added dropwise within 30min. After stirring at 
25 °C for 30 min, the mixture was quenched with saturated aq. NaHCO3 (50 mL), and was 
extracted with dichloromethane (3 x 50 mL). The organic layer was dried over Na2SO4. After 
filtration and evaporation, an amide was purified by column chromatography on silica gel 
(hexane/ethyl acetate = 9:1).  
 
2–Methyl–N–(8–quinolinyl)benzamide (1t). 3.01 g, 96% yield, white 
solid; 
1
H NMR (400 MHz, CDCl3) δ 10.22 (s, 1H), 8.96 (d, J = 7.5 Hz, 1H), 
8.88 – 8.63 (m, 1H), 8.17 (d, J = 7.0 Hz, 1H), 7.70 (d, J = 7.5 Hz, 1H), 7.57 
(m, 2H), 7.48 – 7.37 (m, 2H), 7.33 (m, 2H), 2.62 (s, 3H); 13C NMR (100 
MHz, CDCl3) δ 168.4, 148.5, 138.8, 136.9, 136.8, 136.6, 134.9, 131.6, 130.5, 128.2, 127.6, 127.5, 
126.2, 122.0, 121.9, 116.7, 20.4; IR (KBr, ν/cm–1) 3350, 3049, 3008, 2979, 2861, 1674, 1597, 
1576, 1524, 1386, 1327, 1288, 1262, 1232, 1141, 1106, 1072, 1040, 899, 825, 791, 739, 683, 691; 
HRMS (ESI
+
) Calcd for C17H14N2O (M+Na
+
) 285.0998, Found 285.1011. 
 
N–(8–Quinolinyl)isobutyramide. Prepared by the same method as 1t with 
using isobutyroyl chloride. 2.94 g, 98% yield, yellow oil; 
1
H NMR (400 MHz, 
CDCl3) δ 9.90 (s, 1H), 8.81–8.65 (m, 2H), 8.15 (dd, J = 8.3, 1.6 Hz, 1H), 7.64 
– 7.32 (m, 3H), 2.99 – 2.51 (septet, J = 7.1 Hz, 1H), 1.35 (d, J = 7.1 Hz, 6H); 
13
C NMR (100 MHz, CDCl3) δ 176.0, 148.3, 138.7, 136.6, 134.9, 128.2, 127.7, 121.8, 121.5, 
116.6, 37.4, 20.0; IR (KBr, ν/cm–1) 3357, 2969, 2881, 1684, 1524, 1487, 1458, 1423, 1387, 1323, 
1239, 1191, 1156, 937, 826, 791, 756, 687; HRMS (ESI
+
) Calcd for C13H14N2O (M+Na
+
) 
237.0998, Found 237.0988. 
 
Typical procedure for copper–mediated intermolecular C(sp3)–H acetoxylation. A reaction 
tube was covered with aluminum foil, and a mixture of 2,2–dimethyl–N–(8–
quinolinyl)butanamide (1a, 24.2 mg, 0.100 mmol), Cu(OAc)2 (18.2 mg, 0.100 mmol), NaOAc 
(8.20 mg, 0.100 mmol), AgOAc (83.5 mg, 0.500 mmol), and N–methyl–2–pyrrolidone (1.0 mL) 
was stirred at 145 °C for 24 h under argon atmosphere. Then, the reaction mixture was cooled to 
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room temperature, and water (10 mL) was added to the reaction tube. The mixture was extracted 
with ethyl acetate (3 x 15 mL), and the organic phase was dried over Na2SO4 and was 
concentrated in vacuo. Then the mixture was subjected to column chromatography on silica gel 
(hexane/ethyl acetate = 3:1) to give the desired products (2a, 13.8 mg, 46%; 3a, 11.5 mg, 32%). 
 
2–Methyl–2–(8–quinolinylcarbamoyl)butyl acetate (2a). 13.8 mg, 46% 
yield, yellow oil; 
1
H NMR (400 MHz, CDCl3) δ 10.42 (s, 1H), 8.84 – 8.67 
(m, 2H), 8.16 (dd, J = 8.3, 1.6 Hz, 1H), 7.50 (m, 3H), 4.36 (d, J = 11.1 Hz, 
1H), 4.21 (d, J = 11.1 Hz, 1H), 2.14 (s, 3H), 1.92 (dt, J = 14.8, 7.5 Hz, 1H), 
1.70 (dt, J = 14.8, 7.5 Hz, 1H), 1.41 (s, 3H), 0.98 (t, J = 7.5 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) 
δ 173.8, 171.1, 148.4, 139.0, 136.6, 134.8, 128.2, 127.7, 121.8, 121.7, 116.8, 69.4, 47.6, 29.6, 
21.2, 19.5, 8.8; IR (KBr, ν/cm–1) 3358, 2969, 2881, 1747, 1677, 1596, 1532, 1487, 1425, 1382, 
1324, 1235, 1152, 1038, 986, 935, 906, 827, 791, 756, 691; HRMS (ESI
+
) Calcd for 
C17H20N2NaO3 (M+Na
+
) 323.1366, Found 323.1368. 
 
2–Ethyl–2–(8–quinolinylcarbamoyl)propane–1,3–diyl diacetate (3a). 
11.5 mg, 32% yield, yellow oil; 
1
H NMR (400 MHz, CDCl3) δ 10.56 (s, 
1H), 8.93 – 8.67 (m, 2H), 8.18 (dd, J = 8.3, 1.6 Hz, 1H), 7.50 (m, 3H), 
4.49 (d, J = 11.8 Hz, 2H), 4.42 (d, J = 11.8 Hz, 2H), 2.16 (s, 6H), 1.91 (q, 
J = 7.5 Hz, 2H), 1.00 (t, J = 7.5 Hz, 3H); 
13
C NMR (100 MHz, acetone–d6) δ 172.1, 171.5, 150.4, 
140.1, 138.3, 136.4, 129.8, 128.8, 123.7, 123.4, 117.9, 66.0, 51.9, 26.3, 21.6, 9.4; IR (KBr, ν/cm–1) 
3445, 2971, 2881, 1748, 1678, 1534, 1488, 1425, 1382, 1325, 1233, 1156, 1043, 903, 827, 793, 
759, 712; HRMS (ESI
+
) Calcd for C19H22N2O5 (M+Na
+
) 381.1421, Found 381.1419. 
 
2,2–Dimethyl–3–oxo–3–(8–quinolinylamino)propyl acetate (2b). 11.2 
mg, 39% yield, yellow oil; 
1
H NMR (400 MHz, CDCl3) δ 10.45 (s, 1H), 
8.93 – 8.69 (m, 2H), 8.17 (dd, J = 8.3, 1.6 Hz, 1H), 7.69 – 7.36 (m, 3H), 
4.26 (s, 2H), 2.15 (s, 3H), 1.44 (s, 6H); 
13
C NMR (100 MHz, CDCl3) δ 
174.3, 171.1, 148.4, 139.0, 136.6, 134.9, 128.2, 127.7, 121.84, 121.79, 116.8, 70.6, 43.9, 23.1, 
21.2; IR (KBr, ν/cm–1) 3428, 2968, 2881, 1747, 1646, 1530, 1488, 1424, 1375, 1326, 1235, 1155, 
1039, 826, 793, 698; HRMS (ESI
+
) Calcd for C16H18N2O3 (M+Na
+
) 309.1210, Found 309.1204. 
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2–Methyl–2–(8–quinolinylcarbamoyl)propane–1,3–diyl diacetate 
(3b). 13.1 mg, 38% yield, yellow oil; 
1
H NMR (400 MHz, CDCl3) δ 
10.60 (s, 1H), 8.93 – 8.67 (m, 2H), 8.18 (dt, J = 8.1, 1.6 Hz, 1H), 7.67 – 
7.39 (m, 3H), 4.40 (s, 4H), 2.16 (s, 6H), 1.46 (s, 3H); 
13
C NMR (100 
MHz, CDCl3) δ 171.3, 170.8, 148.4, 139.0, 136.7, 134.7, 128.2, 127.7, 122.1, 121.9, 117.1, 67.0, 
47.3, 21.1, 18.5; IR (KBr, ν/cm–1) 3444, 2968, 2861, 1748, 1683, 1654, 1532, 1489, 1424, 1375, 
1327, 1235, 1040, 826, 793, 756; HRMS (ESI
+
) Calcd for C18H20N2O5 (M+Na
+
) 367.1264, 
Found 367.1280. 
 
2–Methyl–2–(8–quinolinylcarbamoyl)pentyl acetate (2c). 17.3 mg, 55% 
yield, yellow oil; 
1
H NMR (400 MHz, CDCl3) δ 10.43 (s, 1H), 8.81 (dd, 
J = 4.3, 1.5 Hz, 2H), 8.17 (dd, J = 8.3, 1.5 Hz, 1H), 7.60 – 7.42 (m, 3H), 
4.36 (d, J = 11.1 Hz, 1H), 4.20 (d, J = 11.1 Hz, 1H), 2.14 (s, 3H), 1.95 – 
1.75 (m, 1H), 1.67 – 1.57 (m, 2H), 1.43 (s, 3H), 1.41 – 1.25 (m, 1H), 0.93 (t, J = 7.3 Hz, 3H); 13C 
NMR (100 MHz, CDCl3) δ 173.9, 171.1, 148.4, 139.0, 136.6, 134.8, 128.2, 127.7, 121.8, 121.7, 
116.7, 69.8, 47.4, 39.3, 21.2, 20.0, 17.8, 14.8; IR (KBr, ν/cm–1) 3427, 2960, 2872, 1746, 1677, 
1653, 1577, 1530, 1487, 1424, 1375, 1324, 1233, 1153, 1036, 927, 826, 792, 758, 688; HRMS 
(ESI
+
) Calcd for C18H22N2O3 (M+Na
+
) 337.1523, Found 337.1513. 
 
2–Propyl–2–(8–quinolinylcarbamoyl)propane–1,3–diyl diacetate (3c). 
8.57 mg, 23% yield, yellow oil; 
1
H NMR (400 MHz, CDCl3) δ 10.56 (s, 
1H), 8.79 (dd, J = 6.0, 1.9 Hz, 2H), 8.18 (dd, J = 8.3, 1.5 Hz, 1H), 7.65 – 
7.41 (m, 3H), 4.49 (d, J = 11.4 Hz, 2H), 4.41 (d, J = 11.4 Hz, 2H), 2.17 (s, 
6H), 1.80 (dd, J = 10.6, 6.3 Hz, 2H), 1.47 – 1.34 (m, 2H), 0.93 (t, J = 7.2 Hz, 3H); 13C NMR (100 
MHz, CDCl3) δ 171.0, 170.9, 148.4, 139.0, 136.7, 134.7, 128.2, 127.7, 122.0, 121.9, 117.1, 65.4, 
50.4, 34.8, 21.2, 17.5, 14.8; IR (KBr,ν/cm–1) 3420, 2961, 2851, 1747, 1682, 1654, 1532, 1488, 
1425, 1381, 1326, 1230, 1148, 1048, 827, 793, 759; HRMS (ESI
+
) Calcd for C20H24N2O5 
(M+Na
+
) 395.1577, Found 395.1561. 
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2–Methyl–4–phenyl–2–(8–quinolinylcarbamoyl)butyl acetate (2d). 
20.70 mg, 55% yield, yellow oil;
 1
H NMR (400 MHz, CDCl3) δ 10.51 
(s, 1H), 8.91 – 8.75 (m, 2H), 8.19 (dd, J = 8.3, 1.6 Hz, 1H), 7.64 – 7.38 
(m, 3H), 7.36 – 7.07 (m, 5H), 4.41 (d, J = 11.2 Hz, 1H), 4.28 (d, J = 
11.2 Hz, 1H), 2.90 – 2.57 (m, 2H), 2.26 – 2.17 (m, 1H), 2.16 (s, 3H), 1.96 (m, 1H), 1.52 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 173.3, 171.0, 148.4, 141.9, 139.0, 136.7, 134.7, 128.8, 128.7, 
128.6, 128.2, 127.7, 126.2, 121.9, 116.9, 69.6, 47.4, 39.1, 31.0, 21.2, 20.2; IR (KBr, ν/cm–1) 
3444, 3031, 2973, 2871, 1746, 1677, 1530, 1488, 1424, 1375, 1326, 1235, 1165, 1040, 924, 826, 
793, 755, 700; HRMS (ESI
+
) Calcd for C23H24N2O3 (M+Na
+
) 399.1679, Found 399.1672. 
 
2–Phenethyl–2–(8–quinolinylcarbamoyl)propane–1,3–diyl 
diacetate (3d). 9.1 mg, 21% yield, yellow oil; 
1
H NMR (400 MHz, 
CDCl3) δ 10.64 (s, 1H), 8.87 – 8.72 (m, 2H), 8.20 (dd, J = 8.2, 1.6 Hz, 
1H), 7.64 – 7.51 (m, 2H), 7.48 (dd, J = 8.2, 4.2 Hz, 1H), 7.29 – 7.22 (m, 
3H), 7.18 (d, J = 7.1 Hz, 2H), 4.55 (d, J = 11.6 Hz, 2H), 4.49 (d, J = 11.6 Hz, 2H), 2.71 (dd, J = 
8.0, 4.7 Hz, 2H), 2.18 (s, 6H), 2.15 (dd, J = 8.0, 4.7 Hz, 2H); 
13
C NMR (100 MHz, CDCl3) δ 
170.8, 170.5, 148.4, 141.5, 139.0, 136.7, 134.6, 128.7, 128.6, 128.3, 127.7, 126.4, 122.2, 122.0, 
117.2, 65.2, 50.4, 34.7, 30.6, 21.2; IR (KBr, ν/cm–1) 3445, 2987, 2871, 1741, 1651, 1531, 1488, 
1383, 1339, 1238, 1210, 1109, 1040, 826, 792, 756, 701; HRMS (ESI
+
) Calcd for C25H26N2O5 
(M+Na
+
) 457.1734, Found 457.1738. 
 
2–((Benzyloxy)methyl)–2–methyl–3–oxo–3–(8–quinolinylamino)propyl acetate (2e). 21.6 mg, 
54% yield, yellow oil; 
1
H NMR (400 MHz, CDCl3) δ 11.12 (s, 1H), 8.82 
(dd, J = 7.2, 1.8 Hz, 1H), 8.53 (dd, J = 4.1, 1.7 Hz, 1H), 8.13 (dd, J = 8.3, 
1.7 Hz, 1H), 7.57 – 7.47 (m, 2H), 7.45 – 7.37 (m, 3H), 7.36 – 7.28 (m, 
3H), 4.76 (d, J = 12.2 Hz, 1H), 4.72 (d, J = 12.2 Hz, 1H), 4.47 (d, J = 
11.1 Hz, 1H), 4.37 (d, J = 11.1 Hz, 1H), 3.83 (d, J = 9.4 Hz, 1H), 3.72 (d, J = 9.4 Hz, 1H), 2.07 (s, 
3H), 1.42 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 172.7, 171.0, 148.4, 139.2, 138.0, 136.4, 135.3, 
128.6, 128.2, 127.9, 127.8, 127.6, 121.8, 121.7, 117.1, 73.9, 73.2, 67.7, 48.1, 21.2, 18.7; IR (KBr, 
ν/cm–1) 3421, 2969, 2881, 1743, 1676, 1531, 1488, 1424, 1383, 1326, 1238, 1094, 1039, 826, 
793, 738, 698; HRMS (ESI
+
) Calcd for C23H24N2O4 (M+Na
+
) 415.1628, Found 415.1633. 
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2–((Benzyloxy)methyl)–2–(8–quinolinylcarbamoyl)propane–1,3–diyl 
diacetate (3e). 9.9 mg, 22% yield, yellow oil; 
1
H NMR (400 MHz, 
CDCl3) δ 11.15 (s, 1H), 8.79 (dd, J = 6.3, 2.7 Hz, 1H), 8.55 (dd, J = 4.2, 
1.7 Hz, 1H), 8.15 (dd, J = 8.2, 1.6 Hz, 1H), 8.15 (dd, J = 8.2, 1.6 Hz, 2H), 
7.58 – 7.50 (m, 3H), 7.35 (m, 3H), 4.71 (s, 2H), 4.58 (d, J = 11.4 Hz, 2H), 4.51 (d, J = 11.4 Hz, 
2H), 3.88 (s, 2H), 2.07 (s, 6H); 
13
C NMR (100 MHz, CDCl3) δ 170.8, 169.5, 148.4, 139.1, 137.7, 
136.5, 135.0, 128.6, 128.2, 128.0, 127.9, 127.6, 122.1, 121.8, 117.3, 74.0, 69.4, 64.3, 51.5, 21.0; 
IR (KBr, ν/cm–1) 3429, 2969, 1743, 1638, 1534, 1488, 1456, 1425, 1379, 1326, 1231, 1094, 1041, 
887, 827, 698, 634; HRMS (ESI
+
) Calcd for C25H26N2O6 (M+Na
+
) 473.1683, Found 473.1678. 
 
3,3,3–Trifluoro–2–methyl–2–(8–quinolinylcarbamoyl)propyl acetate 
(2f). 24.8 mg, 73% yield, yellow oil; 
1
H NMR (400 MHz, CDCl3) δ 10.7 (s, 
1H), 8.85 – 8.71 (m, 2H), 8.19 (dd, J = 8.2, 1.4 Hz, 1H), 7.61 – 7.43 (m, 
3H), 4.68 (d, J = 11.6 Hz, 1H), 4.46 (d, J = 11.6 Hz, 1H), 2.17 (s, 3H), 1.66 
(s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 170.4, 164.8, 148.7, 138.9, 136.64, 136.60 (q, J = 282 
Hz), 134.2, 128.2, 127.6, 122.7, 122.1, 117.3, 64.3, 53.3 (q, J = 24.8 Hz), 21.0, 15.7; IR (KBr, 
ν/cm–1) 3434, 2969, 1756, 1685, 1647, 1540, 1489, 1427, 1379, 1328, 1231, 1152, 1120, 1047, 
902, 827, 792, 757, 670; HRMS (ESI
+
) Calcd for C16H15F3N2O3 (M+Na
+
) 363.0927, Found 
363.0938. 
 
2–Methyl–4–phenyl–2–(8–quinolinylcarbamoyl)butyl acetate–d5 
(2g). 19.5 mg, 51% yield, yellow oil; 
1
H NMR (400 MHz, CDCl3) δ 
10.50 (s, 1H), 8.90 – 8.77 (m, 2H), 8.23 – 8.15 (m, 1H), 7.61 – 7.42 (m, 
3H), 7.34 – 7.12 (m, 5H), 2.80 – 2.56 (m, 2H), 2.22 (m, 1H), 2.16 (s, 
3H), 2.01 – 1.90 (m, 1H); 13C NMR (100 MHz, acetone–d6) δ 174.4, 171.6, 150.4, 143.7, 140.2, 
138.3, 136.5, 130.0, 129.9, 129.8, 128.8, 127.4, 123.7, 123.2, 117.7, 48.4, 40.3, 32.1, 21.6 
[signals of CD3 and CD2 groups could not be observed. These signals are supposed to be septet 
and quintet, respectively, and therefore, they are too weak to observe in 
13
C NMR.]; IR (KBr, 
ν/cm–1) 3446, 1748, 1717, 1683, 1526, 1508, 1488, 1457, 1373, 1326, 1259, 827, 791, 699; 
HRMS (ESI
+
) Calcd for C23H19D5N2O3 (M+Na
+
) 404.1993, Found 404.1974. 
3. Copper–Mediated C(sp3)–H and C(sp2)–H Acetoxylation  
102 
 
 
2–Phenethyl–2–(8–quinolinylcarbamoyl)propane–1,3–diyl diacetate–d4 (3g). 7.89 mg, 18% 
yield, yellow oil; 
1
H NMR (400 MHz, CDCl3) δ 10.63 (s, 1H), 8.88 – 
8.67 (m, 2H), 8.20 (dd, J = 8.2, 1.6 Hz, 1H), 7.60 – 7.44 (m, 3H), 7.28 – 
7.22 (m, 3H), 7.20 – 7.13 (m, 2H), 2.86 – 2.66 (m, 2H), 2.18 (s, 6H), 
2.17 – 2.10 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 170.9, 170.5, 148.4, 
141.5, 139.0, 136.7, 134.6, 128.7, 128.6, 128.3, 127.7, 126.4, 122.2, 122.0, 117.2, 50.1, 34.6, 
30.6, 21.2 [A signal of CD2 groups could not be observed. This is supposed to be quintet, which 
is too weak to observe in 
13
C NMR.]; IR (KBr,ν/cm–1) 3441, 2972, 1742, 1637, 1533, 1488, 
1424, 1371, 1326, 1256, 1084, 1034, 899, 827, 791, 756, 691; HRMS (ESI
+
) Calcd for 
C25H22D4N2O5 (M+Na
+
) 461.1985, Found 461.2000. 
 
2–(4–Methoxybenzyl)–2–methyl–3–oxo–3–(8–quinolinylamino)propyl acetate (2h). 26.3 mg, 
67% yield, yellow oil; 
1
H NMR (400 MHz, CDCl3) δ 10.37 (s, 1H), 8.92 – 8.68 (m, 2H), 8.17 (d, 
J = 8.4 Hz, 1H), 7.62 – 7.40 (m, 3H), 7.09 (d, J = 6.7 Hz, 2H), 
6.74 (d, J = 6.7 Hz, 2H), 4.33 (d, J = 11.2 Hz, 1H), 4.22 (d, J = 
11.2 Hz, 1H), 3.71 (s, 3H), 3.13 (d, J = 13.4 Hz, 1H), 2.99 (d, J 
= 13.4 Hz, 1H), 2.17 (s, 3H), 1.38 (s, 3H); 
13
C NMR (100 MHz, 
CDCl3) δ 173.4, 171.0, 158.7, 148.4, 141.7, 139.0, 136.6, 134.7, 131.5, 128.4, 128.2, 127.7, 
121.8, 116.9, 113.9, 69.1, 55.4, 48.4, 41.7, 21.2, 19.8; IR (KBr,ν/cm–1) 3566, 2979, 1747, 1717, 
1683, 1615, 1531, 1488, 1423, 1374, 1323, 1246, 1179, 1037, 827, 793, 737; HRMS (ESI
+
) 
Calcd for C23H24N2O4 (M+Na
+
) 415.1628, Found 415.1633. 
 
2–Methyl–2–(4–methylbenzyl)–3–oxo–3–(8–quinolinylamino)propyl acetate (2i). 26.7 mg, 71% 
yield, yellow oil. 
1
H NMR (400 MHz, CDCl3) δ 10.40 (s, 1H), 
8.95 – 8.66 (m, 2H), 8.16 (dd, J = 8.3, 1.6 Hz, 2H), 7.67 – 7.40 
(m, 3H), 7.23 – 6.93 (m, 4H), 4.32 (d, J = 11.2 Hz, 1H), 4.22 (d, 
J = 11.2 Hz, 1H), 3.14 (d, J = 13.4 Hz, 1H), 3.02 (d, J = 13.4 Hz, 
1H), 2.25 (s, 3H), 2.17 (s, 3H), 1.38 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 173.4, 171.0, 148.3, 
139.0, 136.6, 136.5, 134.7, 133.3, 130.4, 129.2, 128.2, 127.7, 121.82, 121.79, 116.9, 69.1, 48.3, 
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42.0, 22.3, 21.2, 19.9; IR (KBr,ν/cm–1) 3432, 2965, 1747, 1717, 1531, 1487, 1424, 1374, 1324, 
1231, 1167, 1038, 989, 917, 826, 792, 757, 699; HRMS (ESI
+
) Calcd for C23H24N2O3 (M+Na
+
) 
399.1679, Found 399.1669. 
 
2–Benzyl–2–methyl–3–oxo–3–(8–quinolinylamino)propyl acetate 
(2j). 26.8 mg, 74% yield, yellow oil; 
1
H NMR (400 MHz, CDCl3) δ 
10.40 (s, 1H), 8.87 – 8.70 (m, 2H), 8.16 (dd, J = 8.2, 1.5 Hz, 1H), 7.62 
– 7.38 (m, 3H), 7.25 – 7.10 (m, 5H), 4.33 (d, J = 11.1 Hz, 1H), 4.24 (d, 
J = 11.1 Hz, 1H), 3.19 (d, J = 13.4 Hz, 1H), 3.05 (d, J = 13.4 Hz, 1H), 2.17 (s, 3H), 1.39 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 173.3, 171.0, 148.4, 139.0, 136.6, 136.5, 134.7, 132.8, 130.5, 
128.5, 128.2, 127.7, 127.0, 121.8, 116.9, 69.1, 48.3, 42.5, 21.2, 19.9; IR (KBr,ν/cm–1) 3444, 
2970, 1747, 1647, 1532, 1488, 1424, 1375, 1325, 1231, 1038, 826, 793, 736, 702; HRMS (ESI
+
) 
Calcd for C22H22N2O3 (M+Na
+
) 385.1523, Found 385.1528. 
 
2–(4–Bromobenzyl)–2–methyl–3–oxo–3–(8–quinolinylamino)propyl acetate (2k). 27.4 mg, 
62% yield, yellow oil; 
1
H NMR (400 MHz, CDCl3) δ 10.34 (s, 1H), 
8.86 – 8.67 (m, 2H), 8.21 – 8.11 (d, J = 8.3 Hz,, 1H), 7.63 – 7.40 
(m, 3H), 7.31 (d, J = 8.3 Hz, 1H), 7.24 – 6.97 (m, 3H), 4.33 (d, J = 
11.2 Hz, 1H), 4.23 (d, J = 11.2 Hz, 1H), 3.15 (d, J = 13.5 Hz, 1H), 
2.96 (d, J = 13.5 Hz, 1H), 2.17 (s, 3H), 1.39 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 172.9, 170.9, 
148.4, 139.0, 136.6, 132.2, 131.8, 131.6, 130.5, 128.6, 128.2, 127.7, 122.0, 121.9, 116.9, 69.1, 
48.3, 41.9, 21.2, 19.9; IR (KBr,ν/cm–1) 3433, 2981, 1736, 1668, 1529, 1487, 1425, 1383, 1337, 
1243, 1210, 1130, 1038, 1011, 826, 792, 702; HRMS (ESI
+
) Calcd for C22H21BrN2O3 (M+Na
+
) 
463.0628, Found 463.0619. 
 
2–(4–Chlorobenzyl)–2–methyl–3–oxo–3–(8–quinolinylamino)propyl acetate (2l). 31.0 mg, 78% 
yield, yellow oil; 
1
H NMR (400 MHz, CDCl3) δ 10.35 (s, 1H), 
8.89 – 8.69 (m, 2H), 8.17 (dd, J = 8.2, 1.6 Hz, 1H), 7.65 – 7.43 (m, 
3H), 7.21 – 7.07 (m, 4H), 4.33 (d, J = 11.2 Hz, 1H), 4.23 (d, J = 
11.2 Hz, 1H), 3.17 (d, J = 13.4 Hz, 1H), 2.97 (d, J = 13.4 Hz, 1H), 
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2.17 (s, 3H), 1.39 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 172.9, 170.9, 148.4, 138.9, 136.6, 
135.0, 134.5, 132.9, 131.8, 128.6, 128.2, 127.6, 122.0, 121.9, 116.9, 69.1, 48.3, 41.9, 21.2, 19.8; 
IR (KBr,ν/cm–1) 3423, 2968, 1746, 1647, 1530, 1489, 1424, 1374, 1323, 1231, 1092, 1038, 
1015, 826, 792, 758, 698; HRMS (ESI
+
) Calcd for C22H21ClN2O3 (M+Na
+
) 419.1133, Found 
419.1122. 
 
2–(4–Fluorobenzyl)–2–methyl–3–oxo–3–(8–quinolinylamino)propyl acetate (2m). 30.8 mg, 
81% yield, yellow oil; 
1
H NMR (400 MHz, CDCl3) δ 10.35 (s, 1H), 
8.85 – 8.72 (m, 2H), 8.17 (d, J = 8.3 Hz, 1H), 7.62 – 7.50 (m, 2H), 
7.45 (dd, J = 8.3, 4.3 Hz, 1H), 7.13 (dd, J = 8.0, 5.8 Hz, 2H), 6.88 
(m, 2H), 4.33 (d, J = 11.2 Hz, 1H), 4.23 (d, J = 11.2 Hz, 1H), 3.17 (d, 
J = 13.5 Hz, 1H), 2.98 (d, J = 13.5 Hz, 1H), 2.17 (s, 3H), 1.39 (s, 3H); 
13
C NMR (100 MHz, 
CDCl3) δ 173.0, 170.9, 162.1 (d, J = 244 Hz), 148.4, 139.0, 136.6, 134.5, 132.2 (d, J = 3.0 Hz), 
132.0 (d, J = 8.9 Hz), 128.2, 127.7, 122.0, 121.9, 116.9, 115.3 (d, J = 21.8 Hz), 69.1, 48.4, 41.7, 
21.2, 19.8; IR (KBr,ν/cm–1) 3434, 1747, 1645, 1530, 1509, 1486, 1425, 1375, 1323, 1223, 1159, 
1038, 826, 791, 759; HRMS (ESI
+
) Calcd for C22H21FN2O3 (M+Na
+
) 403.1428, Found 403.1421. 
 
2–Methyl–3–oxo–3–(8–quinolinylamino)–2–(4–(trifluoromethyl)benzyl)propyl acetate (2n). 
35.7 mg, 83% yield, yellow oil; 
1
H NMR (400 MHz, CDCl3) δ 10.34 (s, 1H), 8.75 (m, 2H), 8.21 
– 8.13 (dt, J = 8.0, 1.5 Hz,, 1H), 7.63 – 7.50 (m, 2H), 7.50 – 7.41 (m, 3H), 7.29 (d, J = 7.9 Hz, 
2H), 4.35 (d, J = 11.2 Hz, 1H), 4.26 (d, J = 11.2 Hz, 1H), 3.26 (d, 
J = 13.4 Hz, 1H), 3.05 (d, J = 13.4 Hz, 1H), 2.17 (s, 3H), 1.41 (s, 
3H); 
13
C NMR (100 MHz, CDCl3) δ 172.7, 170.9, 148.5, 140.8, 
138.9, 136.6, 134.4, 130.8, 129.3 (q, J = 32.4 Hz), 127.6, 127.0 
(q, J = 245 Hz), 125.4 (q, J = 3.7 Hz), 123.0, 122.1, 121.9, 116.9, 69.1, 48.4, 42.3, 21.2, 19.9; IR 
(KBr,ν/cm–1) 3433, 1747, 1645, 1531, 1487, 1424, 1375, 1324, 1229, 1163, 1121, 1067, 1039, 
1019, 918, 826, 791, 755, 691; HRMS (ESI
+
) Calcd for C23H21F3N2O3 (M+Na
+
) 453.1396, Found 
453.1382. 
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2–Ethyl–4–phenyl–2–(8–quinolinylcarbamoyl)butyl acetate (2o). 
30.5 mg, 78% yield, yellow oil; 
1
H NMR (400 MHz, CDCl3) δ 10.49 (s, 
1H), 8.97 – 8.75 (m, 2H), 8.32 – 8.13 (dd, J = 8.2, 1.5 Hz, 1H), 7.69 – 
7.41 (m, 3H), 7.36 – 7.11 (m, 5H), 4.46 (s, 2H), 2.67 (dd, J = 9.7, 7.2 
Hz, 2H), 2.19 (s, 3H), 2.13 – 2.04 (dd, J = 9.7, 7.2 Hz, 2H), 1.95 (q, J = 7.3 Hz, 2H), 1.02 (t, J = 
7.3 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 173.1, 171.1, 148.4, 142.1, 139.0, 136.6, 134.7, 
128.7, 128.6, 128.2, 127.7, 126.2, 121.9, 121.8, 116.9, 66.0, 50.6, 36.3, 30.8, 27.1, 21.2, 8.7; IR 
(KBr, ν/cm–1) 3354, 2968, 2881, 1747, 1716, 1676, 1530, 1488, 1457, 1425, 1382, 1324, 1230, 
1039, 826, 793, 757, 699; HRMS (ESI
+
) Calcd for C24H26N2O3 (M+Na
+
) 413.1836, Found 
413.1856. 
 
2–Benzyl–2–(8–quinolinylcarbamoyl)butyl acetate (2p). 32.4 mg, 86% 
yield, yellow oil; 
1
H NMR (400 MHz, CDCl3) δ 10.41 (s, 1H), 8.83 (dd, J 
= 7.2, 1.7 Hz, 1H), 8.76 (dd, J = 4.2, 1.6 Hz, 1H), 8.17 (dd, J = 8.3, 1.6 
Hz, 1H), 7.59 – 7.51 (m, 2H), 7.45 (dd, J = 8.3, 4.2 Hz, 1H), 7.24 – 7.13 
(m, 5H), 4.35 (d, J = 11.6 Hz, 1H), 4.23 (d, J = 11.6 Hz, 1H), 3.26 (d, J = 13.6 Hz, 1H), 3.09 (d, J 
= 13.6 Hz, 1H), 2.20 (s, 3H), 1.89 (dt, J = 14.9, 7.4 Hz, 1H), 1.82 (dt, J = 14.9, 7.4 Hz, 1H), 1.04 
(t, J = 7.4 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 172.9, 170.9, 148.4, 139.0, 136.7, 136.6, 
134.7, 130.5, 128.5, 128.2, 127.7, 127.0, 121.8, 121.8, 116.9, 65.8, 51.7, 39.8, 27.0, 21.3, 8.9; IR 
(KBr,ν/cm–1) 3444, 2967, 2863, 1745, 1645, 1531, 1488, 1457, 1424, 1384, 1324, 1229, 1035, 
825, 791, 743, 701; HRMS (ESI
+
) Calcd for C23H24N2O3 (M+Na
+
) 399.1679, Found 399.1694. 
 
4–Phenyl–2–(8–quinolinylcarbamoyl)–2–(4–(trifluoromethyl)benzyl)butyl acetate (2q). 45.3 
mg, 87% yield, yellow oil;
 1
H NMR (400 MHz, CDCl3) δ 10.48 (s, 
1H), 8.81 (dd, J = 6.8, 2.1 Hz, 1H), 8.75 (dd, J = 4.2, 1.6 Hz, 1H), 
8.19 (dd, J = 8.3, 1.6 Hz, 1H), 7.63 – 7.54 (m, 2H), 7.51 – 7.43 (m, 
3H), 7.35 – 7.23 (m, 4H), 7.19 (m, 3H), 4.43 (d, J = 11.8 Hz, 1H), 
4.37 (d, J = 11.8 Hz, 1H), 3.39 (d, J = 13.6 Hz, 1H), 3.16 (d, J = 
13.6 Hz, 1H), 2.85 – 2.67 (m, 2H), 2.24 (s, 3H), 2.23 – 2.13 (m, 1H), 2.10 – 1.99 (m, 1H); 13C 
NMR (100 MHz, CDCl3) δ 171.9, 170.8, 148.5, 141.6, 140.8, 139.0, 136.7, 134.4, 130.6 (q, J = 
3. Copper–Mediated C(sp3)–H and C(sp2)–H Acetoxylation  
106 
 
36.3 Hz), 129.2, 128.8, 128.6, 128.3, 127.7, 126.4, 125.4 (q, J = 281 Hz), 125.2 (q, J = 3.7 Hz), 
122.2, 122.0, 117.1, 65.6, 51.6, 40.9, 37.1, 30.9, 21.2; IR (KBr, ν/cm–1) 3430, 2970, 1748, 1671, 
1636, 1530, 1488, 1457, 1424, 1384, 1325, 1229, 1165, 1121, 1067, 1037, 1019, 826, 793, 754, 
700; HRMS (ESI
+
) Calcd for C30H27F3N2O3 (M+Na
+
) 543.1866, Found 543.1881. 
 
(1–(8–Quinolinylcarbamoyl)cyclohexyl)methyl acetate (2r). 25.8 mg, 
79% yield, yellow oil; 
1
H NMR (400 MHz, CDCl3) δ 10.45 (s, 1H), 8.89 – 
8.71 (m, 2H), 8.17 (dd, J = 8.2, 1.7 Hz, 1H), 7.62 – 7.38 (m, 3H), 4.25 (s, 
2H), 2.38 – 2.14 (m, 2H), 2.07 (s, 3H), 1.63 (m, 8H); 13C NMR (100 MHz, 
CDCl3) δ 173.5, 171.1, 148.4, 139.0, 136.6, 134.9, 128.2, 127.7, 121.8, 121.7, 116.7, 69.7, 47.8, 
31.5, 26.0, 22.6, 21.1; IR (KBr, ν/cm–1) 3430, 2934, 2859, 1747, 1637, 1530, 1488, 1424, 1381, 
1326, 1232, 1140, 1037, 826, 792, 757, 615; HRMS (ESI
+
) Calcd for C19H22N2O3 (M+Na
+
) 
349.1523, Found 349.1511. 
 
2–Ethyl–2–((5–methoxy–8–quinolinyl)carbamoyl)–4–phenylbutyl 
acetate (2s). 28.6 mg, 68% yield, yellow oil; 
1
H NMR (400 MHz, 
CDCl3) δ 10.24 (s, 1H), 8.81 (dd, J = 4.2, 1.7 Hz, 1H), 8.75 (d, J = 8.5 
Hz, 1H), 8.59 (dd, J = 8.5, 1.7 Hz, 1H), 7.46 (dd, J = 8.4, 4.2 Hz, 1H), 
7.39 – 7.13 (m, 5H), 6.86 (d, J = 8.4 Hz, 1H), 4.45 (s, 2H), 4.00 (s, 3H), 2.74 – 2.62 (m, 2H), 
2.18 (s, 3H), 2.12 – 2.03 (m, 2H), 1.94 (q, J = 7.5 Hz, 2H), 1.01 (t, J = 7.5 Hz, 3H); 13C NMR 
(100 MHz, CDCl3) δ 172.6, 171.1, 150.5, 148.9, 142.2, 139.7, 131.5, 128.6, 128.6, 128.2, 126.2, 
121.0, 120.7, 117.0, 104.6, 66.1, 56.0, 50.4, 36.3, 30.8, 27.1, 21.3, 8.7; IR (KBr, ν/cm–1) 3555, 
3364, 2968, 2865, 1748, 1649, 1528, 1495, 1457, 1245, 1144, 989, 821, 789, 742, 671; HRMS 
(ESI
+
) Calcd for C25H28N2O4 (M+Na
+
) 443.1941, Found 443.1958. 
 
Preparation of amide 4. To a solution of  pivaloyl chloride (1.20 g, 9.97 mmol) in 
dichloromethane (40 mL), a solution of 18–β–glycyrrhetinic acid (2.04 g, 4.33 mmol) and NEt3 
(1.01 g, 9.97 mmol) in dichloromethane (10 mL) was added dropwise within 30min. After 
stirring at 25 °C for 30 min, the mixture was quenched with saturated aq. NaHCO3 (50 mL), and 
was extracted with dichloromethane (3 x 50 mL). The organic layer was dried over Na2SO4. After 
filtration and evaporation, the obtained yellow compound was not purified. The compound was 
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dissolved in THF (20 mL), and SOCl2 (0.773 g, 6.50 
mmol) was added dropwise. After stirring at 25 °C 
for 1 h, the reaction mixture was concentrated in 
vacuo to give an acid chloride, which was used 
without purification. To a solution of the prepared 
acid chloride in dichloromethane (20 mL), a solution 
of 8–aminoquinoline (0.749 g, 5.20 mmol) and Et3N 
(0.526 g, 5.20 mmol) in dichloromethane (10 mL) 
was added dropwise within 30 min. The resulting 
mixture was stirred at 25 °C for 30 min, was quenched with saturated aq. NaHCO3 (30 mL), and 
was extracted with dichloromethane (3 x 100 mL). The organic layer was dried over Na2SO4. 
After filtration and evaporation, the obtained amide was purified by column chromatography on 
silica gel (hexane/ethyl acetate = 12:1). 2.39 g, 81% yield, yellow foam; 
1
H NMR (400 MHz, 
CDCl3) δ 10.38 (s, 1H), 9.04 (dd, J = 4.1, 1.5 Hz, 1H), 8.82 – 8.68 (d, J = 7.1, 1H), 8.25 – 8.03 (d, 
J = 8.3, 1H), 7.67 – 7.41 (m, 3H), 6.24 (s, 1H), 4.50 (dd, J = 11.3, 4.6 Hz, 1H), 2.87 (d, J = 13.6 
Hz, 1H), 2.47 (m, 2H), 2.31 (m, 1H), 2.20 – 1.98 (m, 3H), 1.91 – 1.79 (m, 1H), 1.65 (m, 5H), 
1.48 (s, 3H), 1.46 – 1.36 (m, 4H) , 1.33 (s, 3H), 1.25 (m, 2H), 1.21 (s, 9H), 1.18 (s, 3H), 1.12 (s, 
3H), 1.07 (m, 1H), 0.91 (s, 3H), 0.89 (s, 3H), 0.85 (m, 1H), 0.78 (s, 3H); 
13
C NMR (100 MHz, 
CDCl3) δ 200.6, 178.4, 174.7, 169.5, 149.1, 139.0, 136.5, 134.6, 129.3, 128.2, 127.5, 122.2, 
121.7, 116.6, 80.2, 62.1, 55.3, 48.1, 45.8, 45.7, 43.5, 42.1, 39.2, 39.1, 38.5, 37.9, 37.3, 33.0, 32.2, 
31.7, 29.9, 28.8, 28.3, 27.5, 26.7, 26.6, 23.8, 23.6, 18.9, 17.6, 17.0, 16.7; IR (KBr, ν/cm–1) 3445, 
2970, 2871, 1719, 1655, 1577, 1526, 1474, 1458, 1423, 1388, 1326, 1284, 1209, 1167, 1140, 
1092, 1032, 981, 937, 892, 826, 793, 736; HRMS (ESI
+
) Calcd for C44H60N2O4 (M+Na
+
) 
703.4445, Found 703.4429.  
 
Gram–scale procedure for copper–mediated C(sp3)–H acetoxylation of 4. A reaction tube 
was covered with aluminum foil, and a mixture of amide 4 (1.92 g, 2.82 mmol), Cu(OAc)2 (512 
mg, 2.82 mmol), AgOAc (2.35 g, 14.1 mmol), NaOAc (231 mg, 2.82 mmol), and N–methyl–2–
pyrrolidone (28.0 mL) was stirred at 145 °C for 24 h under argon atmosphere. The reaction 
mixture was cooled to room temperature, was filtrated through celite, and the residue was washed 
with ethyl acetate (200 mL). Then, water (100 mL) was added to the filtrate, and the mixture was 
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extracted with ethyl acetate (3 x 150 mL). The organic phase was dried over Na2SO4 and was 
concentrated in vacuo. The crude mixture was subjected to column chromatography on silica gel 
(hexane/ethyl acetate = 3:1) to give the desired product (5, 1.10 g). 
 
Acetoxylated product 5. 42.9 mg, 58% yield, yellow oil; 
1
H NMR (400 MHz, CDCl3) δ 10.48 (s, 
1H), 9.02 (dd, J = 4.2, 1.6 Hz, 1H), 8.78 (dd, J = 6.1, 
2.9 Hz, 1H), 8.19 (dd, J = 8.2, 1.6 Hz, 1H), 7.84 – 
7.54 (m, 3H), 6.21 (s, 1H), 4.50 (dd, J = 11.3, 5.0 Hz, 
1H), 4.23 (d, J = 10.9 Hz, 1H), 4.05 (d, J = 10.9 Hz, 
1H), 2.86 (d, J = 13.6 Hz, 1H), 2.56 – 2.40 (m, 2H), 
2.30 – 2.02 (m, 4H), 1.99 (s, 3H), 1.88 (m, 1H), 1.78 
– 1.54 (m, 9H), 1.46 (s, 3H), 1.40 (m, 2H), 1.33 – 
1.23 (m, 2H). 1.21 (s, 9H), 1.18 (s, 3H), 1.13 (s, 3H), 
0.91 (s, 3H), 0.89 (s, 3H), 0.81 (s, 3H); 
13
C NMR 
(100 MHz, CDCl3) δ 200.6, 178.4, 171.3, 171.0, 167.0, 149.1, 139.0, 136.6, 134.3, 129.6, 128.2, 
127.6, 122.3, 122.0, 116.7, 80.3, 72.1, 62.1, 55.3, 49.3, 47.2, 45.8, 43.5, 39.3, 39.1, 38.6, 37.3, 
37.2, 36.8, 32.9, 32.6, 28.7, 28.3, 27.5, 27.0, 26.63, 26.57, 23.8, 23.6, 21.1, 19.0, 17.6, 17.0, 16.7; 
IR (KBr, ν/cm–1) 3435, 2980, 2930, 2876, 1728, 1716, 1645, 1576, 1527, 1425, 1378, 1325, 1210, 
1165, 1141, 1092, 1032, 982, 938, 827, 794; HRMS (ESI
+
) Calcd for C46H62N2O6 (M+Na
+
) 
761.4500, Found 761.4489.  
 
2–Carbamoyl–2–ethyl–4–phenylbutyl acetate (6). Amide 2s (36.3 mg, 
0.10 mmol) was dissolved in a mixture of CH3CN and H2O (5/1, 1.2 mL) 
at rt. CAN (165 mg, 0.300 mmol, 3.0 equiv) was added at 0 
o
C, and the 
reaction mixture was stirred at 0 
o
C for 2 h. The reaction was quenched with sat. NaHCO3 (10 
mL), and extracted with ethyl acetate (3 x 15 mL). The organic layer was dried over anhydrous 
Na2SO4, and concentrated in vacuo. The resulting residue was purified by column 
chromatography on silica gel (hexane/ethyl acetate = 4:1) to give amide 6. 16.6 mg, 63% yield, 
yellow oil; 
1
H NMR (400 MHz, CDCl3) δ 7.34 – 7.26 (m, 2H), 7.19 (m, 3H), 5.81 (brs, 1H), 5.47 
(brs, 1H), 4.28 (s, 2H), 2.66 – 2.49 (m, 2H), 2.10 (s, 3H), 1.97 – 1.80 (m, 2H), 1.79 – 1.61 (m, 
2H), 0.94 (t, J = 7.4 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 176.7, 170.9, 142.0, 128.8, 128.5, 
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126.3, 65.6, 49.4, 35.7, 30.5, 26.5, 21.2, 8.5; IR (KBr,ν / cm–1) 3441, 2969, 2871, 1647, 1542, 
1508, 1458, 1375, 1237, 795; HRMS (ESI
+
) Calcd for C15H21NO3 (M+Na
+
) 286.1414, Found 
286.1407. 
 
3–Methyl–2–(8–quinolinylcarbamoyl)phenyl acetate (7). 12.8 mg, 40% 
yield, yellow oil; 
1
H NMR (400 MHz, CDCl3) δ 10.02 (s, 1H), 8.93 (dd, J = 
6.9, 2.0 Hz, 1H), 8.78 (dd, J = 4.1, 1.6 Hz, 1H), 8.18 (dd, J = 8.3, 1.6 Hz, 
1H), 7.65 – 7.53 (m, 2H), 7.45 (dd, J = 8.3, 4.2 Hz, 1H), 7.37 (dd, J = 7.9, 
7.6 Hz, 1H), 7.19 (d, J = 7.6 Hz, 1H), 7.05 (d, J = 7.9 Hz, 1H), 2.49 (s, 3H), 
2.10 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 169.8, 165.1, 148.7, 147.7, 138.7, 137.8, 136.5, 
134.5, 130.9, 130.3, 128.5, 128.2, 127.6, 122.3, 122.0, 120.5, 117.1, 21.1, 19.8; IR (KBr, ν/cm–1) 
3482, 3411, 3331, 1771, 1677, 1618, 1524, 1484, 1326, 1196, 1028, 794, 756, 691; HRMS (ESI
+
) 
Calcd for C19H16N2O3 (M+Na
+
) 343.1053, Found 343.1045. 
 
N–(8–Quinolinyl)acetamide (8). 5.96 mg, 32% yield, yellow oil; 1H NMR (400 
MHz, CDCl3) δ 9.78 (s, 1H), 8.78 (m, 2H), 8.14 (dd, J = 8.3, 1.3 Hz, 1H), 7.62 
– 7.32 (m, 3H), 2.34 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 169.0, 148.3, 138.4, 
136.6, 134.7, 128.1, 127.6, 121.8, 121.7, 116.7, 25.3; IR (KBr, ν/cm–1) 3358, 3054, 1685, 1577, 
1532, 1487, 1423, 1385, 1327, 1264, 1173, 1092, 1034, 1003, 949, 910, 826, 793, 735, 703, 637; 
HRMS (ESI
+
) Calcd for C11H10N2O (M+Na
+
) 209.0685, Found 209.0676. 
 
Kinetic isotope effect experiments for intermolecular C(sp
3
)–H acetoxylation 
Experiment: A screw cap vial was charged with 2,2–dimethyl–4–phenyl–N–(quinolin–8–
yl)butanamide (31.8 mg, 0.100 mmol) or 2,2–dimethyl–4–phenyl–N–(quinolin–8–
yl)butanamide–d6 (32.4 mg, 0.100 mmol), Cu(OAc)2 (18.2 mg, 0.100 mol), NaOAc (8.20 mg, 
0.100 mol), AgOAc (83.5 mg, 0.500 mol), and N–methyl–2–pyrrolidone (1.0 mL) under Ar 
atmosphere. The vial was sealed and stirred vigorously at 145 ˚C. The reaction was stopped by 
rapid cooling in the indicated reaction period, poured into water, and extracted with ethyl acetate 
(3 x 25 mL). The organic layer was dried, filtered, and concentrated in vacuo. The residue was 
analyzed by 
1
H NMR using 1,1,2,2–tetrachloroethane as an internal standard. 
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Figure S3-1. KIE experiments for C(sp
3
)-H acetoxylation 
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4. Copper–Catalyzed Intramolecular N–S Bond Formation 
4.1. Introduction 
   Cysteine and cystine broadly exist in the natural world, and they can convert each other via 
redox process. If we can interrupt this step, it is possible to modify the protein structure, such as 
formation of an N–S bond or using a reductive method removing the sulfur atom, On the other 
hand, organic compounds bearing heteroatom–heteroatom bond(s) are important as reagents, 
bioactive molecules,
1
 and functional materials.
2
 Among them, there are many natural products 
and drugs that contain heteroatom–heteroatom bond(s) between two different heteroatoms such 
as N–O,3 N–S,4 and S–O5 bonds. One bioactive compound with an N–S bond is 
benzoisothiazolone which has effective antifungal, antibacterial, and antipsychotic properties 
(Figure 4-1).
6
 As illustrated in Figure 4-2, several methods to construct benzoisothiazolone 
skeletons have been reported: (a) condensation of 2–(chlorocarbamoyl)phenyl hypochlorothioites 
with amines;
7
 (b) a CuI/1,10–phenanthroline–mediated reaction using 2–halo–arylamides, sulfur 
powder, and potassium carbonate as a substrate, S source, and base, respectively;
8
 and (c) a 
dehydrogenative N–H/S–H coupling reaction via the formation of an N–acylnitrenium ion using 
a hypervalent iodine reagent as an oxidant.
9
 These synthetic methods require multi–step synthesis 
of the starting materials and/or highly reactive reagents, however, and produce some waste from 
the starting materials and reagents.
10
 Considering the strong electronic effect of nitrogen and 
sulfur atoms, I hypothesized that transition–metal–catalyzed dehydrogenative cross–coupling 
reactions between N–H/S–H bonds might be the direct and efficient methods to produce 
benzoisothiazolones (Figure 4-2 (d)). My findings indicate that a small amount of a copper salt 
can promote an intramolecular dehydrogenative coupling reaction between N–H and S–H bonds 
to give N–S bonds using oxygen as an oxidant. 
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4.2. Optimization Studies 
Considering the environment, I chose aerobic oxygen as an oxidant. After modifying the 
reaction conditions, I found that treatment of 2–mercapto–N–phenylbenzamide (1a) with a 
catalytic amount of copper(I) iodide (CuI) in N,N–dimethylformamide (DMF) at 70 °C for 5 h 
under O2 conditions gave 2–phenylbenzo[d]isothiazol–3(2H)–one (2a) in quantitative yield (eq 
4-1).
11–18
 This reaction did not proceed in the absence of O2. The structure of 2a was determined 
by single crystal X–ray structure analysis and revealed the formation of an N–S bond and 
construction of a five–membered heterocyclic skeleton. 
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4.3. Substrate Scope and Mechanism Research 
 
Next, the substrate scope was investigated (Table 4-1). N–Aryl 2–mercaptobenzamides 1b–1l 
provided the corresponding 2–arylbenzo[d]isothiazol–3(2H)–ones 2b–2l in excellent yields 
(entries 1–11). The reaction was not affected by electron–donating or –withdrawing groups 
(entries 1–4). In entries 5–7, the reaction proceeded without loss of the halogen atoms. The 
cyclization reaction was not inhibited by steric hindrance (entry 8). Pyridyl and quinolyl groups 
could be used as an aromatic ring on a nitrogen atom of the substrates 1k and 1l (entries 10 and 
11). Alkyl–substituted 2–mercaptobenzamides 1m–1o afforded the corresponding 
benzoisothiazolones 2m–2o in excellent yield (entries 12–14). The 4–membered heterocyclic 
product 2p was also obtained in 84% yield (entry 15).  
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In the case of 2–(((4–fluorophenyl)amino)methyl)benzenethiol, N–S bond formation 
proceeded; however, the reaction did not stop at this step and further oxidation of the benzylic 
position also occurred to give 2d in 29% yield (eq 4-2). 
 
 
 
A double–cyclization reaction also proceeded and product 4 was obtained in 87% yield (eq 
4-3). In this reaction, the yield of product 4 was comparable to that of single–cyclization 
products. 
 
 
 
The present reaction was applied to the synthesis of a drug precursor, which named proxican. 
(Scheme 4-1). Piroxicam is a non–steroidal anti–inflammatory drug used to relieve the symptoms 
of rheumatoid and osteoarthritis, primary dysmenorrhea, and postoperative pain.
19,20
 
Benzoisothiazolone 2q could be synthesized using the present method. Oxidation of 2q
21 
would 
give a precursor of piroxicam, 5, and several successive transformations would lead to piroxicam 
following the reported method.
18a 
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Benzoisothiazolone 2a was not obtained from the corresponding disulfide, which may be 
formed by dehydrogenative homo–coupling of 1a. This result indicated that cyclization did not 
proceed via formation of the disulfide. The proposed mechanism for the formation of 
benzoisothiazolone 2 is as follows (Scheme 4-2): (1) coordination of 2–mercaptobenzamide 1 to 
a copper atom; (2) oxidative formation of a Cu–S bond via the elimination of H2O, (3) oxidative 
formation of a Cu–N bond via the elimination of H2O
 22
 (or the order of steps 2 and 3 is reversed), 
and (4) reductive elimination
23
 to give benzoisothiazolone 2 and regenerate the copper catalyst. 
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   The reaction can be performed in gram scale. Treatment of 1.10 g of 1d with a catalytic 
amount of CuI produced 1.03 g of 2d in 95% yield (eq 4-4), which is comparable to the yield in 
eq 1 (46 mg scale). 
 
 
 
4.4. Summary 
 
In summary, I successfully achieved a copper–catalyzed synthesis of benzo[d]isothiazol–
3(2H)–ones and N–acyl–benzothiazetidine by intramolecular dehydrogenative cyclization (Figure 
4-3). This reaction proceeded using a small amount of the catalyst (0.3 mol%) and oxygen as an 
oxidant to form a new N–S bond by N–H/S–H coupling. Many natural products and drugs 
contain heteroatom–heteroatom bond(s) such as N–S bond(s), and it is therefore important to 
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develop novel and efficient methods to construct N–S bonds. There have been several reports on 
the construction of N–S bonds, but there is a room for improvement of the efficiency. On the 
other hand, the present reaction is more efficient because N–S bond–containing heterocyclic 
skeletons can be constructed catalytically by the direct formation of N–S bonds from NH and SH 
bonds. The present reaction affords products in gram scale. This method promotes double 
cyclization, allowing for the synthesis of a drug precursor. I believe that this reaction will be a 
useful method for the synthesis of heterocyclic compounds with an N–S bond. 
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4.6. Experimental 
 
General. All reactions were carried out in dry solvents under argon atmosphere unless 
otherwise noted. Methyl thiosalicylate was purchased and was used without further purification. 
CuI (99.999% purity) was purchased from Aldrich Co. and used as received. N,N–
Dimethylformamide, methanol, dichloromethane, and dimethyl sulfoxide were purchased and 
were dried and degassed before use. 1q
24,25
 was synthesized following the reported method. 
NMR spectra were recorded on 500 MHz (500 MHz for 
1
H NMR and 125 MHz for 
13
C NMR) 
and 400 MHz (400 MHz for 
1
H NMR and 100 MHz for 
13
C NMR) spectrometers. Proton 
chemical shifts are reported relative to residual solvent peak (CDCl3 at 7.26 ppm, CD3OD at 3.31 
ppm, and DMSO–d6 at 2.50 ppm). Carbon chemical shifts are reported relative to solvent peaks 
(CDCl3 at 77.3 ppm, CD3OD at 49.1 ppm, and DMSO–d6 at 39.5 ppm). IR spectra were recorded 
on Fourier transform infrared spectrophotometer. High–resolution mass spectra (HRMS) were 
measured on a TOF spectrometer (for HRMS). The known starting materials 1b, 1f,
 
1g, 1j, and 
1o, were identified by comparing these spectroscopic data with those of reported data.
9
 
 
Typical procedure for the synthesis of 2–mercapto–N–phenylbenzamide (1a). To a cooled (0 
ºC) solution of aniline (6.64 g, 71.3 mmol) in CH2Cl2 (150 mL) was added a solution of AlMe3 in 
hexane (2.0 M, 35.7 mL, 71.3 mmol). The reaction mixture was warmed to room temperature and 
was continued to stir for 30 minutes until the gas evolution ceased. Then, methyl thiosalicylate 
(5.00 g, 29.7 mmol) was added and the solution was refluxed for 12 h. The reaction mixture was 
cooled in an ice bath and aq. HCl (10%, 60 mL) was added carefully. The solution was extracted 
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with CH2Cl2 (3 x 150 mL) and the combined organic extracts were washed with a saturated 
aqueous solution of NaHCO3 (150 mL) and brine (150 mL) consequently. Then, the organic layer 
was dried over sodium sulfate. After filtration and removal of the solvent under vacuum, the 
residue was purified by crystallization from Et2O to afford 2–mercapto–N–phenylbenzamide (1a) 
as a white solid (6.52 g, 95% yield). TLC (hexane/AcOEt = 3/1): Rf = 0.14, 
1
H NMR (400 MHz, 
CDCl3) δ 7.83 (brs, 1H), 7.61 (d, J = 7.9 Hz, 2H), 7.57 (d, J = 7.7 Hz, 1H), 7.36 (dd, J = 11.0, 4.2 
Hz, 3H), 7.33–7.24 (m, 1H), 7.23–7.12 (m, 2H), 4.55 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 
ν / cm–1) 
3448, 1646, 1639, 1599, 1540, 1508, 1438, 1322, 1253, 1176, 1003, 889, 753, 690; HRMS (ESI
+
) 
Calcd for C13H11NOS (M+Na
+
) 252.0454, Found 252.0454. 
 
2–Mercapto–N–(4–methylphenyl)benzamide (1c). p–Toluidine (3.82 g, 
35.7 mmol), instead of aniline, was used following the general procedure. 
Purification: crystallization from Et2O/hexane (1/1). 3.47 g, 96%, white 
solid. TLC (hexane/AcOEt = 3/1): Rf = 0.15, 
1
H NMR (500 MHz, CDCl3) δ 7.81 (brs, 1H), 7.55 
(d, J = 7.4 Hz, 1H), 7.49 (d, J = 7.5 Hz, 2H), 7.34 (d, J = 7.4 Hz, 1H), 7.28 (dd, J = 7.4, 7.4 Hz, 
1H), 7.17 (m, 3H), 4.65 (brs, 1H), 2.34 (s, 3H);
 13
C NMR (125 MHz, CDCl3) δ 166.8, 135.2, 
134.8, 133.7, 133.2, 131.5, 131.1, 129.8, 128.2, 125.6, 120.6, 21.2; IR (KBr, ν / cm–1) 3435, 1644, 
1514, 1403, 1321, 1300, 1253, 1113, 1060, 1038, 941, 894, 814, 785, 741, 652; HRMS (ESI
+
) 
Calcd for C17H11NOS (M+Na
+
) 264.0454, Found 264.0456. HRMS (ESI
+
) Calcd for C14H13NOS 
(M+Na
+
) 266.0610, Found 266.0610. 
 
N–(4–Fluorophenyl)–2–mercaptobenzamide (1d). 4–Fluoroaniline 
(6.51 mL, 71.3 mmol), instead of aniline, was used following the 
general procedure. Purification: crystallization from Et2O/hexane (3/1). 
6.01 g, 82%, white solid, TLC (hexane/AcOEt = 3/1): Rf = 0.39, 
1
H 
NMR (500 MHz, DMSO) δ 10.44 (brs, 1H), 7.75 (dd, J = 8.9, 8.9 Hz, 2H), 7.62 (d, J = 7.7 Hz, 
1H), 7.50 (d, J = 7.7 Hz, 1H), 7.36 (td, J = 7.7, 1.2 Hz, 1H), 7.26 (d, J = 7.7 Hz, 1H), 7.24–7.14 
(m, 2H), 5.28 (brs, 1H);
 13
C NMR (100 MHz, DMSO) δ 166.4, 158.3 (J = 238 Hz), 135.4 (J = 2.4 
Hz), 133.9, 133.2, 130.6, 128.6, 124.7, 121.7 (J = 8.4 Hz), 115.3 (J = 22.7 Hz); IR (KBr, ν / cm–1) 
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3333, 2955, 2928, 2856, 1634, 1540, 1457,1433, 1314, 1038, 742; HRMS (ESI
+
) Calcd for 
C13H10FNOS (M+Na
+
) 270.0359, Found 270.0357. 
 
N–(4–Cyanophenyl)–2–mercaptobenzamide (1e). 4–
aminobenzonitrile (3.37 g, 11.9 mmol), instead of aniline, was used 
following the general procedure. Purification: crystallization from 
Et2O/hexane (3/1). 1.84 g, 61%, light yellow solid, TLC 
(hexane/AcOEt = 2/1): Rf = 0.31, 
1
H NMR (400 MHz, CDCL3) δ 7.81–7.74 (m, 2H), 7.67–7.56 
(m, 3H), 7.34 (m, 2H), 7.22 (t, J = 7.4 Hz, 1H), 4.35 (s, 1H). 
13
C NMR (100 MHz, CDCL3) δ 
166.8, 142.0, 133.54, 133.49, 132.8, 132.0, 131.8, 128.4, 125.9, 120.2, 119.0, 107.8; IR (KBr, ν / 
cm
–1
) 3446, 2887, 2778, 2359, 2342, 1637, 1541, 1275, 1104, 749, 668, 648; HRMS (ESI+) 
Calcd for C14H10N2OS (M+Na
+
) 277.0406, Found 277.0415.  
 
N–(2–Bromo–4–methylphenyl)–2–mercaptobenzamide (1h). 2–
Bromo–4–methylaniline (3.98 g, 21.4 mmol), instead of aniline, was used 
following the general procedure. Purification: crystallization from 
Et2O/hexane (2/1). 2.57 g, 90%, white solid, TLC (hexane/AcOEt = 3/1): 
Rf = 0.25, 
1
H NMR (500 MHz, CDCl3) δ 8.36 (s, 1H), 8.22 (s, 1H), 7.66 (d, J = 8.0 Hz, 1H), 7.44 
(d, J = 8.0 Hz, 1H), 7.40 (d, J = 8.0 Hz, 1H), 7.36–7.32 (m, 1H), 7.27–7.22 (m, 1H), 6.86 (d, J = 
8.0 Hz, 1H), 4.59 (d, J = 0.8 Hz, 1H), 2.37 (s, 3H);
 13
C NMR (125 MHz, CDCl3) δ 166.5, 139.0, 
135.4, 134.6, 132.9, 132.1, 131.9, 131.5, 128.0, 126.8, 125.8, 122.8, 110.8, 21.6; IR (KBr, ν / cm–
1
) 3257, 1643, 1526, 1474, 1303, 1029, 797, 740; HRMS (ESI
+
) Calcd for C14H12BrNOS (M+Na
+
) 
343.9715, Found 343.9711. 
 
N–(2,6–Dimethylphenyl)–2–mercaptobenzamide (1i). 2,6–
Dimethylaniline (2.59 g, 21.4 mmol), instead of aniline, was used 
following the general procedure. Purification: crystallization from 
Et2O/hexane (1/1). 2.08 g, 90%, yellow white solid, TLC (hexane/AcOEt = 
3/1): Rf = 0.11, 
1
H NMR (500 MHz, CDCl3) δ 7.63 (d, J = 7.7 Hz, 1H), 7.38 (d, J = 7.7 Hz, 2H), 
7.32 (dd, J = 7.7, 7.7 Hz, 1H), 7.23–7.04 (m, 4H), 4.84 (s, 1H), 2.30 (s, 6H); 13C NMR (125 MHz, 
CDCl3) δ 167.5, 135.8, 133.6, 133.5, 131.4, 131.1, 128.5, 128.2, 128.1, 127.9, 125.5, 18.8; IR 
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(KBr, ν / cm–1) 3433, 2956, 2928, 2856, 1634, 1540, 1457, 1433, 1313, 1263, 1038, 1009, 742, 
649; HRMS (ESI
+
) Calcd for C15H15NOS (M+Na
+
) 280.0767, Found 280.0770. 
 
2–Mercapto–N–(3–pyridinyl)benzamide (1k). Pyridin–3–amine (2.01 g, 
21.4 mmol), instead of aniline, was used following the general procedure. 
Purification: crystallization from Et2O. 1.78 g, 87%, white solid, TLC 
(hexane/AcOEt = 1/1): Rf = 0.42, 
1
H NMR (500 MHz, CD3OD) δ 8.86 (d, J = 2.3 Hz, 1H), 8.31 
(dd, J = 4.5, 1.2 Hz, 1H), 8.25 (d, J = 7.9 Hz, 1H), 7.65 (dd, J = 7.9, 1.2 Hz, 1H), 7.46 (t, J = 4.5 
Hz, 1H), 7.45 (s, 1H), 7.35 (td, J = 7.9, 1.2 Hz, 1H), 7.25 (td, J = 7.9, 1.2 Hz, 1H);
 13
C NMR (125 
MHz, CD3OD) δ 169.9, 145.5, 142.4, 137.7, 135.0, 134.8, 132.4, 132.2, 129.9, 129.7, 126.2, 
125.5; IR (KBr, ν/cm–1) 3442, 2721, 1637, 1558, 1540, 1456, 1419, 1330, 1302, 1129, 1005, 742, 
630; HRMS (ESI
+
) Calcd for C12H10N2OS (M+Na
+
) 253.0406, Found 253.0407. 
 
2–Mercapto–N–(3–quinolinyl)benzamide (1l). Quinolin–3–amine 
(3.08 g, 21.4 mmol), instead of aniline, was used following the general 
procedure. Purification: crystallization from Et2O. 2.11 g, 84%, brown 
white solid, TLC (hexane/AcOEt = 1/1): Rf = 0.45, 
1
H NMR (400 
MHz, CDCl3) δ 8.95 (d, J = 2.3 Hz, 1H), 8.85 (d, J = 2.3 Hz, 1H), 8.26 (s, 1H), 8.07 (d, J = 7.8 
Hz, 1H), 7.90–7.81 (m, 1H), 7.72–7.68 (m, 1H), 7.67–7.64 (m, 1H), 7.57 (ddd, J = 7.8, 7.8, 1.3 
Hz, 1H), 7.41 (dd, J = 7.8, 1.3 Hz, 1H), 7.35 (td, J = 7.8, 1.3 Hz, 1H), 7.25 (td, J = 7.8, 1.3 Hz, 
1H); 
13
C NMR (125 MHz, CDCl3) δ 167.3, 145.5, 144.1, 133.6, 132.9, 131.9, 131.7, 131.6, 129.1, 
128.9, 128.43, 128.39, 128.1, 127.7, 125.9, 124.8; IR (KBr, ν/cm–1) 3438, 1637, 1542, 1508, 
1489, 1466, 1420, 1366, 1300, 1144, 990, 782, 741; HRMS (ESI
+
) Calcd for C16H12N2OS 
(M+Na
+
) 303.0563, Found 303.0562. 
 
N–hexyl–2–mercaptobenzamide (1m). Hexan–1–amine (3.64 g, 
35.7 mmol), instead of aniline, was used following the general 
procedure. Purification: flash column chromatography with 
hexane/EtOAc (5/1). 3.26 g, 92%, blue white solid, TLC (hexane/AcOEt = 3/1): Rf = 0.23, 
1
H 
NMR (500 MHz, CDCl3) δ 7.40 (dd, J = 7.6, 1.2 Hz, 1H), 7.30 (dd, J = 7.6, 1.2 Hz, 1H), 7.23 (td, 
J = 7.6, 1.2 Hz, 1H), 7.11 (dd, J = 7.6, 7.6 Hz, 1H), 6.14 (s, 1H), 4.75 (s, 1H), 3.41 (m, 6.9 Hz, 
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2H), 1.64–1.53 (m, 2H), 1.42–1.24 (m, 6H), 0.89 (t, J = 6.8 Hz, 3H); 13C NMR (125 MHz, CDCl3) 
δ 168.8, 133.7, 133.0, 131.1, 130.7, 128.0, 125.3, 40.3, 31.7, 29.7, 26.9, 22.8, 14.2; IR (KBr, 
ν/cm–1) 3433, 2955, 2928, 2855, 1634, 1620, 1540, 1457, 1433, 1313, 1263, 1162, 1038, 742; 
HRMS (ESI
+
) Calcd for C13H19NOS (M+Na
+
) 260.1080, Found 260.1080. 
 
N–(tert–Butyl)–2–mercaptobenzamide (1n). 2–Methylpropan–2–amine (2.27 
mL, 21.4 mmol), instead of aniline, was used following the general procedure. 
Purification: crystallization from Et2O/hexane (3/1). 1.76 g, 95%, brown white 
solid, TLC (hexane/AcOEt = 3/1): Rf = 0.27, 
1
H NMR (500 MHz, CDCl3) δ 7.39 (dd, J = 7.7, 1.3 
Hz, 1H), 7.32–7.28 (m, 1H), 7.26–7.22 (m, 1H), 7.13 (m, 1H), 5.80 (s, 1H), 4.62 (s, 1H), 1.48 (s, 
9H);
 13
C NMR (125 MHz, CDCl3) δ 168.4, 135.0, 132.3, 131.0, 130.4, 127.9, 125.4, 52.2, 29.0; 
IR (KBr, ν/cm–1) 3298, 2977, 2890, 1632, 1587, 1536, 1470, 1446, 1361, 1319, 1272, 1221, 1044, 
878, 742, 676; HRMS (ESI
+
) Calcd for C11H15NOS (M+Na
+
) 232.0767, Found 232.0764. 
 
N–(2–Mercaptophenyl)benzamide (1p). 0.75 g, 75%, white solid, TLC 
(hexane/AcOEt = 1/2): Rf = 0.15, 
1
H NMR (500 MHz, CDCl3) δ 8.94 (s, 
1H), 8.50 (d, J = 7.8 Hz, 1H), 7.73–7.66 (m, 2H), 7.56 (dd, J = 7.8, 7.8 Hz, 
1H), 7.50–7.41 (m, 3H), 7.31 (dd, J = 7.8, 7.8 Hz, 1H), 6.95 (td, J = 7.8, 1.0 Hz, 1H); 13C NMR 
(125 MHz, CDCl3) δ 165.2, 140.2, 136.9, 134.6, 132.6, 132.3, 129.1, 127.3, 124.6, 123.7, 120.8; 
IR (KBr, ν/cm–1) 3445, 3120, 2980, 2960, 1681, 1577, 1509, 1478, 1433, 1313, 1225, 963, 766, 
729, 688, 623; HRMS (ESI
+
) Calcd for C13H11NOS (M+Na
+
) 252.0454, Found 252.0451. 
 
Methyl 2–(2–mercaptobenzamido)acetate (1q). 1.02 g, 76%, yellow oil, 
TLC (hexane/AcOEt = 1/2): Rf = 0.35,
 1
H NMR (400 MHz, CDCl3) δ 
7.78 (d, J = 7.6 Hz, 1H), 7.56 (d, J = 7.6 Hz, 1H), 7.45–7.35 (m, 1H), 
7.29–7.19 (m, 1H), 6.64 (s, 1H), 4.23 (d, J = 5.1 Hz, 2H), 3.81 (s, 3H); 13C NMR (125 MHz, 
CDCL3) δ 170.5, 167.9, 137.7, 133.4, 131.9, 128.2, 127.9, 126.6, 52.8, 42.0; IR (KBr, ν/cm
–1
) 
3420, 2924, 2851, 1748, 1734, 1646, 1636, 1541, 1212, 1173, 1092, 801, 745, 635; HRMS (ESI
+
) 
Calcd for C10H11NO3S (M+Na
+
) 248.0352, Found 248.0350. 
 
Typical procedure for copper–catalyzed intramolecular N–S bond formation: Synthesis of 
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2–phenylbenzo[d]isothiazol–3(2H)–one (2a). A mixture of 2–mercapto–N–phenylbenzamide 
(1a, 45.9 mg, 0.20 mmol), CuI (0.11 mg, ), and DMF (2.0 mL) was stirred at 70 °C 
for 5 h under oxygen. Then, the reaction mixture was cooled to room temperature, diluted with 
water, and extracted with ethyl acetate. The organic layer was dried over sodium sulfate. After 
filtration and removal of the solvent in vacuo, the residue was subjected 
to the flash column chromatography on silica gel with hexane/AcOEt (3/1) 
as eluent to give 2–phenylbenzo[d]isothiazol–3(2H)–one (2a, white solid, 
45.6 mg, >99% yield). TLC (hexane/AcOEt = 2/1): Rf = 0.43, 
1
H NMR (500 MHz, CDCl3) δ 
8.09 (d, J = 7.7 Hz, 1H), 7.70 (d, J = 7.7 Hz, 2H), 7.63 (dd, J = 7.7, 7.7 Hz, 1H), 7.55 (d, J = 7.7 
Hz, 1H), 7.50–7.39 (m, 3H), 7.30 (t, J = 7.7 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 164.2, 140.0, 
137.4, 132.5, 129.5, 127.3, 127.2, 125.9, 125.0, 124.7, 120.3; IR (KBr, ν/cm–1) 3447, 1653, 1592, 
1487, 1448, 1323, 1301, 1267, 1114, 1017, 753, 737, 688, 670, 609; HRMS (ESI
+
) Calcd for 
C13H9NOS (M+Na
+
) 250.0297, Found 250.0299. 
 
2–(4–Methoxyphenyl)benzo[d]isothiazol–3(2H)–one (2b). 48.6 mg, 
95%, white solid, TLC (hexane/AcOEt = 3/1): Rf = 0.29, 
1
H NMR 
(500 MHz, CDCl3) δ 8.09 (d, J = 7.6 Hz, 1H), 7.64 (dd, J = 7.6, 7.6 Hz, 
1H), 7.57–7.53 (m, 3H), 7.43 (dd, J = 7.6, 7.6 Hz, 1H), 7.02–6.90 (m, 2H), 3.83 (s, 3H); 13C 
NMR (125 MHz, CDCl3) δ 164.5, 158.9, 140.2, 132.3, 129.9, 127.3, 127.0, 125.9, 124.8, 120.3, 
114.8, 55.8; IR (KBr, ν/cm–1) 3465, 2835, 1651, 1508, 1447, 1329, 1297, 1248, 1179, 1128, 1030, 
972, 860, 826, 783, 738, 671; HRMS (ESI
+
) Calcd for C14H11NO2S (M+Na
+
) 280.0403, Found 
280.0402. 
 
2–(p–Tolyl)benzo[d]isothiazol–3(2H)–one (2c). 45.8 mg, 95%, white 
solid, TLC (hexane/AcOEt = 3/1): Rf = 0.54, 
1
H NMR (500 MHz, CDCl3) 
δ 7.81 (dd, J = 8.0, 8.0 Hz, 1H), 7.40–7.32 (m, 1H), 7.27 (m, 3H), 7.18–
7.10 (m, 1H), 6.98 (d, J = 8.0 Hz, 2H), 2.10 (s, 3H);
 13
C NMR (125 MHz, CDCl3) δ 164.4, 140.2, 
137.4, 134.8, 132.4, 130.1, 127.3, 125.9, 125.1, 124.9, 120.3, 21.3; IR (KBr, ν/cm–1) 3458, 1644, 
1505, 1447, 1330, 1313, 1269, 1127, 928, 883, 814, 786, 749, 676, 636; HRMS (ESI
+
) Calcd for 
C14H11NOS (M+Na
+
) 264.0454, Found 264.0456. 
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2–(4–Fluorophenyl)benzo[d]isothiazol–3(2H)–one (2d). 46.5 mg, 
95%, white solid, TLC (hexane/AcOEt = 3/1): Rf = 0.32, 
1
H NMR (500 
MHz, CDCl3) δ 8.06 (d, J = 7.9 Hz, 1H), 7.69–7.59 (m, 3H), 7.55 (d, J 
= 7.9 Hz, 1H), 7.42 (dd, J = 7.9, 7.9 Hz, 1H), 7.13 (dd, J = 7.9, 7.9 Hz, 2H);
 13
C NMR (125 MHz, 
CDCl3) δ 164.3, 161.3 (J = 246 Hz), 139.9, 133.2, 132.6, 127.3, 126.9 (J = 8.4 Hz), 126.0, 124.6, 
120.3, 116.4 (J = 22.7 Hz); IR (KBr, ν/cm–1) 3450, 1657, 1599, 1505, 1460, 1447, 1417, 1333, 
1310, 1298, 1233, 1159, 1127, 824, 802, 732, 669; HRMS (ESI
+
) Calcd for C13H8FNOS (M+Na
+
) 
268.0203, Found 268.0204. 
 
4–(3–Oxobenzo[d]isothiazol–2(3H)–yl)benzonitrile (2e). 50.2 mg, 
99%, white solid, TLC (hexane/AcOEt = 3/1): Rf = 0.30, 
1
H NMR 
(500 MHz, CDCL3) δ 8.10 (d, J = 7.8 Hz, 1H), 7.99–7.92 (m, 2H), 7.78–7.68 (m, 3H), 7.60 (d, J 
= 7.8 Hz, 1H), 7.47 (dd, J = 11.3, 4.3 Hz, 1H). 
13
C NMR (125 MHz, CDCL3) δ 164.4, 141.8, 
139.4, 133.5, 133.4, 127.7, 126.5, 124.8, 123.5, 120.4, 118.5, 109.7; IR (KBr, ν/cm–1) 3446, 2887, 
2778, 2359, 2342, 1637, 1541, 1275, 1104, 749, 668, 648; HRMS (ESI+) Calcd for C14H8N2OS 
(M+Na
+
) 275.0255, Found 275.0261. 
 
2–(2–Bromophenyl)benzo[d]isothiazol–3(2H)–one (2f). 59.8 mg, 98%, 
brown solid, TLC (hexane/AcOEt = 3/1): Rf = 0.36, 
1
H NMR (400 MHz, 
CDCl3) δ 8.16–8.12 (m, 1H), 7.74 (dd, J = 7.8, 1.6 Hz, 1H), 7.71–7.66 (m, 
1H), 7.62–7.58 (m, 1H), 7.46 (m, 3H), 7.34 (ddd, J = 7.8, 7.8, 1.6 Hz, 1H); 
13
C NMR (125 MHz, CDCl3) δ 164.9, 141.5, 135.5, 134.1, 132.7, 131.5, 131.2, 128.7, 127.6, 
126.0, 124.3, 123.6, 120.5; IR (KBr, ν/cm–1) 3446, 3063, 1667, 1595, 1471, 1445, 1328, 1309, 
1250, 1131, 1047, 782, 755, 739, 671, 656, 613; HRMS (ESI
+
) Calcd for C13H8BrNOS (M+Na
+
) 
327.9402, Found 327.9398. 
 
2–(2–Iodophenyl)benzo[d]isothiazol–3(2H)–one (2g). Reaction 
conditions: DMSO (2 mL), 100 
o
C, 5 h. Purification: silica gel column 
chromatography (hexane/AcOEt = 1/1), 58.6 mg, 83%, brown solid, TLC 
(hexane/AcOEt = 3/1): Rf = 0.28, 
1
H NMR (500 MHz, CDCl3) δ 8.14 (d, J 
= 8.0 Hz, 1H), 7.98 (d, J = 8.0 Hz, 1H), 7.71–7.66 (m, 1H), 7.62–7.58 (m, 1H), 7.50–7.41 (m, 
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3H), 7.19–7.15 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 164.7, 141.4, 140.4, 139.1, 132.7, 131.3, 
130.9, 129.7, 127.7, 126.0, 123.9, 120.6, 99.7; IR (KBr, ν/cm–1) 3447, 2921, 1660, 1596, 1464, 
1447, 1328, 1308, 1250, 1131, 1019, 908, 781, 755, 738, 670, 613; HRMS (ESI
+
) Calcd for 
C13H8INOS (M+Na
+
) 375.9263, Found 375.9258. 
 
2–(2–Bromo–4–methylphenyl)benzo[d]isothiazol–3(2H)–one (2h). 
62.0 mg, 97%, white solid, TLC (hexane/AcOEt = 3/1): Rf = 0.33, 
1
H 
NMR (500 MHz, CDCl3) δ 8.12 (d, J = 8.0 Hz, 1H), 7.67 (td, J = 8.0, 
1.5 Hz, 1H), 7.58 (d, J = 8.0 Hz, 2H), 7.45 (dd, J = 8.0, 8.0 Hz, 1H), 
7.30 (d, J = 1.5 Hz, 1H), 7.14 (dd, J = 8.0, 1.5 Hz, 1H), 2.35 (s, 3H);
 13
C NMR (125 MHz, CDCl3) 
δ 165.0, 141.5, 139.1, 135.1, 133.6, 132.6, 132.1, 132.0, 127.6, 125.9, 123.7, 120.7, 120.5, 21.0; 
IR (KBr, ν/cm–1) 3446, 1645, 1474, 1444, 1400, 1324, 1308, 1249, 1113, 1038, 1017, 810, 785, 
737, 670, 623; HRMS (ESI
+
) Calcd for C14H10BrNOS (M+Na
+
) 341.9559, Found 341.9557. 
 
2–(2,6–Dimethylphenyl)benzo[d]isothiazol–3(2H)–one (2i). 50.1 mg, 
98%, white solid, TLC (hexane/AcOEt = 3/1): Rf = 0.38, 
1
H NMR (500 
MHz, CDCl3) δ 8.14 (d, J = 7.8 Hz, 1H), 7.72–7.64 (m, 1H), 7.61 (d, J = 
8.0 Hz, 1H), 7.45 (m, 1H), 7.29–7.24 (m, 1H), 7.17 (d, J = 7.8 Hz, 2H), 2.20 (s, 6H); 13C NMR 
(125 MHz, CDCl3) δ 164.6, 141.6, 138.4, 133.6, 132.3, 129.9, 128.8, 127.6, 125.7, 124.4, 120.7, 
18.2; IR (KBr, ν/cm–1) 3444, 2951, 2919, 2854, 1653, 1598, 1471, 1445, 1325, 1307, 1245, 1129, 
775, 740; HRMS (ESI
+
) Calcd for C15H13NOS (M+Na
+
) 278.0610, Found 278.0607. 
 
2–(1–Naphthalenyl)benzo[d]isothiazol–3(2H)–one (2j). 52.8 mg, 95%, white 
solid, TLC (hexane/AcOEt = 3/1): Rf = 0.30, 
1
H NMR (500 MHz, CDCl3) δ 8.19 
(d, J = 7.8 Hz, 1H), 7.99–7.92 (m, 2H), 7.73 (d, J = 7.8 Hz, 1H), 7.70 (d, J = 7.8 
Hz, 1H), 7.63 (d, J = 7.8 Hz, 2H), 7.59–7.47 (m, 4H); 13C NMR (125 MHz, CDCl3) 
δ 165.6, 141.7, 134.7, 132.8, 132.6, 130.9, 130.3, 128.7, 127.9, 127.6, 127.5, 127.0, 
126.0, 125.6, 123.9, 123.2, 120.5; IR (KBr, ν/cm–1) 3444, 1659, 1596, 1507, 1446, 1394, 1305, 
1272, 1139, 908, 798, 770, 739, 672, 645, 613; HRMS (ESI
+
) Calcd for C17H11NOS (M+Na
+
) 
300.0454, Found 300.0449. 
 
4. Copper–Catalyzed Intramolecular N–S Bond Formation  
129 
 
2–(3–Pyridinyl)benzo[d]isothiazol–3(2H)–one (2k). 43.8 mg, 95%, 
brown solid, TLC (hexane/AcOEt = 2/1): Rf = 0.43, 
1
H NMR (500 MHz, 
CDCl3) δ 8.93 (d, J = 2.2 Hz, 1H), 8.53 (d, J = 3.9 Hz, 1H), 8.16 (m, 1H), 
8.09 (d, J = 8.0 Hz, 1H), 7.69–7.64 (m, 1H), 7.59 (d, J = 8.0 Hz, 1H), 7.44 (dd, J = 8.0, 8.0 Hz, 
1H), 7.40 (dd, J = 8.0, 8.0 Hz, 1H);
 13
C NMR (125 MHz, CDCl3) δ 164.6, 147.7, 145.1, 139.9, 
134.7, 133.1, 131.7, 127.5, 126.3, 124.3, 124.0, 120.5; IR (KBr, ν/cm–1) 3688, 3647, 3472, 3098, 
1670, 1652, 1574, 1481, 1446, 1424, 1322, 1301, 1133, 801, 781, 734, 699, 670, 633; HRMS 
(ESI
+
) Calcd for C12H8N2OS (M+Na
+
) 251.0250, Found 251.0240. 
 
2–(3–Quinolinyl)benzo[d]isothiazol–3(2H)–one (2l). Reaction 
conditions: DMSO (2.0 mL), 100 
o
C, 5 h. Purification: silica gel column 
chromatography (hexane/AcOEt = 1/1). 50.2 mg, 90%, brown solid, 
TLC (hexane/AcOEt = 3/1): Rf = 0.25, 
1
H NMR (500 MHz, CDCl3) δ 
9.28 (d, J = 2.6 Hz, 1H), 8.54 (d, J = 2.4 Hz, 1H), 8.15 (d, J = 7.8 Hz, 2H), 7.88 (d, J = 7.8 Hz, 
1H), 7.77–7.69 (m, 2H), 7.66–7.59 (m, 2H), 7.49 (dd, J = 7.8, 7.8 Hz, 1H); 13C NMR (125 MHz, 
CDCl3) δ 164.8, 146.8, 146.6, 140.1, 133.1, 131.4, 130.3, 130.1, 129.6, 128.1, 127.93, 127.87, 
127.6, 126.4, 124.4, 120.6; IR (KBr, ν/cm–1) 3442, 1664, 1630, 1597, 1426, 1344, 1320, 1296, 
1423, 1107, 974, 781, 733, 670; HRMS (ESI
+
) Calcd for C16H10N2OS (M+Na
+
) 301.0406, Found 
301.0409. 
 
2–Hexylbenzo[d]isothiazol–3(2H)–one (2m). 46.8 mg, >99%, pale 
yellow solid, TLC (hexane/AcOEt = 3/1): Rf = 0.52, 
1
H NMR (500 
MHz, CDCl3) δ 8.03 (d, J = 7.5 Hz, 1H), 7.62–7.57 (m, 1H), 7.57–
7.52 (m, 1H), 7.39 (ddd, J = 7.5, 7.5, 1.3 Hz, 1H), 3.89 (td, J = 7.4, 2.6 Hz, 2H), 1.82–1.68 (m, 
2H), 1.42–1.24 (m, 6H), 0.88 (t, J = 5.7 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 165.5, 140.3, 
131.8, 126.8, 125.6, 125.1, 120.5, 44.2, 31.6, 29.7, 26.5, 22.7, 14.2; IR (KBr, ν/cm–1) 3457, 2955, 
2928, 2857, 1649, 1598, 1447, 1339, 1303, 1248, 1189, 740, 673; HRMS (ESI
+
) Calcd for 
C13H17NOS (M+Na
+
) 258.0923, Found 258.0918. 
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2–(tert–Butyl)benzo[d]isothiazol–3(2H)–one (2n). 38.2 mg, 92%, white 
solid, TLC (hexane/AcOEt = 3/1): Rf = 0.55, 
1
H NMR (500 MHz, CDCl3) δ 
7.94 (d, J = 7.7 Hz, 1H), 7.55 (dd, J = 7.7, 7.7 Hz, 1H), 7.48 (d, J = 7.7 Hz, 
1H), 7.34 (dd, J = 7.7, 7.7 Hz, 1H), 1.69 (s, 9H);
 13
C NMR (125 MHz, CDCl3) δ 165.8, 139.6, 
131.5, 127.1, 126.3, 125.3, 119.9, 58.9, 28.6; IR (KBr, ν/cm–1) 3479, 3065, 2970, 2929, 1644, 
1594, 1540, 1394, 1365, 1324, 1303, 1204, 1155, 786, 741, 675; HRMS (ESI
+
) Calcd for 
C11H13NOS (M+Na
+
) 230.0616, Found 230.0608. 
 
2–Allylbenzo[d]isothiazol–3(2H)–one (2o). 36.2 mg, 95%, yellow white 
solid, TLC (hexane/AcOEt = 3/1): Rf = 0.35, 
1
H NMR (500 MHz, CDCl3) δ 
8.03 (d, J = 8.2 Hz, 1H), 7.59 (m, 1H), 7.54 (d, J = 8.0 Hz, 1H), 7.39 (dd, J = 
7.6, 7.6 Hz, 1H), 5.93 (ddt, J = 17.8, 12.0, 7.4 Hz, 1H), 5.33 (ddt, J = 17.8, 1.1, 1.0 Hz, 1H), 5.30 
(ddt, J = 12.0, 1.3, 1.1 Hz, 1H), 4.56 (ddd, J = 7.4, 1.3, 1.0 Hz, 2H); 
13
C NMR (125 MHz, CDCl3) 
δ 165.3, 140.6, 132.6, 132.0, 126.9, 125.7, 124.9, 120.6, 119.5, 46.4; IR (KBr, ν/cm–1) 3447, 
2918, 1644, 1447, 1334, 1314, 1284, 1240, 1192, 990, 932, 785, 740, 673; HRMS (ESI
+
) Calcd 
for C10H9NOS (M+Na
+
) 214.0297, Found 214.0293. 
 
7–Thia–8–azabicyclo[4.2.0]octa–1,3,5–trien–8–yl(phenyl)methanone 
(2p). Reaction conditions: DMSO (2.0 mL), 100 
o
C, 5 h. Purification: silica 
gel column chromatography (hexane/AcOEt = 3/1). 38.0 mg, 84%, white 
solid, TLC (hexane/AcOEt = 3/1): Rf = 0.63, 
1
H NMR (500 MHz, CDCl3) δ 8.09 (m, 3H), 7.91 (d, 
J = 7.6 Hz, 1H), 7.50 (m, 4H), 7.39 (dd, J = 7.6, 7.6 Hz, 1H); 
13
C NMR (125 MHz, CDCl3) δ 
168.3, 154.4, 135.3, 133.9, 131.2, 129.3, 127.8, 126.6, 125.4, 123.5, 121.9; IR (KBr, ν/cm–1) 
3065, 3019, 1509, 1478, 1455, 1314, 1225, 1159, 1071, 963, 908, 764, 730, 688, 666, 622; 
HRMS (ESI
+
) Calcd for C13H9NOS (M+Na
+
) 250.0297, Found 250.0298. 
 
Methyl 2–(3–oxobenzo[d]isothiazol–2(3H)–yl)acetate (2q). 43.0 mg, 
96%, yellow oil, TLC (hexane/AcOEt = 1/2): Rf = 0.34, 
1
H NMR (400 
MHz, CDCl3) δ 8.06 (d, J = 7.8 Hz, 1H), 7.63 (d, J = 7.8 Hz, 1H), 7.56 (d, 
J = 7.8 Hz, 1H), 7.42 (dd, J = 7.8, 7.8 Hz, 1H), 4.62 (s, 2H), 3.79 (s, 3H); 
13
C NMR (100 MHz, 
CDCl3) δ 168.3, 166.1, 141.0, 132.6, 127.1, 125.9, 123.5, 120.6, 52.9, 44.8; IR (KBr, ν/cm
–1
) 
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3446, 1749, 1647, 1636, 1339, 1316, 1213, 1088, 742; HRMS (ESI
+
) Calcd for C10H9NO3S 
(M+Na
+
) 246.0195, Found 246.0186. 
 
N,N'–(Hexane–1,6–diyl)bis(2–mercaptobenzamide) 
(3). 3.43 g, 93%, light green solid, TLC 
(hexane/AcOEt = 1/2): Rf = 0.18; 
1
H NMR (400 MHz, 
DMSO) δ 8.51 (s, 2H), 7.47 (d, J = 7.5 Hz, 2H), 7.40 
(d, J = 7.5 Hz, 2H), 7.27 (dd, J = 7.5, 7.5 Hz, 2H), 7.15 (dd, J = 7.5, 7.5 Hz, 2H), 5.36 (s, 2H), 
3.29–3.11 (m, 4H), 1.52 (m, 4H), 1.36 (m, 4H); 13C NMR (125 MHz, CDCl3) δ 168.9, 133.7, 
133.1, 131.2, 130.8, 128.1, 125.5, 39.8, 29.7, 26.4; IR (KBr, ν/cm–1) 3455, 3010, 2920, 1702, 
1637, 1540, 1424, 1368, 1317, 1236, 1093, 744; HRMS (ESI
+
) Calcd for C20H24N2O2S2 (M+Na
+
) 
411.1171, Found 411.1156. 
 
2,2'–(Hexane–1,6–diyl)bis(benzo[d]isothiazol–3(2H)–
one) (4). 66.0 mg, 87%, white solid, TLC (hexane/AcOEt 
= 1/2): Rf = 0.34; 
1
H NMR (400 MHz, CDCl3) δ 8.02 (d, 
J = 7.5 Hz, 2H), 7.59 (dd, J = 7.5, 7.5 Hz, 2H), 7.54 (d, J 
= 7.5 Hz, 2H), 7.40 (dd, J = 7.5, 7.5 Hz, 2H), 3.89 (t, J = 7.1 Hz, 4H), 1.81–1.73 (m, 4H), 1.50–
1.41 (m, 4H);
 13
C NMR (125 MHz, CDCl3) δ 165.6, 140.3, 131.9, 126.9, 125.7, 125.0, 120.6, 
44.0, 30.0, 26.4; IR (KBr, ν/cm–1) 3453.9, 2929.3, 2856.1, 2799.2, 1638.2, 1459.9, 1446.4, 
1187.9, 1160.0, 1100.2, 786.8, 741.5, 674.0; HRMS (ESI
+
) Calcd for C20H20N2O2S2 (M+Na
+
) 
407.0858, Found 407.0840. 
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5. Molybdenum–Mediated Desulfurization of Thiols and Disulfides 
5.1. Introduction 
   I realized a copper–catalyzed N–S bond formation reaction in Project 4. I herein developed a 
molybdenum–catalyzed desulfurization reaction. Desulfurization reactions are important in 
organic syntheses,
1
 production of non–polluting fuels,2 and decomposition of sulfur–containing 
wastes to reduce the environmental burden of industrial processes. Desulfurization reactions have 
a long history and several methods have been developed. Reductive desulfurization using Raney 
nickel is one of the most important and practically useful methods (Figure 5-1a).
3
 Despite its 
wide application, this method has several problems, such as catalyst instability (unstable to air 
and ignitable), poor functional group tolerance, and formation of toxic H2S gas. Several other 
desulfurization methods are available that use the following compounds: nickel boride (Figure 
5-1b);
4
 sodium hydride containing Ni complex reducing reagents (Figure 5-1c);
5
 Fe3(CO)12 or 
Co2(CO)8 under phase transfer catalysis (Figure 5-1d);
6
 carbon monoxide and water in the 
presence of Co2(CO)8 at high temperature under high pressure (Figure 5-1e);
7
 Co–Mo/Al2O3 
catalyst at high temperature (Figure 5-1f);
8
 molybdenum vapor (Figure 5-1g);
9
 Mo(110);
10
 and 
formic acid at high temperature (Figure 5-1h).
11
 Only a few examples of desulfurization reactions 
with high functional group tolerance and high transformation, however, are reported. I realized 
molybdenum–mediated desulfurization of thiophenols, benzylic thiols, primary and secondary 
alkanethiols, and disulfides. This desulfurization reaction has wide substrate scope and high 
functional group tolerance. One of superiorities is that molybdenum salts are very stable in air or 
moisture, which are easy to be operated and measured. 
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5.2. Optimization Studies 
   I used 2–mercapto–N–methyl–N–phenylbenzamide (1a) as a starting material. When I 
modified the reaction conditions, I found that the selection of a transition metal complex was 
quite important in this reaction, and a series of transition–metal carbonyl complexes were 
investigated. The desulfurization reaction only proceeded using molybdenum hexacarbonyl 
(Mo(CO)6). However, only a trace amount of desulfurized product was formed in DMF when 
using the following other transition metal carbonyl complexes: Cr(CO)6, W(CO)6, MnBr(CO)5, 
Mn2(CO)10, Re2(CO)10, ReBr(CO)5, [ReBr(CO)3(thf)]2, CpRe(CO)3, Fe(CO)5, Fe2(CO)9, 
Fe3(CO)12, Ru3(CO)12, [CpFe(CO)2]2, [CpRu(CO)2]2, RuHCl(CO)(PPh3)3, Co2(CO)8, 
[RhCl(CO)4]2, Ir4(CO)12, and IrH(CO)(PPh3)3. The desulfurization reaction proceeded in many 
organic solvents using Mo(CO)6 (Table 5-1, entries 1–17). When acetone was used as a solvent, 
the yield was improved by decreasing both the reaction temperature and the reaction time: 
treatment of 2–mercapto–N–methyl–N–phenylbenzamide (1a) with 1.0 equiv of Mo(CO)6 in 
acetone at 120 °C for 6 h gave desulfurized product 2a in 81% yield (entry 18).
12,13,14
  In this 
reaction, the amide group remained unchanged and did not inhibit the desulfurization. 
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5.3. Substrate Scope and Mechanism Research 
With the best reaction conditions in hand, I then investigated the substrate scope of the 
molybdenum–catalyzed desulfurization reaction (Table 5-2). The desulfurization reaction 
proceeded in good to excellent yields when thiophenol derivatives 2b–2k were used as substrates 
(entries 1–10). The desulfurization reaction was not affected by the electronic effect (entries 2–5) 
and steric effect (entries 2–10). In addition, the functional groups, such as methoxy, fluoro, chloro, 
bromo, cyano, ester, amide, and pyridyl groups (entries 2–8), and C=C double bond (entry 15) 
were intact, whereas several functional groups, such as bromo
15
 and cyano
16
 groups and the C=C 
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double bond,
17
 are unstable by using the Raney nickel method. Desulfurization of benzyl thiol 1l 
as well as primary and secondary alkanethiols 1m–1p also proceeded in 66%–85% yields (entries 
11–15). Interestingly, the desulfurization reaction also proceeded using disulfides 1q and 1r as 
substrates (entries 16 and 17). A driving force behind the desulfurization reaction is the strong 
molybdenum–sulfur bond (Hf = 659 kJ/mol).
18
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To elucidate the hydrogen source, I performed the reaction using thiophenol 1a or disulfide 1r 
with Mo(CO)6 in acetone–d6 (eq 5-1 and 5-2). Non–deuterated amide 2a was formed from thiol 
1a in 79% yield (eq 5-1). In the case of disulfide 1r, deuterated amide 2a–d was obtained in 83% 
yield [D: >99%] (eq 5-2). These results suggest that the hydrogen sources of 1a and 1r are the 
hydrogen atoms of an SH group and acetone (solvent), respectively.  
 
 
 
The proposed mechanism of the desulfurization reaction is as follows (Scheme 5-1): (1) 
oxidative addition of a thiol to a molybdenum center;
19
 (2) formation of molybdenum–carbon 
bond via the formation of a Mo=S double bond;
19
 and (3) reductive elimination to give a 
desulfurized product (Figure 5-1a). In the case of disulfides, the following mechanism is 
proposed: (i) oxidative addition of a disulfide to a molybdenum center; (ii) formation of 
molybdenum–carbon bond via the formation of Mo=S double bond(s);20 and (iii) quench of the 
organomolybdenum intermediate with acetone (solvent) to give a desulfurized product (Scheme 
1b). 
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5.4. Summary 
 
In summary, I successfully achieved a molybdenum–mediated desulfurization reaction of 
thiophenols, alkanethiols (benzylic, primary, and secondary), and disulfides. This reaction has 
high functional group tolerance, and the desulfurization reaction proceeded with maintenance of 
the functional groups, such as amide, methoxy, cyano, ester, and pyridyl groups, halogen atoms 
(fluorine, chlorine, and bromine atoms), and the C=C double bond. The functional group 
maintenance is an advantage of this method compared with the widely used reductive Raney 
nickel method. In addition, the desulfurization reaction was not affected by steric hindrance. One 
of important features of this reaction is that molybdenum is stable against air and moisture, the 
operation of this reaction is easy to carry out. The present reaction is anticipated to become a 
choice reaction for desulfurization of thiophenols, alkanethiols, and disulfides. 
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5.6. Supporting Information 
 
General. All reactions were carried out in a dry solvent under argon atmosphere unless otherwise 
noted. Mo(CO)6 (99.9%) were purchased from Aldrich. THF were purchased from Wako Pure 
Chemical Industries, and were dried and degassed before use. NMR spectra were recorded on 
JEOL ECX500 (500 MHz for 
1
H NMR and 125 MHz for 
13
C NMR) spectrometer 400 MHz (400 
MHz for 1H NMR and 100 MHz for 
13
C NMR) spectrometers. Proton chemical shifts are 
reported relative to residual solvent peak (CDCl3 at 7.26 ppm). Carbon chemical shifts are 
reported relative to residual solvent peak (CDCl3 at 77.3 ppm). The following abbreviations are 
used to designate multiplicities: s = singlet, d = doublet, t = triplet, q = quartet, quint = quintet, m 
= multiplet, br = broad. IR spectra were recorded on a JASCO FT/IR–410. High–resolution mass 
spectra (HRMS) were measured on a JEOL JMS–T100LC AccuTOF spectrometer (for HRMS). 
Compounds 2a,
1
 2b,
2
 2c,
3
 2d,
4
 2e,
5
 2f,
6
 2g,
7
 2h,
8
 2i,
9
 2j,
10
 2k,
3
 2l,
11
 2m,
12
 2n,
4
 2o,
4 
and 2p,
13
 
were known and identified by comparison with the reported 
1
H and/or 
13
C NMR spectra. 
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mixture of 2–mercapto–N–methyl–N–phenylbenzamide (1a, 24.2 mg, 0.100 mmol), Mo(CO)6 
(3.63 mg, 20.0 mol), and THF (1.0 mL) was stirred at 140 °C for 24 h. Then, the reaction 
mixture was subjected to column chromatography on silica gel (hexane/ethyl acetate = 3:1) to 
give 2a. 
 
N–Methyl–N–phenylbenzamide (2a). 17.5 mg, 83% yield, yellow solid, 1H 
NMR (500 MHz, CDCl3) δ 7.30–7.28 (m, 2H), 7.24–7.20 (m, 3H), 7.17–
7.12 (m, 3H), 7.03 (d, J = 8.0 Hz, 2H), 3.50 (s, 3H); 
13
C NMR (100 MHz, 
CDCl3) δ 170.9, 145.1, 136.1, 129.8, 129.4, 128.9, 127.9, 127.1, 126.7, 38.6. 
 
1,1'–Biphenyl (2b). 12.5 mg, 81% yield, yellow oil, 1H NMR (500 MHz, CDCl3) 
δ 7.62–7.57 (m, 4H), 7.44 (dd, J = 7.5, 7.5 Hz, 4H), 17.35 (t, J = 7.5 Hz, 2H); 13C 
NMR (126 MHz, CDCl3) δ 141.5, 129.0, 127.5, 127.4. 
 
N–(4–Methoxyphenyl)benzamide (2c). 18.0 mg, 79% yield, white 
solid, 
1
H NMR (400 MHz, CDCl3) δ 7.89–7.82 (m, 3H), 7.55–7.51 (m, 
3H), 7.44 (dd, J = 7.4, 7.4 Hz, 2H), 6.88 (d, J = 8.2 Hz, 2H), 3.80 (s, 
3H); 
13
C NMR (100 MHz, CDCl3) δ 165.8, 156.8, 135.3, 131.9, 131.2, 129.0, 127.2, 122.4, 114.5, 
55.7.  
 
N–(4–Fluorophenyl)benzamide (2d) 17.2 mg, 80% yield, white solid, 
1
H NMR (500 MHz, CDCl3) δ 7.86 (d, J = 8.4 Hz, 2H), 7.80 (s, 1H), 
7.63–7.54 (m, 3H), 7.49 (dd, J = 7.6, 7.6 Hz, 2H), 7.07 (dd, J = 8.4, 8.4 
Hz, 2H); 
13
C NMR (126 MHz, CDCl3) δ 165.9, 159.3 (d, J = 244 Hz), 135.0, 134.1 (d, J = 3.3 
Hz), 132.2, 129.1, 127.2, 122.3 (J = 7.5 Hz), 116.0 (J = 22.7 Hz). 
 
N–(2–Bromophenyl)benzamide (2e). 19.9 mg, 72% yield, white solid, 1H 
NMR (500 MHz, CDCl3) δ 8.56 (d, J = 7.9 Hz, 1H), 8.47 (s, 1H), 7.94 (d, J 
= 7.4 Hz, 2H), 7.59–7.51 (m, 4H), 7.38 (dd, J = 7.9, 7.9 Hz, 1H), 7.02 (dd, J 
= 7.3, 7.3 Hz, 1H); 
13
CNMR (126 MHz, CDCl3) δ 165.5, 136.1, 134.9, 
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132.5, 132.4, 129.2, 128.8, 127.4, 125.5, 122.0, 114.0. 
 
N–(4–Cyanophenyl)benzamide (2f). 15.8 mg, 71% yield, white 
solid, 
1
H NMR (400 MHz, CDCl3) δ 8.15 (s, 1H), 7.90–7.83 (m, 2H), 
7.83–7.74 (m, 2H), 7.68–7.54 (m, 3H), 7.55–7.43 (m, 2H); 13C NMR 
(100 MHz, CDCl3) δ 166.2, 142.3, 134.3, 133.5, 132.7, 129.2, 127.4, 
120.2, 119.1, 107.5. 
 
Methyl 2–benzamidoacetate (2g). 14.3 mg, 74% yield, white solid, 1H 
NMR (500 MHz, CDCl3) δ 7.81 (d, J = 8.3 Hz, 2H), 7.52 (t, J = 6.8 Hz, 
1H), 7.44 (dd, J = 8.3, 6.8 Hz, 2H), 6.72 (s, 1H), 4.25 (d, J = 5.0 Hz, 2H), 
3.80 (s, 3H); 
13
CNMR (126 MHz, CDCl3) δ 170.8, 167.7, 133.9, 132.1, 128.9, 127.3, 52.7, 42.0. 
 
N–(Pyridin–3–yl)benzamide (2h). 14.5 mg, 73% yield, yellow solid, 1H 
NMR (500 MHz, CDCl3) δ 8.69 (s, 1H), 8.41 (s, 1H), 8.33 (d, J = 8.7 Hz, 
1H), 7.95–7.88 (m, 3H), 7.61–7.50 (m, 3H), 7.34 (d, J = 7.5 Hz, 1H); 13C 
NMR (100 MHz, CDCl3) δ 167.5, 145.5, 141.7, 138.5, 135,8, 132.6, 129.2, 
128.77, 127.3, 124.0. 
 
N–(4–Chlorophenyl)–N–methylbenzamide (2i). 17.4 mg, 73% yield, 
white solid, 
1
H NMR (400 MHz, CDCl3) δ 7.34–7.23 (m, 3H), 7.20–
7.17 (m, 4H), 6.96 (d, J = 8.5 Hz, 2H), 3.46 (s, 3H); 
13
C NMR 
(100MHz, CDCl3) δ 170.8, 143.7, 135.8, 132.3, 130.1, 129.5, 128.9, 
128.3, 128.2, 38.6.  
 
N,N–Diphenylbenzamide (2j). 24.1 mg, 88% yield, white solid, 1HNMR 
(400 MHz, CDCl3) δ 7.53–7.45 (m, 2H), 7.38–7.28 (m, 5H), 7.26 (m, 8H); 
13C NMR (100 MHz, CDCl3) δ 170.9, 144.1, 136.3, 130.4, 129.4, 129.3, 
128.1, 127.7, 126.6. 
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N–Phenylbenzamide (2k). 13.2 mg, 67% yield, white solid, 1HNMR (500 
MHz, CDCl3) δ 7.87 (d, J = 8.1 Hz, 2H), 7.82 (s, 1H), 7.65 (d, J = 8.1 Hz, 
2H), 7.56 (t, J = 6.8 Hz, 1H), 7.49 (dd, J = 8.1,6.8 Hz, 2H), 7.38 (dd, J = 8.1, 
7.4 Hz, 2H), 7.16 (t, J = 7.4 Hz, 1H); 
13
C NMR (126 MHz, CDCl3) δ 166.1, 
138.2, 135.2, 132.0, 129.3, 129.0, 127.3, 124.8, 120.5. 
 
N–Phenyl–2–(o–tolyl)acetamide (2l). 18.0 mg, 80% yield, white solid, 
1
H NMR (500 MHz, CDCl3) δ 7.39 (d, J = 8.3 Hz, 2H), 7.30–7.24 (m, 
6H), 7.13 (s, 1H), 7.08 (dd, J = 7.4, 7.4 Hz, 1H), 3.74 (s, 2H), 2.34 (s, 3H); 
13
C NMR (126 MHz, CDCl3) δ 169.2, 137.8, 137.6, 133.2, 131.2, 130.8, 129.1, 128.4, 127.0, 
124.7, 120.1, 43.1, 19.8. 
 
Octadecane (2m). 21.6 mg, 85% yield, white solid, 
1H NMR (500 MHz, CDCl3) δ 1.34–1.19 (m, 32H), 0.88 (t, J = 6.9 Hz, 6H); 
13
C NMR (126 MHz, 
CDCl3) δ 32.2, 30.0 (8C), 29.9, 29.6, 23.0, 14.4.  
 
N–Phenylpropionamide (2n). 9.8 mg, 66% yield, white solid, 1HNMR (500 
MHz, CDCl3) δ 7.52 (d, J = 7.5 Hz, 2H), 7.32 (dd, J = 7.5,7.5 Hz, 2H), 7.17 (s, 
1H), 7.10 (t, J = 7.5 Hz, 1H), 2.40 (q, J = 7.4 Hz, 2H), 1.25 (t, J = 7.4 Hz, 3H); 
13C NMR (126 MHz, CDCl3) δ 172.2, 138.2, 129.2, 124.4, 120.0, 31.0, 9.9. 
 
N–Phenylacetamide (2o). 10.0 mg, 74% yield, white solid, 1H NMR (500 MHz, 
CDCl3) δ 7.49 (d, J = 7.7 Hz, 2H), 7.45 (s, 1H), 7.31 (dd, J =7.7, 7.7 Hz, 2H), 7.10 
(t, J = 7.7 Hz, 1H), 2.16 (s, 3H); 
13
C NMR (126 MHz, CDCl3) δ 168.7, 138.1, 
129.2, 124.5, 120.2, 24.8. 
 
Cholest–5–ene (2p). 30.0 mg, 81% yield, white solid, 1H NMR 
(500 MHz, CDCl3) δ 5.34–5.20(m, 1H), 2.34–2.17 (m, 1H), 2.05–
1.92 (m, 3H), 1.88–1.78 (m, 2H), 1.72 (d, J = 12.4 Hz, 1H), 1.63–
1.02 (m, 23H), 1.00 (s, 3H), 0.92 (d, J = 6.5 Hz, 3H), 0.87 (d, J = 
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2.2 Hz, 3H), 0.86 (d, J = 2.2 Hz, 3H), 0.68 (s, 3H); 
13
C NMR (126 MHz, CDCl3) δ 143.9, 119.2, 
57.1, 56.4, 50.8, 42.6, 40.14, 40.12, 39.8, 37.8, 36.5, 36.1, 33.2, 32.15, 32.14, 28.5, 28.32, 28.27, 
24.5, 24.1, 23.1, 22.8, 21.0, 19.7, 19.0, 12.1.  
 
Deuterated N–methyl–N–phenylbenzamide (2a–d). 1H NMR (500 MHz, 
CDCl3) δ 7.55 (d, J = 7.9 Hz, 1H), 7.25–7.05 (m, 6H), 7.05–6.88 (m, 2H), 
3.50 (s, 3H); 
13
C NMR (126 MHz, CDCl3) δ 170.9, 145.2, 136.1, 129.8, 
129.4, 129.0, 128.0, 127.8, 127.2, 126.7, 38.6 (A carbon signal which is connected to a deuterium 
atom was not observed.); HRMS (ESI+) Calcd for C14H12DNO (M+Na+) 235.0952, Found 
235.0959. 
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